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Abstract
Streptococcus pneumoniae (the pneumococcus) is a bacterial pathogen that continues to be 
associated with considerable morbidity and mortality worldwide. The infection process 
exposes the pneumococcus to numerous stress conditions, including temperature shift 
between the upper respiratory tract and deeper tissues, pH changes, exposure to reactive 
oxygen species generated by host phagocytes, and nutritional deprivation.
This thesis aimed at the investigation of the role of the stress response in the virulence 
process. The functions of caseinolytic protease specificity subunit, ClpC and the protease 
subunit, ClpP were investigated as an example of ATP-dependent proteases, hi addition, 
the role of the high temperature requirement A protein, HtrA, which is an example of the 
ATP-independent proteases, was also studied. Mutants lacking these proteins were 
constructed in different genetic backgrounds and their phenotypes were compared to the 
wild types both in vitro and in vivo.
ClpC was found to contribute to auto lysis of the pneumococcus in a strain-dependent 
manner. ClpC was required for the release of autolysin A and pneumolysin in serotype 2 S. 
pneumoniae strain T>39. In vivo, ClpC was required for the growth of the pneumococcus in 
the lungs and blood in a murine model of disease but it does not affect the overall outcome 
of pneumococcal disease. This thesis also reports the requirement of ClpP for the growth at 
elevated temperatuie and virulence of serotype 4 strain, TIGR4 and confirms its 
contribution to the thermotolerance, oxidative stress resistance and virulence of D39. Data 
also revealed that HtrA is a key vimlence factor of S. pneumoniae. The virulence of hhtrA 
mutants were completely abolished (type 2) or significantly reduced (type 4) in mouse 
pneumonia and bacteraemia models. HtrA was involved in the ability of the pneumococcus 
to grow at higher temperatures, to resist oxidative stress and to undergo genetic 
transfonnation. Fmthermore, the regulation of virulence by the two-component system 
CiaR/H was found to be mediated through HtrA. Further analysis of di.htrA mutants by 
proteomics and microaiTay is also shown in this thesis.
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INTRODUCTION
Introduction
1.1 History of the pneum ococcus
The pneumococcus, Streptococcus pneumoniae, has been one of the most extensively 
studied microorganisms since its first isolation in 1881. It was the object of many 
investigations that led to important scientific discoveries (Watson et a l, 1993). Recently, 
Rosenow has summarized the findings of the pneumococcal research between 1881 and 
1917. These are shown in table 1.1. In 1928, Griffith observed that when heat-killed 
encapsulated pneumococci and live strains constitutively lacking any capsule were 
concomitantly injected into mice, the nonencapsulated could be converted into 
encapsulated pneumococci with the same capsular type as the heat-killed strain (Watson et 
a l, 1993).
In 1933, DNA was discovered to be the basis of heritable changes in living organisms, 
when it was found that DNA from a killed pneumococcus could transform a living strain to 
a new serotype (Avery et a l, 1944). Soon after the commercial production of penicillin, it 
was recognized that penicillin resistance could similarly be transformed by DNA from 
penicillin-resistant killed pneumococcus to live susceptible strains (Hotchkiss, 1951). In 
1975, Streptococcus pneumoniae phages were first isolated from throat swabs o f healthy 
children (McDonnell et a l, 1975). These phages have represented a useful tool for 
expanding the knowledge of genetic interchange mechanisms in the pneumococcus as well 
as to gain information on the relationship between host and parasite. In recent years, 
several pneumococcal bacteriophages from different sources have been isolated and 
characterized. Lysins encoded by pneumococcal bacteriophages have been characterized 
such as lysozyme from Cp-9 and the amidase from the temperature bacteriophage HB-3. 
The structural analysis of these enzymes provided the basis to establish the hypothesis on 
the modular evolution of the pneumococcal cell wall lytic enzymes. The analysis of 
choline-binding proteins encoded by bacteriophages has also been of great relevance to 
determine the molecular basis of choline recognition (Garcia et a l, 1990, Romero et a l, 
1990, Diaz et a l, 1992).
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Table 1.1- Pneumococcus: time line of early discoveries.
Year Finding(s)/advance(s) Investigator(s)
1881 First demonstration, microscopically, of pneumococci in 
blood of rabbits that died after injection of saliva from a 
child who died of rabies (in study by Pasteur) and after 
injection of normal saliva (in study by Sternberg)
L. Pasteur (Paris), 
Sternberg (New 
York)
1883 Observation, on the basis of Gram stain, of encapsulated 
diplococci in alveolar exudates of all but a few of 50 cases 
of pneumonia; cultivation of pneumococci on Koch's 
coagulated blood semm
C. Friedlander 
(Gemiany)
1884 Isolation of pneumococcus from all cases of "fibrinous 
pneumonia," then fulfillment of Koch's postulates
A. Fraenkel 
(Germany)
1886 Separation of pneumonia into lobar, lobular, and hypostatic 
types; identification of pneumococcus with lobar types
A. Weichselbaum 
(Austria)
1891 Initial underpinnings of anti-pneumococcic-serum therapy: 
serum (postcrisis) fi'om patients with pneumonia protected 
rabbits injected with pneumococci, whereas similar serum 
(4-6 ml, subcutaneous) given to patients with pneumonia 
led, in all of them, to decrease in temperature in 6-12 h (in 2 
of these patients, it returned to nonnal, where it remained)
G. Klemperer and 
F. Klemperer 
(Germany)
1902 Capsular swelling (quelling) reaction produced by exposmn 
to homologous antiserum
F. Neufeld 
(Germany)
1910 Observation that pneumococci differ in immunologic 
properties, by use, in animals, of antiserum obtained by use 
of strains from patients with pneumonia: semm against 1 
strain (designated "typical") protected mice against majority 
of strains (all other strains were designated "atypical")
F, Neufeld and L.
Haendel
(Germany)
1913 Subdivision of pneumococci into 3 distinct groups (I-III) 
(>60% strains) and a fourth, heterogeneous gi'oup (IV), on 
the basis of homologous-semm agglutination reactions and 
mouse-protection tests
L. Gillespie and 
A. Dochez (New 
York)
1917 Demonstration of immunologic differentiation of 
pneumococci into types based on specific soluble substances 
comprising capsules
A. Dochez and O. 
Avery (New 
York)
1917 Establislrment of basis for semm therapy, by demonstration 
that, to be effective, antiserum must be type specific and 
given in adequate amounts and that, to be most effective, 
must be administered early
O. Avery, H. 
Chickering, H. 
Cole, and A. 
Dochez (New 
York)
Adapted from (Rosenow, 2004)
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Because of its importance as a human pathogen, S. pneumoniae has been studied 
intensively for many decades. In 1977, a pneumococcal vaccine based on the capsular 
polysaccharide surrounding the pneumococcal cells was licensed in South Africa 
(Austrian, 1999).
It was recently that the advent of whole-genome sequencing of microbes, including 
microbial pathogens, has revolutionized the methods by which these organisms are studied 
and has heightened expectations regarding the ability to predict potential targets for 
antimicrobial agents and vaccines (Nowak, 1995, Baltz et a l, 1998) and S. pneumoniae is 
not an exception to this approach.
1.2 Microbiology of the organism
1.2.1 Colonial morphology
Colonies of the pneumococcus on blood agar appear smooth, glistening, and flat or dome­
shaped with a diameter of 0.5-1.5 cm. Encapsulated organisms form mucoid colonies on 
agar. After 48 hours of incubation, the centre of the colony collapses due to autolysis, 
producing a doughnut or umbilicated form. If incubation exceeds 72 hours, the remainder 
of the organism spontaneously lyses and only a depression in the agar remains. Colonies of 
the pneumococcus produce greenish discolouration on blood agar (a-haemolysis) (Roberts, 
1979, Murray et a l, 1998).
1.2.2 Direct morphology
The pneumococcus is a Gram-positive coccus, which may be spherical or oval. Typically, 
it is lancet-shaped and occurs in pairs (diplococcus). The cells are 0.5-1.2 pm in diameter. 
It may also occur singly or in short chains (figure 1.1). Chain formation is more likely to 
occur in broth culture. Older cultures decolourize readily and appear Gram-negative. 
Pneumococci are non-motile and do not form spores (Roberts, 1979, Muiray et a l, 1998).
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(A) (B)
Figure 1.1- Morphology of S. pneumoniae
Electron micrographs of pneumococcal strain Rxl. (A), Growth In pairs and (B), 
chain formation, >100 cells (only part of It Is shown). Magnification x 50,000. 
Adapted from (Yother et a/., 1998).
1.2.3 Taxonomy and classification
Although the pneumococcus has for many years been referred to as either Streptococcus 
pneumoniae or Diplococcus pneumoniae, the organism has been officially classified in the 
genus Streptococcus. The similarities between the pneumococcus and other streptococci 
include the following characteristics: (1) Pneumococci grow in short chains in broth 
cultures. (2) Streptococci, including the pneumococcus, are lactic acid bacteria, which 
ferment glucose to yield lactic acid. (3) Both pneumococci and streptococci contain group- 
specific carbohydrate and M protein. However, the pneumococcal M protein is not anti­
phagocytic. (4) Antibiotic resistance and other genetic markers have been transferred from 
one species to another. (5) Nucleic acid homology; the GC content of DNA in 15 
streptococci species, including the pneumococcus, has ranged from 33-42 % (Roberts, 
1979).
Skerman and colleagues (Skerman et a i, 1980) describe the taxonomy of Streptococcus 
pneumoniae as follows: Bacteria (eubacteria), Firmicutes (Gram-positive bacteria), 
Bacillus/Clostridium group (low G+C Gram-positive bacteria), Streptococcaceae, 
Streptococcus. In addition, the capsular polysaccharide of the pneumococcus has been used 
for serological classification of strains. More than 90 serotypes are currently recognized 
(Murray et a i,  1998).
1.2.4 identification
Methods that may be used for the laboratory identification of S. pneumoniae include; Gram 
stain morphology, colony morphology and haemolysis on sheep blood agar, pyrrolidonyl
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arylamidase reactivity, opto chin susceptibility, solubility in deoxycholate (bile), 
carbohydrate utilization, latex agglutination, Quellung reaction, and DNA probes based on 
the detection of specific ribosomal RNA sequences that are unique to S. pneumoniae 
(Kellogg et a l, 2001).
For the optochin test, a disk containing ethylhydrocupreine HCl is placed on the surface of 
freshly streaked SBA plate and a zone of inliibition is measured after overnight incubation 
at 37°C in 5 % CO2 . An isolate with a zone of 14 mm or greater is considered susceptible 
(Chandler et a l,  2000). Isolates of S. pneumoniae are rapidly lysed when the autolysins are 
activated after exposure to bile. The organism can be identified presumptively by placing a 
drop of bile on an isolated colony. Most colonies of 6'. pneumoniae are solubilized within a 
few minutes. This test can also be performed by adding bile to a broth culture, which 
causes the organisms to be rapidly lysed and the broth to clear (Murray et a l,  1998). For 
the DNA probe test, 1-2 freshly propagated colonies are lysed and hybridized to a DNA 
probe, then read on luminometer. The measured relative light units (RLU) are scored as 
positive when it is more than 50,000 (Chandler et a l, 2000). The Quellung reaction, or 
capsular precipitin reaction, provides rapid identification o f pneumococci in various 
clinical specimens. The procedure is to mix loopfuls of bacteria in suspension, anti serum to 
pneumococcal capsule, and methylene blue on the surface of a glass slide and examine 
under oil immersion. If positive, the organism will be surrounded by a large capsule. The 
capsular appearance is probably due both to capsular swelling and greater refraction 
(Roberts, 1979).
Chandler and co-workers (Chandler et a l, 2000) suggested that a-haemolytic 
Streptococcus pneumoniae from an appropriate source (respiratory system, blood, 
cerebrospinal fluid) should be tested for optochin susceptibility. If the colony morphology 
is consistent with S, pneumoniae, the bile solubility or latex test could be used. The DNA 
probe could be used to evaluate any isolates giving questionable results by any of the other 
methods. Other methods currently used for the identification of the pneumococcus include 
the colony blot assay developed by Bogaert and co-workers (Bogaert et a l,  2004b), which 
allows the detection of multiple serotypes of the pneumococcus, i.e. mixed colonization 
within clinical specimens. Multilocus sequence typing (MLST) is now widely used for 
deteimining the relatedness of pneumococcal strains, through which alleles of several 
housekeeping genes are directly assessed by nucleotide sequencing, each unique allele 
combination determining a sequence type of a strain (Platonov et a l,  2000, Sa-Leao et a l, 
2001, Jefferies et a l, 2003).
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1.2.5 Nutrition and growth
Members of the genus Streptococcus are facultatively anaerobic. They are unique among 
bacteria able to grow anaerobically in that they do not synthesize poiphyiins, cytochromes 
or catalase, and are not capable of forming ATP via an electron transport system. They 
generate energy through feimentation of carbohydrates. The pneumococcus is an obligate 
parasite with nutritional requirements resembling those of the host. It is classified among 
the lactic acid bacteria, facultative anaerobes that derive energy primarily from 
fermentation of carbohydrates to lactic acid. The ability to ferment inulin differentiates 
pneumococci from most a-haemolytic streptococci. Because pneumococci lack catalase, 
the H2O2 formed during gi'owth is thought to cause loss of viability and it is not entirely 
understood how the pneumococcus can survive oxidative stress caused by its own 
production of H2 O2 . Recently, Pericone et al have shown that pyruvate oxidase (SpxB), the 
enzyme responsible for endogenous H2O2 production, was required for survival of S. 
pneumoniae during exposure to high levels of exogenously added H2O2 suggesting that 
SpxB is among the factors that contrihute to hydrogen peroxide resistance of the 
pneumococcus (Pericone et a l, 2003).
An uncommon growth requirement of the pneumococcus is choline, which is incorporated 
into cell wall teichoic acid. Choline plays a crucial role in the structure and functions of the 
cell wall, for substitution of ethanolamine for choline in a synthetic medium gives rise to 
several abnormalities: (1) the cells fail to divide normally and fonn long chains; (2) they 
are resistant to autolysis even when grown in the presence of penicillin; (3) they lose their 
ability to undergo transformation; (4) they do not adsorb phages (Austrian, 1990).
1.3 Pattern of Pneum ococcal Infection in Man
Streptococcus pneumoniae is earned asymptomatically in the upper respiratory tract by 
many healthy individuals and most infections do not occur after prolonged carriage but 
follow the acquisition of recently acquired serotypes. This suggests that the immune status 
of the host at the moment of colonization, as well as the virulence of the particular strain, 
determines whether pneumococci will remain confined to the nasopharynx or become 
invasive (Gray et a l, 1980, Johnston, 1991).
During the establishment of pneumococcal disease, pneumococci undergo spontaneous 
phase variation marked by switching from opaque to transparent colony morphotypes.
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Although the nature of the molecular switch is unknown, transparent strains are adapted for 
nasopharyngeal adherence and display less capsule, more surface choline and more of the 
adhesin, choline binding protein A (CbpA). Opaque strains show improved survival in the 
bloodstream and bear more capsule, less choline and more of the protective antigen, 
pneuomococcal surface protein A (PspA) (Kim and Weiser, 1998).
The first step in the development of pneumococcal infection in man is the colonization of 
the nasopharynx by S. pneumoniae. From this site, S. pneumoniae can gain access to the 
lung or eustachian tube. If the bacteria enter the eustachian tube and begin growing there, 
they trigger an inflammatory response that causes the pain and fever associated with the 
middle ear infection (otitis media). Evidence indicates that otitis media occurs only in the 
presence of eustachian tube dysfunction, which is caused principally by respiratory viruses 
(adenovirus, influenza) (Giebink, 1999). If the bacteria are inhaled into the lung, they 
survive by evading phagocytosis by the alveolar macrophages and cause a local 
inflammatory response that results in a breakdown of the gas exchange mechanism, and the 
patient becomes cyanotic. The classical form of pneumococcal pneumonia is rapid onset of 
symptoms, high temperature, shaking chills, a productive cough, and blood in the sputum. 
In 15-30 % of patients with pneumonia, the bacteria enter the bloodstream, where lysis of 
bacteria releases cell wall components that trigger cytokine release, resulting in fever and 
shock. Meningitis occurs when bacteria that have gained access to the bloodstream infect 
the meninges, a set of membranes that covers the brain and spinal column, protecting them 
from harmful substances in blood (blood-brain barrier). Normally only glucose and 
electrolytes can cross the blood-brain banier, but local inflammation caused by the bacteria 
breaches the blood-brain barrier and admits bacteria and phagocytes to this fragile area. 
Damage to the brain can lead to hearing loss, blindness, learning disabilities, paralysis, and 
death. Pneumococcal meningitis is characterized by fever, initability, and drowsiness in 
early stages and seizures and coma in later stages (Salyers and Whitt, 1994, Giebink, 
1999).
1.4 Virulence Factors
Pneumococci elaborate a variety of factors that contribute to virulence. These factors 
include the capsule, surface proteins like PspA, PspC and PsaA, proteins like pneumolysin 
(Ply), and others. Recent advances in the field of bacterial pathogenesis and the availability 
of genome sequence of the organism have allowed a large-scale identification of various 
genes involved in the pathogenicity of such life-threatening bacteria (Polissi et a l, 1998,
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Paten and Giammarinaro, 2001, Hava and Camilli, 2002, Marra et a l,  2002a). Figure 1.2 
shows some of the possible virulence factors of S. pneumoniae (Briles et a l, 1998).
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Figure 1.2- Hypothetical representation of the pneumococcal surface showing possible 
virulence factors.
Adapted from (Briles et a/., 1998).
1.4.1 The Capsule
The capsule surrounding the pneumococcal cell forms the outermost layer of the majority 
o f fresh clinical isolates of the pneumococcus. A total of 90 distinct types of capsule are 
currently known (Henrichsen, 1995). It consists of high-molecular weight polymers made 
up of units of repeating oligosaccharides, which can contain between two and eight 
monosaccharides (VanDam et a i, 1990). In the past, the polysaccharide capsule was 
considered the primary virulence factor of S. pneumoniae because nonencapsulated 
bacteria are almost completely harmless compared with the same encapsulated strain and 
the loss of the capsule is accompanied by a 100,000-fold reduction of virulence (Avery and 
Dubos, 1931). Capsular types were originally differentiated by the Quellung reaction in 
which addition of type specific anti serum causes agglutination and microscopically visible 
swelling of the capsule. Capsular type is classified by one of two systems: the American 
system, which assigns numbers in the chronological order of their discovery, and the 
Danish system, which is based on antigenic similarities. The lowest numbered serotypes
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such as 1 and 2 are classified identically by both systems. The Danish serotype 
nomenclature is now generally employed (VanDam et a l,  1990). Some pneumococcal 
capsular serotypes are listed in table 1.2.
Table 1.2-The capsule loci for which DNA sequence is available.
Capsule locus Reference
1 (Munoz et a l, 1997)
2 (lannelli et a l, 1999)
3 (AiTecubieta et a l, 1995, Dillard et a l, 1995)
4 (Tettelin et a l, 2001)
14 (Kolkman et al., 1997)
19A (Morona et a l, 1999b)
19B (Morona a/., 1999b)
19C (Morona a/., 1999b)
19F (Morona et a l, 1997)
23F (Morona et a l , 1999a)
33F (Llull et a l, 1998)
Adapted from {Mitchell and Kerr, 2002),
The various capsular polysaccharides in purified form are completely non-toxic and cannot 
themselves account for death from pneumococcal infection. Mizrachi Nebenzahl and co­
workers have shown that the virulence of the pneumococcus can be determined 
independently of the capsule (Mizrachi Nebenzahl et a l, 2004). However, the role of the 
capsule in pathogenicity is quite apparent in that it provides resistance to phagocytosis and 
thus promotes the escape of pneumococci fr om the host immune defence. It was found that 
nonencapsulated pneumococci are readily phagocytized when added to a suspension of 
leukocytes in normal serum, whereas mucoid capsulated organisms are resistant to 
phagocytosis and multiply rapidly (Wood and Smith, 1949). More recently, a reduction of 
vimlence was achieved by transposon mutagenesis of one gene apparently essential for 
pneumococcal type 3 capsular biosynthesis (Watson and Musher, 1990). It was also shown 
that the capsule plays an important role in the nasopharyngeal colonization. The 
requirement for the capsule in colonization may reflect its ability to prevent clearance of 
the organism by innate defences. Alternatively, or in addition, the capsule itself may be an 
adhesin (Magee and Yother, 2001) promoting adliesion of the pneumococcus to human 
cells. Moreover, Femebro et al have demonstrated that capsular polysaccharides negatively 
influence the lytic process and contribute to antibiotic tolerance in clinical isolates of 
pneumococci (Femebro et a l, 2004).
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1.4.2 Pneumolysin
Pneumolysin (Ply) is a 53-kDa protein produced by all clinical isolates of S. pneumoniae 
(Paton et a l, 1983, Paton et a l, 1993). It is an intracellular protein that belongs to the 
family o f thiol-activated toxins (Boulnois, 1992), which is widespread among Gram- 
positive pathogens. Unlike the thiol-activated toxin produced by other members of the 
family, pneumolysin lacks an N-terminal export signal sequence for transport to the 
extracellular environment (Walker et a l,  1987). Although pneumolysin is not secreted by 
pneumococci, it can be released upon lysis of pneumococci under the influence o f the 
major lytic enzyme autoiysin (LytA). The vimlence properties of Ply are therefore directly 
dependent on the action of autoiysin. However, the extracellular release of pneumolysin 
from the pneumococcal strain WU2 (type 3) was found to be independent of autoiysin 
action. A mutant lacking autoiysin showed the same pattern of pneumolysin release as the 
wild-type strain (Balachandran et a l, 2001).
The role of pneumolysin in pathogenesis has been established in several ways. It was 
found that pneumolysin-negative mutants are less vimlent than their parental strains and 
the immunization with pneumolysin prolongs the survival of mice after challenge with 
pneumococci o f different serotypes (Paton et a l, 1983, BeiTy et a l,  1989b, Alexander et 
a l, 1994). Pneumolysin has at least two biological activities that contribute to vimlence in 
animal models; lytic activity and ability to activate complement (Mitchell, 2000). Ply 
action during pneumococcal infection dismpts the alveolar-capillary boundary, which 
produces an alveolar flooding providing nutrients for bacterial growth and facilitates 
penetration through the epithelium into the bloodstream (Rubins and Janoff, 1998). 
Pneumolysin stimulates the production of inflammatory cytokines like tumor necrosis 
factor alpha and interlukin-lp by human monocytes and inliibits the beating of cilia on 
human respiratory epithelial cells (Houldsworth et a l, 1994). The ability of these cells to 
clear mucus from the lower respiratory tract is reduced and as a result, facilitates the spread 
of pneumococcal infection. Ply was also found to be responsible for hearing loss in 
experimental pneumococcal meningitis by inducing specific and devastating cochlear 
damage (Winter et a l, 1997).
1.4.3 Surface proteins
The pneumococcal cell displays a range of surface proteins that may play a role in 
pathogenesis. These proteins have a wide range of functions, including adherence to host 
tissues, binding to specific immune system components, protein processing, nutrient
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acquisition, and uptake of DNA from the environment (Overweg et a l, 2000b). Proteins 
that are attached to the cell surface can be divided into choline binding proteins (CBPs), 
LPXTG-anchored proteins, and lipoproteins. Examples of these proteins are discussed 
below.
1.4.3.1 Choline binding proteins
CBPs are proteins that are linlced to the pneumococcal cell surface by non-covalent 
interactions with cell wall phosphorylcholine. This group includes LytA, PspA, CbpA and 
others.
1.4.3.1.1 Autolysins
Autolysins are members of a widely distributed group of enzymes that degrade the 
peptidoglycan backbone of bacterial organisms. These enzymes are located in the cell 
envelope and are postulated to play a role in a variety o f physiological cell functions 
associated with cell wall gi'owth, its turnover, and cell separation in microorganisms 
(Tomasz, 1984). An example of one such enzyme is the major autolytic enzyme N- 
acetyImuramoyl-L-alanine amidase (LytA) of Streptococcus pneumoniae (Lopez et a l, 
1992). Other autolysins such as LytB have also been identified (Garcia et a l, 1999). The 
pneumococcal LytA is thought to be bound to choline moieties of lipotechoic acid, which 
in turn is anchored to the cell membrane. In this form, autoiysin is inactive but when cell 
wall biosynthesis ceases, either because of nutrient starvation or treatment with antibiotics, 
this association is disrupted and the enzyme is then able to cleave the covalent bond 
between the glycan chain and the peptide side chain of the choline-containing cell wall, 
thereby bringing about cellular autolysis (Briese and Hakenbeck, 1985).
The contribution of autoiysin to pneumococcal virulence has been studied using autolysin- 
negative mutants o f pneumococci constmcted by insertion-duplication mutagenesis (Berry 
et a l, 1992). It was found that these mutants have attenuated virulence in animal models 
compared to that of wild-type pneumococci. This suggests a role for autoiysin and possibly 
for the inflammation that follows autolysis in pneumococcal virulence and pathogenesis 
(Canvin et a l, 1995). It has been suggested that autoiysin plays its role in pathogenesis in 
two ways (1) by generating inflammatory cell wall degradation products and (2) by 
releasing the pneumococcal cytoplasmic contents, including vimlence factors such as 
pneumolysin (Mitchell et a l, 1997).
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Tuomanen et al (Tuomanen et a l, 1985) demonstrated that both peptidoglycan and 
teichoic acid components of the pneumococcal cell wall were potent mediators of 
meningeal inflammation in a rabbit model. They proposed that treatment with (3-lactam 
antibiotics, which induce autolysin-mediated release of the above components, might 
further contribute to inflammatory tissue injury and possibly mortality. Other studies on 
LytA also have shown that this amidase induces a protective response in mice to 
streptococci when inoculated in the lungs (Berry et a l,  1994, Canvin et a l, 1995). The 
degree of protection in mice immunized with autoiysin and pneumolysin were shown to be 
similar, and no additional protection was observed in animals immunized with both 
proteins. These data are consistent with the idea that the anti-autolysin antibodies exert 
their effects primarily by preventing the release of pneumolysin. On the other hand, 
autoiysin played a major effect in middle ear infection in a chinchilla otitis media model, 
where the role of Ply was more limited (Sato et a l, 1996).
Tomasz and co-workers have reported that LytA mutant strains showed the same degree of 
virulence in mice as did the isogenic LytA-H parent (Tomasz et a l ,  1988), a finding that 
contradicts other reports (Berry et a l,  1989a, Canvin et a l, 1995). Despite this controversy 
regarding the role of autoiysin in pathogenesis, its protective property for mice challenged 
with pneumococci makes it a potential component of novel anti-pneumococcal vaccines 
(Locket a l,  1992).
1.4.3.1.2 Pneumococcal surface protein A
Pneumococcal surface protein A (PspA) is a surface protein with variable molecular size 
ranging from 67 to 99 kDa. Based on sequence analysis, the protein has four distinct 
domains: an N-terminal highly charged a-helical region, a proline-rich domain, a stretch of 
10 highly conseiwed 20-amino-acid repeats, and a tail of 17 slightly hydrophobic residues 
at the C-terminus. The N-terminal portion of this choline-binding protein has been 
predicted to have a coiled-coil stmcture reminiscent of the M protein of group A 
streptococci and this might be expected to protrude through the capsule and contains the 
epitopes recognized by protective monoclonal antibodies while the C-terminal portion is 
involved in attachment of the protein to the cell (Watman et a l,  1990, Yother and Briles, 
1992).
Although the precise function of PspA is imcertain, it has been shown to inhibit 
complement activation and is proposed to exert a function in virulence by recruitment of 
the alternative complement pathway, thereby reducing the effectiveness of complement 
receptor-mediated pathways of clearance (Tu et a l, 1999). In addition, PspA functions as a
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lactofemn-binding protein and is suggested to be involved in iron uptake, thus contributing 
to pneumococcal growth under iron-limited conditions in the human host (Hammerschmidt 
et a l,  1999). It was found that immunization with rough pneumococci protected mice 
against challenge with virulence organisms, but no protection was conferred by 
immunization with rough pneumococci in which the PspA gene had been inactivated by 
insertion-duplication mutagenesis. Moreover, PspA-deficient type 2 pneumococci were 
more readily cleared from the blood of mice during the first hour after inti'avenous 
challenge than were othei*wise isogenic wild-type organisms (McDaniel et a l, 1987).
1.43.1.3 Choline binding protein A
Another example of CBPs is the choline binding protein CbpA, also referred to as PspC 
and SpsA (Hammerschmidt et a l, 1997, Brooks-Walter et a l, 1999) and was identified as 
a major pneumococcal adhesin (Rosenow et a l, 1997). It is a 110-kDa protein with eight 
choline-binding repeats that are nearly identical to PspA, with shared amino acid sequence 
in the a-helix, proline-rich, and choline-binding regions (Brooks-Walter et a l, 1999). In 
the absence of CbpA, pneumococci fail to enter and traverse an in vitro blood-brain barrier, 
indicating a critical role for this protein in invasion (Ring et a l,  1998). If the gene for 
CbpA is disrupted by insertion-duplication mutagenesis the mutant pneumococci have a 
reduced ability to bind to cytokine-activated type II pneumocytes and endothelial cells in 
vitro suggesting that this protein plays a role in adherence. Moreover, the mutant organism 
is less able to colonize the nasopharyx of infant rats (Rosenow et a l,  1997). Immunization 
with CbpA of strain D39 (PspC/D39) elicits antibodies that cross-react with PspA/D39 and 
are able to protect against pneumococcal infection. CbpA interacts with the immune 
system in a variety of ways. CbpA binds specifically to the secretory component of 
immunoglobulin A (Hammerschmidt et a l, 1997). PspC may also regulate the complement 
system by either adhering to glycoconjugates, sialic acid, and lactotetraoses on the surface 
of activated human epithelial cells or binding to the C3 component of complement system 
(Rosenow et a l,  1997, Smith and Hostetter, 2000). More recently, PspC was found to bind 
human complement factor H (Dave et a l, 2001).
1.4.3.2 LPXTG-anchored proteins
LPXTG-anchred proteins are attached to the pneumococcal cell surface by the covalent 
interaction of the conserved amino acid sequence LPXTG with the cell wall. Examples of 
this group are neuraminidase, hyaluronidase and IgAI protease.
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1,43.2.1 Neuraminidase
Neuraminidase is another potential Streptococcus pneumoniae virulence factors. The 
enzyme cleaves terminal sialic acid from cell surface glycans such as mucin, glycolipids, 
glycoproteins, and oligosaccharides, and such activity has the potential to cause great 
damage to the host. Neuraminidase might also umnask potential cell sui'face receptors for 
putative pneumococcal adhesins (Krivan et a l, 1988). At least two studies on fresh, 
clinical isolates of S. pneumoniae showed that all strains examined (104 in all) had 
neuraminidase activity (Kelly et a l,  1967, O'Toole et a l,  1971). Moreover, S. pneumoniae 
neuraminidase has been detected in 78 % of culture-positive middle ear effusions from 
patients with acute otitis media and in 96 % of S, pneumoniae positive middle ear effusions 
from patients with chronic otitis media (Diven et a l,  1988). Histochemical studies of 
organs from mice dying after intraperitoneal administration of partially purified 
pneumococcal neuraminidase have indicated marked decreases in the sialic acid contents 
of the kidneys and liver compared with those of controls (Kelly and Greiff, 1970). Coma 
and bacteraemia occur significantly more often in patients with pneumococcal meningitis 
when the concentration of N-acetylneuramic acid in the cerebrospinal fluid is elevated 
(O'Toole e ta l ,  1971).
There appear to be at least two forms of the pneumococcal neuraminidase enzymes. Nan A 
and NanB. The stmctural genes for both have been cloned and sequenced (Camara et a l, 
1994, BeiTy et a l, 1996). The benefits to the pneumococcus of production of two distinct 
neuraminidases are unclear. Apart from their difference in size, the two enzymes have 
widely different pH optima, which implies that these enzymes may assist exploitation of 
distinct environmental niches (BeiTy et a l,  1996).
The role of neuraminidase in streptococcal pathogenesis has been inferred from 
immunization studies showing that the purified protein partially protected mice against 
pneumococcal infection (Lock et a l, 1988a). Although the precise role for neuraminidase 
in the pathogenesis of S, pneumoniae has not been established, it has been proposed that 
neuraminidase could enhance colonization by decreasing viscosity of mucus or by 
exposing cell surface receptors for S. pneumoniae (Linder et a l,  1992, Rosenfeld et a l, 
1992, Linder et a l, 1994). It has been demonstrated that the treatment of chinchilla 
tracheas with neuraminidase in vitro increases S. pneumoniae adherence and reverses the 
inhibitory effects of lacto-N-neotetraose (LNnT), suggesting that neuraminidase treatment 
results in an increase in the number of available receptors of S. pneumoniae (Tong et a l,
1999). Like pneumolysin, the purified neuraminidase was toxic for mice, and 
immunization with the protein partially protected mice from challenge with virulent S.
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pneumoniae (Lock et a l, 1988a). This protection, however, was not as great as that 
achieved by immunization with pneumolysin, and no additive protection could be obtained 
when mice were immunized with both proteins. In addition, Tong and colleagues indicated 
that the disruption of nanA gene diminishes the ability of 6". pneumoniae to colonize and 
persist in the chinchilla nasophai'ynx and middle ear (Tong et a l,  2000). In a study by 
Long and co-workers, immunization of chinchillas with recombinant neuraminidase 
resulted in a significant reduction in nasopharyngeal colonization as well as in the 
incidence of otitis media with effusion (Long et a l, 2004). Recently, King et al 
demonstrated that NanA has no contribution to adherence of S. pneumoniae to epithelial 
cells or colonization in an animal model. However, they observed NanA-dependent 
desialylation of human airway components that bind to the organism and may mediate 
bacterial clearance (King et a l, 2004).
1.4.3.2.2 Hyaluronidase
Hyaluronidase is an enzyme produced by a variety of wound and mucosal pathogens, 
including the pneumococcus (Humphery, 1944). The enzyme degrades hyaluronic acid, 
which is found associated with mammalian connective tissues and extracellular matrix. 
Thus hyaluronidase might play a role in pneumococcal pathogenesis by allowing greater 
microbial access to host tissues for colonization. It may also take part in the migration of 
the organism between tissues, for example translocation from the lung to the vascular 
system. As well as playing a role in tissue integrity, hyaluronic acid also plays a role in the 
generation of the inflammatory response. Production o f hyaluronidase by the 
pneumococcus could also affect the inflammatory response in the lung (Mitchell, 2000).
Increased tissue penneability caused by the action of hyaluronidase on the extracellular 
matrix appears to play a role in wound infections, pneumonia, and other sepses such as 
bacteraemia and meningitis, hi S. pneumoniae cultures, the enzyme is found in both the 
culture and the cell-associated fractions. This may suggest at least part of the enzyme is 
released by the pathogen to surrounding host tissues during infection to facilitate the 
bacterial invasion (Berry et a l, 1994). Kostyukova and colleagues have confinned the 
hypothesis that hyaluronidase enzyme plays an important role in bacterial dissemination 
and breaching of the blood brain bairier by pneumococci. They have reported that high 
hyaluronidase activity is the most important factor contributing to the development of 
pneumococcal meningitis (Kostyukova et a l,  1995).
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1,4.3,23 IgAI Protease
Secretory IgA protects mucous membranes from attack by pathogenic microorganisms. It 
acts by neutralizing toxins, enzymes, and viruses, agglutinating bacteria, and preventing 
bacterial adhesion to mucous membranes by blocking receptors and, by virtue of its 
hydrophobic nature, causing repelling interactions with the mucosal epithelium (Liljemark 
et a l, 1979, Kilian and Russell, 1994). However, a few pathogenic bacteria such as 
Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria gonorrhoeae produce a 
variety of enzymes called IgAI pro teases. They are so called because they cleave only 
human IgAI and not the IgA2 isotype. These enzymes may be important virulence factors 
because they are produced in vivo (Blalce et a l, 1979, Insel et a l, 1982). A survey of 114 
isolates of S. pneumoniae revealed that at least 94 % demonstrated the ability to hydrolyze 
human IgAI (Lomholt, 1995). The protease in S. pneumoniae demonstrates marked 
antigenic variation, since at least 17 antigenic forms have been identified (Lomholt, 1995).
The S. pneumoniae gene encoding the IgAI enzyme has been cloned before, but instability 
prevented any further characterization (Pratt and Boulnois, 1987). More recently, Wani et 
al have succeeded to identify, clone and characterize the pneumococcal IgAI protease 
(Wani et a l, 1996) but the role of the enzyme in the virulence of the pneumococcus has 
not been investigated. Access to the cloned gene will permit construction of defined IgAI 
protease-negative mutant and will enable the assessment of the impact of such enzyme on 
the pathogenicity of the pneumococcus. Weiser and colleagues have reported a role of 
IgAI protease in the antibody-enhanced pneumococcal adlierence (Weiser et a l, 2003). 
The authors of this study provided evidence that this protease enables the pneumococci to 
subvert the antigen specificity of the humoral immune response to facilitate adhesive 
interactions and persistence on the mucosal surface.
1,4.3.3 Lipoproteins
Lipoproteins are attached to the cell surface via palmitic acid and the motif LXXC in the 
N-terminus of the protein seiwes as the point of lipidation. Pneumococcal surface adhesin 
A (PsaA) is an example of these lipoproteins. Pneumococci possess an ATP-binding 
cassette (ABC) transporter for Mn^ "^ , the Psa transporter (Dintilhac et a l, 1997, Novak et 
a l, 1998). This transporter is composed of the products of three genes, (ATP-binding 
protein), psaC  (integral membrane protein), and psaA (solute-binding lipoprotein), which 
are organized in an operon with a gene encoding PsaD, a thiol peroxidase (Novak et a l, 
1998). PsaA protein was originally identified as being located on the pneumococcal cell 
surface and acts as an adhesin and virulence factor (Berry and Paton, 1996). There is a
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recent report, however, showing that PsaA is not exposed on the surface of the bacterial 
cell, ruling out its possible function as a direct adhesin (Johnston et a l, 2004). The likely 
function of PsaA is the transport of Mn^’*' and Zn^ "*" into the cytoplasm of the bacteria 
(Beny and Paton, 1996, Dintilhac et a l, 1997). Intranasal immunization of mice with PsaA 
was observed to reduce the bacterial load in nasopharyngeal carriage (Briles et a l, 2000a,
De et a l, 2000). PsaA negative mutants of pneumococci were avimlent in a mouse model. 
Mutations in the psa operon result in an almost complete attenuation of virulence for all 
tested models of animal infection, including respiratory tract, systemic, intraperitoneal 
chamber, and otitis media models (Marra et a l, 2002b).
1.5 Com petence for genetic transform ation
Transformation is one of the simplest modes of genetic exchange and involves uptake of 
exogenous native donor DNA and subsequent homology-dependent integration into the 
recipient cliromosome. Streptococcus pneumoniae (the pneumococcus) is naturally 
competent for genetic transformation. Indeed, genetic transformation was originally 
discovered in S. pneumoniae (Griffith, 1928). Genetic transformation is likely to play a 
significant role in the lifestyle of this bacterium by favouring genetic plasticity. | 
Transformation with naked DNA allows intraspecies and interspecies gene transfer, which 
helps this human pathogen to adapt to its host and bypass host defences. Such exchanges 
involve homologous recombination and so, they did not result in the creation of novel 
sequences but simply in a redistribution of previously existing genes. Homologous 
recombination then leads to the production of mosaic genes, as exemplified in the case of 
the genes for penicillin binding proteins ipbp) of S. pneumoniae that encode altered 
penicillin-binding proteins with decreased affinity for (3-lactam antibiotics (Hakenbeck et 
a l,  1999).
1.5.1 Induction of competence
Competence, the state o f cells able to take up DNA, develops suddenly in response to a 
cell-cell signal at some point during exponential growth phase and reaches a maximum 
about 20 mill after its induction (induction phase). It then disappears abmptly (shutoff 
phase) and remains off for about 40 to 60 min during a period in which cells are refractory 
to the signal (Tomasz and Hotchkiss, 1964, Chen and Morrison, 1987, Momson, 1997). In 
S. pneumoniae and related streptococcal species from the mitis phylogenetic group, the 
competent state is not a constitutive property but is induced by a peptide pheromone
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through a quorum-sensing mechanism. The quorum-sensing signal responsible for 
competence induction is a heptadecapeptide, named CSP (competence-stimulating peptide) 
(Havarstein et al., 1995), which derives from a precursor (ComC) by cleavage and 
transport into the medium by an ATP-binding cassette (ABC) transporter, ComAB (Hui et 
a l, 1995). The competence is triggered when CSP reaches an extracellular concentration 
of 1-10 ng/ml, which corresponds to a population density of about 10  ^cells/ml (Havarstein 
et a l, 1995). The signalling cascade, which leads to the induction of competence state, 
begins with the interaction of CSP with its histidine kinase receptor (ComD), which 
responds by transfemng a phosphate group to its cognate response regulator (ComE). After 
phosphorylation, the response regulator activates transcription of several genes containing 
a ComE-binding site, such as comAB and comCDE opérons (Pestova et a i, 1996), 
establishing a positive feedback loop ensuring an abmpt rise in CSP levels, making all cells 
in a culture competent simultaneously. Recently, the mechanism through which this 
quorum-sensing circuit (comCDE and comAB) evokes the expression of the genes for the 
machinery of genetic transfoimation started to be revealed. ComE (the quorum-sensing 
transducer) might act as a transcription factor to induce both the competence machinery 
genes and those of the CSP circuit (Alloing et a l, 1998). ComE was also reported to 
induce the expression of ComX, which acts as an alternative sigma factor to enable core 
polymerase to transcribe competence-specific genes whose up-regulation is required for 
competence (Lee and Morrison, 1999, Luo et a l, 2003). How competence is shut off after 
induction is unknown, although it has been proposed that ComE has dual functions, 
activation at low doses of the CSP stimulus and repression at high doses for the regulation 
of comCDE, which could account for the successive induction and suppression of 
competence in response to increasing levels of CSP (Alloing et a l,  1998).
Lee and colleague (Lee and Morrison, 1999) identified ComX as a competence-specific 
transcription modulator, and showed that it (1) is induced through ComE by the 
competence-stimulating peptide, (2) is required for the expression o f competence-specific 
opérons which contain a cin-box but not of those of the quorum-sensing opérons or of 
comX  itself, and (3) is present in two copies in the Rx derivative strain studied. Lee and 
eolleague also reported that the quorum-sensing system alone causes neither competence 
shutoff nor the CSP rehactory period, and proposed that a ComX-induced gene may be 
responsible for these post-competence phenomena. Luo and co-workers (Luo and 
Morrison, 2003) have tested the hypothesis that ComX acts as a transient alternative sigma 
factor and found that ComX polymerase produced transcripts for the competence-specific 
genes ssbB, cinA, cglA, celA and dalA and was inhibited by anti-ComX antibody. This 
report concluded that ComX is unstable and acts as a competence-specific sigma factor
38
Introduction
(Luo and Morrison, 2003). More recently, Luo et al identified ComW as a new positive 
factor involved in competence regulation (Luo et at., 2004). The authors of this study 
reported that co-expression of ComW and ComX complemented the ComE deficiency. The 
model of genetic transformation in S. pneumoniae proposed by Luo et al (Luo et al., 2004) 
is shown in Figure 1.3.
CSP
Environmental 
.cues ComD
ComAB ComE
pre-CSP
hcomAB
comWcomX
6 Other opérons
Proteolysis
ComX Core-RNAP a^-holoenzyme
DNA uptake 
machinery genes
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Genes for 
DNA release ?
Genes with 
unknown function
Figure 1.3- Model for the genetic transformation in Streptococcus pneumoniae.
The quorum-sensing system that accumulates CSP and an active form of ComE 
induces the expression of comX. ComX acts as an alternative sigma factor to 
enable core polymerase to transcribe competence-specific genes, whose up- 
regulation is required for competence. ComW, a putative ComE-dependent 
gene, promotes the translation of ComX and the expression of ComX-dependent 
genes, and may function at multiple sites in the regulation pathway. Solid 
arrows indicate processing (thin lines) or activation (thick lines) steps that are 
supported by previous and current results. Dashed lines suggest hypothetical 
links, T-bars indicate negative regulation and the double line represents the cell 
membrane. Adapted from (Luo et a/., 2004).
1.5.2 Uptake of DNA
During the period of competence, double-stranded DNA encountered by pneumococcal 
cells is bound to the cell surface and one strand of the DNA is degraded into short 
oligonucleotides in the medium while part of the other strand is imported inside the cell 
(Mejean and Claverys, 1988). The nuclease responsible for degradation in S. pneumoniae 
is the product of the endA gene (Lacks et a l,  1975, Puyet et a l, 1990). EndA is 
constitutively expressed membrane-located protein (Lacks and Neuberger, 1975) and is 
required for transport but not for binding of donor DNA to the cell surface (Lacks et a l.
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1975). The imported single strand of DNA is protected from nuclease activity by a single­
stranded DNA binding protein (SSB) (Morrison and Mannarelli, 1979) and is finally 
incorporated into the chromosome by homologous recombination involving the general 
recombination machinery, including RecA (Mortier-Baniere et a l,  1998).
Several competence-specific opérons which are probably involved with the DNA uptake 
process and recombination were identified, such as cilA, cilB (Karudapuram et a l, 1995), 
cilC, cilD, cilE, and coi (Campbell et a l,  1998, Pestova and Morrison, 1998, Luo et a l,
2003). These opérons and additional competence-related opérons, such as cinA-recA and 
cfl (Londono-Vallejo and Dubnau, 1993, Lee et a l, 1999, Luo et a l,  2003), all contain an 
unusual perfectly conserved consensus sequence, TACGAATA (cin-box), at position 10 
from the transcription start and a T-rich region at 25 (Campbell et a l,  1998).
1.5.3 Competence and virulence
Competence and virulence are highly regulated, and there is increasing evidence linking 
the two phenomena together. For example, the histidine kinase, ComD, the target for CSP 
is required for vimlence (Lau et al., 2001). Transcription of the comCDE operon is 
negatively controlled by the two-component system CiaR/H (Echenique et a l,  2000), 
which is also involved in virulence (Throup et a l,  2000). In addition, the vimlence factor 
LytA, a choline binding protein showing autolytic activity (Berry et a l,  1989a), belongs to 
a late competence operon (Mortier-Baniere et a l, 1998). Clearly, vimlence expression 
depends on events involved in the competence-signalling pathway. Furthermore, the ABC 
transporters encoded by psa (and ado), involved in the uptake of Mif"^ (and possibly Zn^ "^ ), 
are important for growth and competence (Dintilhac et a l, 1997), and the psaA product is 
an essential vimlence factor (Berry and Paton, 1996). Mutations of LicD2 and of Nox lead 
to the alteration of both competence and vimlence expression (Auzat et a l,  1999, Zhang et 
a l,  1999, Lau et a l, 2001, Yu et a l,  2001).
Using differential fluorescence induction (DFI) technology, Marra and colleagues have 
reported that competence genes were up-regulated during infection (Marra et a l, 2002a). 
Recently, the two-component signalling system, MicAB, which contributes to repression 
of competence when oxygen is limited, was also found to be involved in the adaptive 
response of the pneumococcus to changes in oxygen level during the course of infection. A 
mutation in the histidine kinase, micB attenuates the pneumococcal strain for vimlence 
when given intranasally (Kadioglu et a l, 2003). Chapuy-Regaud et al have investigated 
the role of the global regulator, RegR in competence development and virulence of the
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pneumococcus by mutational analysis. RegR was found in this study to be involved in the 
adaptive response of S. pneumoniae tlurough its control of competence and vimlence 
(Chapuy-Regaud et a l, 2003). Furthermore, the role of the serine/threonine kinase StkP in 
competence signalling and in experimental vimlence was investigated by Echenique et al 
(Echenique et a l, 2004). Data presented in this study demonstrated that StkP belongs to 
the signalling network involved in competence triggering in vitro and lung infection and 
bloodstream invasion in vivo. In competence, functional StkP is required for activation of 
comCDE upstream of the autoregulated ring orchestrated by the competence-stimulating 
peptide. This was the first description of positive regulation of comCDE transcription in 
balance with its repression by CiaR/H (Echenique et a l, 2004).
1.6 A dherence and Invasion
Adherence to and invasion of eukaryotic cells are the main strategies used by pathogenic 
bacteria for colonization, evasion of immune defences, survival, and causing disease in the 
mammalian hosts. It is becoming apparent that microorganisms, using their surface 
proteins, interact with host cell receptor molecules and regulate intercellular signalling 
pathways to induce their own adherence, colonization, and internalization (Pancholi,
2000). The ability of Streptococcus pneumoniae to adhere to specific sites on host tissues 
has been investigated by using various cell culture models, such as human nasopharyngeal 
epithelial cells and alveolar type II epithelial cells, as well as human vascular endothelial 
cells (Andersson et al., 1983, Geelan et a l, 1993, Cundell and Tuomanen, 1994). It is 
widely believed that S. pneumoniae adherence to nasopharyngeal epithelium is a 
prerequisite for induction of otitis media, pneumonia, and other pneumococcal diseases. 
Initially, S. pneumoniae is believed to target an anatomical niche, such as the nasopharynx, 
in the host by binding to any of several surface glycoconjugates, which exist on normal, 
resting respiratory epithelial or endothelial cells. Pneumococcal adherence in the 
nasopharynx is presumably mediated by A-acetyl-D-glucosamine p i -3 galactose 
(GlcNAcpl-3Gal) glycoconjugate receptors (Andersson et a l, 1983). The second phase of 
adherence, which is believed to lead to invasion and disease, is induced by cytokine 
activation, and results in the de novo expression of new sugar specificities on the cytokine- 
activated cells which results in a concomitant increase in pneumococcal adherence (Tong 
et a l, 1999). Activation of human epithelial and endothelial cells by interleukin, IL - la  
and tumor necrosis factor, TN F-a produced in inflamed sites has been shown to induce the 
adherence of S. pneumoniae to platelet activating factor receptor, PAF-R (Cundell et a l, 
1995a). This has been confirmed by Ishizuka et al who have demonstrated that S.
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pneumoniae adheres to cultured human tracheal epithelial cells via binding to PAF-R 
(Ishizuka et a l,  2001). The latter group also suggested that rhino virus infection stimulates 
S. pneumoniae adhesion to airway epithelial cells via increases in PAF-R and that 
increased adherence o f S. pneumoniae may be one of the reasons that pneumonia develops 
after rhinovirus infection (Ishizuka et a l, 2003),
Adherence by S. pneumoniae is a complex process and adhesins or ligands that potentially 
contribute to the regulation of adherence are actively being investigated. These include 
peptide permeases, choline-binding proteins, opaque-transparent phenotypic variants, and 
the release of bacterial cell wall components which are responsible for epithelial and 
endothelial cell activation (Rosenow et a l,  1997, Tuomanen, 1997), A chinchilla trachea 
organ culture model was used by Tong and colleagues to evaluate adherence o f S. 
pneumoniae otitis media strains in vitro. The strains were showed to adhere within 30 
minutes of exposure to chinchilla tracheal epithelial tissues and neuraminidase was found 
to enhance the adherence of S. pneumoniae to upper respiratory tract epithelium (Tong et 
a l, 1999).
In contrast to colonization, invasion appears to be a more stringently selected capability. 
Pneumococci can traverse the respiratory epithelium in vivo and in vitro, but the route 
taken from the respiratory epithelium to the bloodstream may be via lymphatics or direct 
invasion of endothelial cells. Invasion is considered a multistage process initiated by 
adherence. A key step in the transition from adherence to invasion is the activation of host 
cells. Activated cells synthesize glycoconjugates bearing sialic acid and lacto-N-tetraoses. 
These determinants and others are recognized by pneumococci, such as platelet activating 
factor (PAF) receptor, secretory IgA, and the third component of complement. A critical 
adhesive ligand of the pneumococcus that binds all of these targets is CbpA (Cundell et a l, 
1995a, Hammerschmidt et a l, 1997, Gosinlc and Tuomanen, 2000). Phase variation of 
pneumococci also determines the ability of the bacteria to invade the host cells. Ring et al 
have investigated the ability of pneumococci to invade and transmigrate tlirough 
monolayers of rat and human brain microvascular endothelial cells (BMEC). Results of 
this study indicated that phase variation to the transparent phenotype increased invasion as 
much as 6-fold. Invasion of transparent pneumococci required choline in the pneumococcal 
cell wall and was partially inhibited by PAF receptor on the BMEC. Most of the opaque 
variants were killed in that assay. This study suggested that interaction of pneumococci 
with the PAF receptor results in sorting so as to transcytose bacteria across the cell while 
non-PAF receptor entry shunts bacteria for exit and re-entry on the apical surface in a 
novel recycling pathway (Ring et a l,  1998).
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Most studies on pneumococcal epithelial cell interactions and on invasion have been done 
in vitro with cultured cell lines. However, Kadioglu and colleagues (Kadioglu et a l, 2001) 
introduced the first report of pneumococcal invasion and cellular internalization of 
broncho-epithelial cells in vivo by making pneumococci expressing green fluorescent 
protein (GFP) and used it to trace pneumococcal adherence and invasion. Since broncho- 
epithelial cells are the first host cells to be encountered and penetrated by the 
pneumococcus in the lower respiratory system, they would appear to play a vital role in 
subsequent pneumococcal invasiveness and lung pathogenesis. It was demonstrated that 
pneumococcal invasion into host cells not only involves cell surface contact and 
penetration, but also bacterial trans-cellular migration throughout epithelial cells. S. 
pneumoniae was shown to cause the separation of tight junctions in an organ culture of 
human adenoid ciliated and unciliated epithelium (Rayner et a l,  1995). However, 
Kadioglu and colleagues did not find pneumococci within cell junctions in vivo, indicating 
differences between the in vivo and the in vitro culture systems. The key to this 
discrepancy may lie with epithelial cell receptors expressed only under inflammatory in 
vivo conditions or to other factors not present within in vitro systems (Kadioglu et a l, 
2001).
1.7 Antibiotic R esistance
Management of pneumococcal infections used to be relatively straightforward, and 
penicillin generally was the antibiotic of choice. However, the emergence of penicillin- 
resistant and multi-resistant strains during the last 20 years has posed serious problems in 
the treatment of pneumococcal diseases. The first reports on resistance to penicillin were 
made in the 1930s in Australia and New Guinea (Meis and Neeleman, 1996). It took until 
1977 before highly resistant pneumococci were reported in South Afiica (MIC >1.0 mg/1). 
In addition, these strains were also resistant to other penicillins and cephalosporins 
(Appelbaum et a l, 1977). It has been reported that penicillin kills pneumococci through 
two distinct mechanisms; one triggers an autolytic enzyme, amidase, and the other, which 
is enzyme-independent, involves the cid gene (Moreillon et a l, 1990). The mechanism of 
resistance of pneumococci to penicillin is due to alterations of the penicillin binding 
proteins (PBPs) that have reduced their affinity for penicillin and other related p-lactams. 
S. pneumoniae possesses five high molecular weight penicillin binding proteins PBPla, 
PBPlb, PBP2a, PBP2b, PBP2x, and the low molecular weight D, D-carboxypeptidase 
PBP3. These PBPs together with p-lactamases are members o f a superfamily o f penicilloyl 
serine transferases that interact with p-lactam antibiotics via the formation of covalent
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serine ester-linked penicilloyl complexes (Ghuysen and Dive, 1991, Krauss and 
Hackenbeck, 1997, Hakenbeck et a l, 1998). These alterations in PBPs are believed to be 
due to the ability of S. pneumoniae to acquire DNA by transformation of small segments of 
DNA from organisms sharing the same ecological niche. Molecular techniques have 
identified genetic mosaicism among the PBPs of resistant pneumococcal isolates. This 
mosaicism suggests that genes for these proteins were imported from some heterogeneous 
non-pneumococcal source (such as the mitis group) rather than evolving in an individual 
organism (Dowson et a l, 1994).
Higher mortality has been found among patients infected with S. pneumoniae strains 
resistant to penicillin than among patients infected with susceptible strains (Choi and Lee,
1998) and few studies have investigated the relationship between the overuse of penicillin 
and the colonization and/or infection risk with penicillin-resistant pneumococci. Other risk 
factors appear to be adolescent age group, previous hospitalization history, attending a 
nursery and living in areas from which resistant strains are frequently isolated (Klugman, 
1996). Filipe and Tomasz (Filipe and Tomasz, 2000) have identified two genes, murM  and 
murN, that encode enzymes involved with the biosynthesis of branched muropeptides. The 
inactivation of these genes restores penicillin susceptibility to p-lactam-resistant 
pneumococci. These genes therefore appear to be essential for pneumococci to make the 
branched cell wall associated with penicillin resistance. It is conceivable therefore, that 
antibiotics able to inhibit the action of these enzymes may be used in conjunction with 
penicillin or amoxicillin to prevent the expression of penicillin resistance.
Concurrent with this gi'owing penicillin resistance problem is an associated decrease in 
susceptibility among S. pneumoniae to a range of other traditional empiric antimicrobials 
such as macrolides, trimethoprim-sulfamethoxazole, tetracyclines, and to a lesser extent 
chloramphenicol (Pallares et a l, 1987). In 1998, 24 % of all invasive pneumococcal 
isolates captured by a multistate, population-based surveillance network were resistant to 
penicillin, and 14% of all isolates were resistant to tln*ee or more drug classes (Whitney et 
a l, 2000). In addition, recent studies have reported cases of vancomycin-tolerant 
pneumococcal strains, although vancomycin is an antibiotic that had not previously been 
shown to have any pneumococcal resistance (Novak et a l,  1999, McCullers et a l, 2000). 
Cefditoren is a novel cephalosporin that is unusual in that it has greater antimicrobial 
activity against the pneumococcus than does penicillin. In an analysis of 312 
pneumococcal strains, Johnson and co-workers showed that all these strains were inhibited 
by a cefditoren MIC of 1 pg/ml or less. Only 14 % of these strains were fully penicillin
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resistant (Johnson et a l,  2000). These data clearly suggest that more studies on the 
susceptibility of pneumococcus to cefditoren are required.
The CDC National Center for Infectious Diseases has published that seven pneumococcal 
serotypes, namely (6A, 6B, 9V, 14, 19A, 19F, and 23F) account for most drug resistant 
pneumococci. Until 2000, S. pneumoniae infections caused 60,000 cases of invasive 
disease each year and up to 40 % of these were caused by pneumococci non-susceptible to 
at least one drug. These figures have decreased substantially following the introduction of 
the pneumococcal conjugate vaccine for children. In the year 2002, there were 37,000 
cases of invasive pneumococcal disease. Of these, 34 % were caused by pneumococci non- 
susceptible to at least one dmg and 17 % were due to a strain non-susceptible to 3 or more 
drugs (information from CDC National Center for Infectious Diseases at 
http://www.cdc.gov/).
1.8 Pneum ococcal vaccines
It has long been recognized that the best management of most infectious diseases is 
prevention. Moreover, the possibility that antibiotics might one day be ineffective in curing 
at least some cases o f pneumococcal pneumonia and other pneumococcal infections has 
increased the importance of having an effective vaccine. Soon after the pneumococcal 
capsule was identified as a major immunogen in 1930s, subsequent vaccine development 
focused on purified polysaccharides (PS). Pneumococci are now known to possess one of 
at least 90 different PS types, although pneumococci of less than 30 types cause the vast 
majority of human disease. It has become apparent that immunization with pneumococcal 
polysaccharide was effective in preventing bacteraemic pneumococcal pneumonia, and two 
hexavalent polysaccharide vaccines were commercially introduced. However, in the 1940s 
antibiotics were becoming widely available and the perceived impact of pneumococcal 
infections had greatly diminished. The two vaccines were withdrawn from the market for 
lack of demand (Austrian, 1981a, b). Despite the use of antibiotics, morbidity and 
mortality from invasive pneumococcal infections remained high. Renewed interest in 
pneumococcal vaccines led to further clinical trials of polysaccharide vaccines. Based on 
two large trials in South Africa and New Guinea, a 14-valent polysaccharide vaccine was 
licensed in the United States in 1977 and the formulation was expanded to include 23 PS 
types in 1983 (Salyers and Whitt, 1994, Briles et a l, 2000c).
The use of a 23-valent vaccine containing capsular polysaccharides from pneumococci 
commonly causing disease has had limited effect in reducing the morbidity and mortality
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associated with this organism especially in the elderly and young children (Shapiro et a l, 
1991, Butler et a l, 1998). One frequently postulated reason for the incomplete protection 
afforded by the polysaccharide vaccine is the poor imniunogenicity of PS in elderly adults. 
Certain PS types in the 23-valent vaccine, notably 6B, 9V, 19F, and 23F, induce relatively 
weak antibody responses that diminish to prevaccination levels in a short time (Sankilampi 
et a l, 1997). Young children also respond poorly to polysaccharide antigens and are 
particularly susceptible to infections with encapsulated bacteria. The reasons for this 
immune response are complex and not fully known, but it is clear that children less than 2 
years of age do not have a fully developed capacity to respond to many T-cell-independent 
polysaccharide antigens (Bijkers et a l, 1996).
The poor immunogenicity of polysaccharides in the very young and elderly has spurred the 
development of pneumococcal vaccine that involves T-cell responses. Covalent attachment 
of polysaccharide antigens to protein (conjugate vaccine) should improve the efficacy of 
the vaccine by making it more immunogenic in young children than polysaccharide 
vaccine. The proteins in the conjugate vaccine cause a switch in the immune response to 
polysaccharide from T-cell-independent to T-cell-dependent. This results in an increase in 
the antibody response and the generation of memory T-lymphocytes (Butler, 1997). 
Vaccine manufacturers have prepared many conjugate vaccines such as pncOMPC 
vaccine, which contains polysaccharides from seven serotypes conjugated to the 
meningococcal outer membrane complex, the pncCRM vaccine which contains either 
oligosaccharides or polysaccharides coupled to a non-toxic mutant of diphtheria toxin 
CRM197, the pncT vaccine that contains eight PSs coupled to tetanus toxoid, and pncD 
vaccine which contains the same PSs coupled to diphtheria toxoid (Flogerman et a l, 1995, 
Ahman et a l, 1996, Anderson et a l, 1996). Some pneumococcal conjugate vaccines and 
their manufacturers are shown in table 1.3.
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Table 1.3- Some pneumococcal poiysaccharide-protein conjugate vaccines currently or 
previously used or approaching licensure.
Saccharid(s) Proteiii(s) Mauufacturer(s) Trade name
Serotypes 4, 9V, 14, 19F 
and 23F polysaccharides; 
6B saccharide
Mutant non-toxic 
diphtheria toxin 
CRM197
Wyeth Prevenar®
As above plus types 1 
and 5 polysaccharides
Mutant non-toxic 
diphtheria toxin 
CRM197
Wyeth Not-licensed
1, 4, 5, 7F, 9V, 19F and 
23F polysaccharides; 
types 3, 14 18C and 6B 
polysaccharides
Tetanus toxoid; 
Diphtheria toxoid
Aventis Pasteur Not-licensed
1, 3, 4, 5, 6B, 7F, 9V, 
14, 18C, 19F and 23F 
polysaccharides
Non-typeable H. 
influenzae outer 
membrane protein
Glaxo SmithKline Not-licensed
Adapted from (Finn, 2004).
Black and co-workers have carried out a clinical efficacy trial o f pneumococcal conjugate 
vaccine in infants. Seven-valent vaccine conjugated to CRM197, or meningococcal type C 
conjugate vaccine (Placebo) were given to 37, 868 children in northern California at 2, 4, 
and 6 months of age, and a booster was given at 12-15 months of age. The vaccine efficacy 
was 97.4 % against invasive disease caused by the vaccine serotypes (Black et a l, 2000). 
On the other hand, evidence recently reported fiom a clinical trial of pneumococcal 
conjugate vaccine suggests that vaccinated childi'en have higher rates of otitis media from 
non-vaccine serotypes than do unvaccinated children (Eskola et a l,  2001). Conjugate 
vaccines have also been tested in elderly adults and found to be safe and immunogenic 
(Powers et a l, 1996, Shelly et a l, 1997). However, the pneumococcal serotypes 
responsible for invasive infections in adults are more diverse than those in children, and 
the formulation of conjugate vaccines to cover this larger variety of serotypes may prove to 
be a developmental and financial hurdle that may be difficult to overcome.
A possible solution to the vaccine problem was suggested by the discovery that a 
pneumococcal surface protein, PspA, elicits a protective antibody response that is effective 
against more than one capsular serotype (Salyers and Whitt, 1994). Moreover, because it is 
a protein, it would be an effective vaccine for high-risk groups as infants and the elderly. 
Other pneumococcal virulence factors have been considered as promising vaccine 
candidates or as carrier proteins in pneumococcal conjugate vaccine, these include
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neuraminidase, autolysin, pneumolysin, and pneumococcal surface adhesin A (PsaA)
(Lock et a l, 1988a, Sampson et a l, 1994). PspA, PsaA and pneumolysin are cuiTently the 
leading vaccine candidates (Briles et a l,  2000b). However, none of the proteins are 
considered to elicit species-wide pneumococcal protection so far. This can be explained by
the occurrence of allelic variation within most individual proteins (Briles et a l, 1998, f
i'
lannelli et a l,  2002). Antibodies raised against a single protein may not recognize allelic 
variants. Therefore, immunological interference using multiple variants of a single protein 
or using multiple proteins will limit immunological escape by the pneumococcus. 
Therefore, a combination of proteins should be considered in future protein vaccine 
strategies. CuiTent strategies used for producing pneumococcal vaccines are reviewed in 
(Bogaert et a l, 2004a).
1.9 Signal transduction in bacteria
1.9.1 An overview
Bacteria must modulate the expression of specific genes in response to changes in 
environmental conditions. This adaptive response is mediated in part by two-component 
regulatory systems, also Icnown as histidine-aspartate phosphorelay systems. One 
component of the system acts as an environmental sensor, often located in the cytoplasmic 
membrane, that transmits a signal to the second component, a cytoplasmic response 
regulator, which then mediates changes in gene expression (Stock et a l, 1995). The mode 
of molecular communication between a "sensor kinase" and its cognate "response 
regulator" is principally based on histidine-to-aspartate (His-Asp) phosphotransfer. 
According to the model that has been proposed for the transduction of environmental 
signals by these two-component systems, the sensor protein, commonly a histidine kinase 
(HK), responds to an environmental stimulus by autophosphorylation on a histidine 
residue. The phosphoryl group is then transferred to an aspartate residue in the response 
regulator (RR), which generates a cascade of events leading to transcription factors whose 
affinity for specific DNA sequence is modulated by phosphorylation (Stock et a l, 1995).
By these means, bacterial two-component pathways control a dazzling array of functions 
including cell division, virulence, antibiotic resistance, metabolite fixation and utilization, 
response to environmental stress and sporulation. A number of two-component systems in 
some prokaryotic organisms and their regulatory functions are shown in table 1.4. hr 
addition, the existence of a cross talk between the sensor of one system and the regulator of 
another system has been obseiwed (Verhamme et a l, 2002). However, the mechanisms by
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which different two-component systems are integrated into a coordinated cellular response 
is not well understood.
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Table 1.4- Two-component systems in some prokaryotic organisms.
Organism HK/RR Regulatory function Reference
Escherichia coli
Bacillus subtilis
Staphylococcus
aureus
Campylobacter
jejuni
Vibrio fischeri
Listeria
monocytogenes
Caulobacter
crescentus
Rhodobacter
sphaeroides
Streptomyces
coelicolor
Rhizobium
meliloti
CheA/CheY3
EnvZ/OmpR
Ai'cB/Ai’cA
BasS/BasR
VanS/VanR
KinA/SpoOF
ComP/ComA
DegS/DegU
SrhS/SrhR
YycF/YycG
RacR-RacS
LuxFLuxR
LisR/LisK
Cck/CtrA
Pn'A/PrrB
AbsAl/AbsA2
FixL/FixJ
Chemotaxis.
Adaptation to external 
osmotic changes by 
regulating the levels o f the 
outer membrane porin 
proteins.
Aerobic/anaerobic regulation 
of respiration/fermentation. 
Responses to iron.
Vancomycin tolerance.
Regulation of sporulation. 
Regulation of competence.
Regulation of exprotein 
production, catabolism, 
competence development 
and motility.
Regulation of energy 
transduction in response to 
changes in oxygen 
availability.
Regulation of bacterial cell 
wall.
T emperature-dependent 
growth and colonization. 
Quoiaim sensing and 
induction of bioluminescent 
genes.
Response to ethanol, pH and 
H2O2 stresses.
Cephalosporin tolerance. 
Coordination of cell cycle 
progression and polar 
morphogenesis.
Expression of photosynthetic 
and Calvin cycle CO2 fixing 
opérons.
Antibiotic synthesis.
Nitrogen fixation.
(Hess et a l, 1988) 
(EggQX et a l, 1997, 
Yoshida et a l, 
2002)
(Lynch and Lin,
1996)
(Hagiwara et a l,
2004)
(Evers and 
Courvalin, 1996) 
(Wang et a l, 2001) 
(Weinrauch et a l,  
1990)
(Ogura et a l,
2001)
(Throup et a l , 
2001)
(Martin et a l ,
1999)
(Bras et a l, 1999)
(Salmond et a l, 
1995)
(Kallipolitis and 
Ingmer, 2001, 
Cotter et a l,  2002) 
(Jacobs et a l,
1999, Wheeler and 
Shapiro, 1999) 
(Emmerich et a l,
2000)
(Brian et a l, 1996, 
Anderson et a l,
2001)
(Weinstein et a l, 
1992)___________
The basic biochemical events of two-component signal transduction were first established 
in Escherichia coli (Ninfa and Magasanik, 1986) for the NR system, a regulatory system
50
Introduction
that controls gene expression in response to nitrogen-source availability. At about the same 
time, Nixon and co-workers (Nixon et a l, 1986) recognized amino acid sequence 
similarities between the components of the NR system and components of numerous other 
bacterial sensory systems that had not been characterized at a biochemical level. Such 
similarities raised the exciting possibility that these other systems operated via a signalling 
mechanism analogous to that utilized by the NR system. Subsequent work has supported 
this idea, and the list of two-component systems has expanded to include hundreds of 
distinct systems and numerous review articles on the topic have been published (Bourret et 
a l, 1991, Parkinson and Kofoid, 1992, Hoch and Silhavy, 1995, Chang and Stewart, 1998, 
Stock et a l,  2000, Wick and Egli, 2004).
1.9.1.1 Domain structure and phosphorylation pathway
Histidine kinases are generally composed of a highly variable transmembrane-spanning 
amino-terminal sensor kinase and a more conserved carboxyl-terminus composed of the 
transmitter and kinase domains. Within the carboxyl-terminal domain are four, or 
occasionally five, recognizable amino acid motifs or boxes, which are named after the 
single-letter amino acid code for the most conseiwed residues, the H, N, D, F and G boxes. 
The H box centres on a strictly conserved histidine residue, the site of autophosphorylation 
(Stock et a l, 1989). The amino-temiinal receiver domain of response regulators typically 
contains a stretch of four hydrophobic residues followed by the D1 and D2 boxes, each of 
which contains a conserved aspartate residue, and an additional K box, which contains an 
invariant lysine residue. The conserved aspartate, which lies within the D2 box, is 
considered to be the site of phosphorylation (Volz, 1993). Comparison of different 
response regulators reveals a highly conserved region, called the receiver domain, within 
the N-teiminal half (approximately 125 amino acids). The C-terminal part coiTesponds to 
the effector or output domain, hi most cases this domain has DNA binding properties, and 
many response regulators have been shown to function as transcriptional regulators.
A prototypical two-component pathway (figure 1.5) serves to demonstrate the basic 
phosphotransfer mechanism that forms the core of both simple and more complicated 
systems. Stimuli, detected by a sensor domain of the histidine kinase, regulate HK 
activities. The HK catalyzes ATP-dependent autophosphorylation of a specific His residue 
within the HK dimerization domain. The RR then catalyzes transfer of the phosphoryl 
group from the phosphoHis to one of its own Asp residues. Phosphorylation of the 
conserved regulatory domain of the RR activates an effector domain that elicits the specific 
output response (West and Stock, 2001).
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Figure 1.4-Two-component mechanism.
A typical two-component phosphotransfer system consists of a dimeric 
transmembrane sensor histidine kinase (HK) and a cytoplasmic response 
regulator (RR). A monomer of a representative HK is shown with 
transmembrane segments indicated by TM1 and TM2. Conserved sequence 
motifs N, G1, F and G2, are located in the ATP-binding domain. HKs cataiyze 
ATP-dependent autophosphorylation of a specific conserved His residue (H). 
The activities of HKs are modulated by environmental signals. The phosphoryl 
group (P) is then transferred to a specific Asp residue (D) located within the 
conserved regulatory domain of an RR. Phosphorylation of the RR typically 
activates an associated (or downstream) effector domain, which uitimately 
eiicits a specific cellular response. Adapted from (West and Stock, 2001).
1.9.1.2 Role o f IC S  in virulence
Pathogenic bacteria coordinate an intricate network of virulence factors, whose expression 
must be precisely controlled to maximize the chance of establishing a successful infection. 
Two-component systems are recognized for their role in the regulation of genes important 
for different stages of the infection process. For example, elevated temperature and low pH 
might be early signals heralding entry of an enteric pathogen into the host. Chemotactic 
signals affecting motility might then enable the pathogen to reach its desired local site. 
Once there, the pathogen must express new genes to compete with normal host flora for 
essential and limited nutrients (Hoch and Silhavy, 1995). All of these steps and many 
others are coordinated in part by TCS. The Staphylococcus aureus Agr is a very well 
characterized TCS and acts as a global regulator capable of inducing and repressing 
different groups of virulence-associated genes depending on the site of infection (Lyon et 
a i, 2000, Bronner et a i, 2004). Moreover, Zahrt and co-workers (Zahrt et a l, 2003) 
presented evidence demonstrating that sensor kinase MprB and response regulator MprA 
of Mycobacterium tuberculosis function as an intact signal-transducing pair both in vitro 
and in vivo. Sensor kinase MprB can be autophosphorylated, can donate phosphate to 
MprA, and can act as a phospho-MprA phosphatase in vitro. Mutagenesis of residues 
His^ '*^  in MprB and Asp'’* in MprA abolished the ability of these proteins to be 
phosphorylated in vitro. Introduction of these alleles into Mycobacterium bovis BCG 
attenuated virulence in macrophages in vivo (Zahrt et a l, 2003). The role of two- 
component systems in virulence has been reported in many other pathogenic bacteria,
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including Helicobacter pylori (Panthel et ah, 2003), Haemophilus influenzae (De Souza- 
Hart et a l, 2003), Brucella abortus (Guzman-Verri et a l, 2002), Enterococcus faecalis 
(Teng et a l,  2002), Campylobacter jejuni (Mackichan et a l,  2004) and many others. The 
integral role of two-component systems in virulence and antibiotic sensitivity, and the 
existence of essential two-component systems in several pathogenic bacteria, suggest that 
these systems may be novel targets for antimicrobial intervention (Stephenson and Hoch,
2002).
1,9.2 Pneumococcal two-component systems
Two separate genomic-based approaches have identified the two-component signal 
transduction systems in S. pneumoniae (Lange et a l, 1999, Throup et a l, 2000). A total of 
14 open reading frames (ORFs) were identified as putative response regulators, 13 of 
which were adjacent to genes encoding probable histidine kinases (Throup et a l, 2000). 
Analysis of protein sequences of the 13 TCS identified by Lange and co-workers (Lange et 
a l,  1999) revealed that two of them have been described before, ciaR/H and comDE, and 
two are homologous to \hQyycFG (Fabret and Hoch, 1998) and the phoRP  (Hulett, 1996) 
genes of Bacillus subtilis, these are the pneumococcal TCS02 and TCS04, respectively. All 
the 13 TCS identified by Lange and co-workers (Lange et a l, 1999) and their possible 
functions are shown in table 1.5.
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Table 1.5- The pneumococcal two-component systems.
TCS Acc. No. Gene
Organisation
G+C-
Content
Possible regulatory 
function
TCS01 AJ06391 -41%
TCS02 AJ06392 -40% redox/enerqy sensing
TCS03 AJ06393 -45%
TCS04 AJ06394 -41% phosphate sensing
GiaH/R AJ05926 -38% competence and 
penicillin susceptibility
TCS06 AJ06395 -35%
TCS07 AJ06396 -41%
TCS08 AJ06397 : — # -42%
TCS09 AJ06398 -41% nutrient perception
TCS10 AJ06399 -44%
TCS11 AJ06400 Baa^^m^ -44%
Com D/E AJ05925 -31% quorum
sensing/competence
TCS13 AJ06401 -40% pheromone/peptlde
sensing
All response regulators (short arrows, light gray) and histidine kinases (long 
arrows, dark gray) are arranged in pairs (column 3). Adapted from (Lange et al.,
1999).
Best described among these systems is ComDE, which activates the genetic competence 
system in response to competence-stimulating peptide (Pestova et a l, 1996, Cheng et a l,
1997). A second system, CiaR/H, appears to operate upstream of the ComDE pathway and 
has been shown to modulate competence expression but is also associated with other 
characteristics such as resistance to the (3-lactam antibiotic cefotaxime (Guenzi et a l, 1994, 
Echenique et a l,  2000). Other pneumococcal TCS have been linked to a coordinated cell- 
death pathway (Novak et a l, 1999, Novak et a l, 2000b) and to the regulation of a 
bacteriocin-like peptide locus (de Saizieu et a l, 2000).
The response regulator of the TCS02 has recently been crystallized (Riboldi-Tunnicliffe et 
a l, 2004b). This system has been shown to be essential for bacterial growth as knockout 
mutations in these genes lead to non-viable bacterial strains, thus making it a prime target 
for new antibacterial agent design (Lange et a l, 1999). It has also been shown to regulate 
the transcription of ComCDE under oxygen limiting conditions and therefore involved in 
competence repression (Echenique et a l,  2000). Recently, the essentiality of TCS02 
(referred to as VicRK) was shown to be due to its positive regulation of the expression of 
PcsB, a protein potentially involved in cell wall hydrolysis and the regulation of cell wall 
biosynthesis. The pcsB gene was identified as a target of the TCS02 (Ng et a l, 2003). 
Constitutive expression of pcsB^ suppressed the essential requirement for VicRK and
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allowed the isolation of VicR-null mutants (Ng et a l, 2003). Reduced expression of PcsB 
resulted in formation of long chains of cells suggesting a role for PcsB as a murein 
hydrolase that balances the extent of cell wall synthesis in Streptococcus pneumoniae R6 
strain (Ng et a l, 2004). Physiological defects that resulted from depletion of PcsB strongly 
resembled those caused by depletion of TCS02, an observation that supports the hypothesis 
that PcsB is positively regulated by the TCS02 (Ng et a l, 2004). Furthennore, TCS04 has 
been linked to the ATP-binding transporter Psa, which has been associated with virulence 
(Marra et a l,  2002b) and resistance to oxidative stress and reduced adhesion to tissue 
cultured cells (Berry and Paton, 1996). The psa operon was found to be down-regulated in 
a rr04 mutant of TIGR4 which could contribute to the reduced virulence of that mutant 
(McCluskey et a l,  2004).
Signal transduction systems are also important for the in vivo adaptation and pathogenesis 
of S, pneumoniae. The capability of null mutants in these systems to cause disease in 
animals has been previously examined in two studies of virulence. In a murine model of 
pneumonia developing after intranasal inoculation in which all of the TCS except ComDE 
were tested, deletions in eight of the systems led to a dramatic attenuation of gi*owth in the 
mouse (Tlu'oup et a l,  2000). hi contrast, a second study testing a collection of single­
crossover mutants in a different genetic backgiound showed no evidence of decreased 
virulence for any o f the strains in a murine model of intraperitoneal infection in which the 
requirements of adaptation to the mucosal surface of the airway were circumvented (Lange 
et a l,  1999). TCS04 and TCS09 have been reported to play a role in the virulence of S. 
pneumoniae and have been found to be strain-dependent (Blue and Mitchell, 2003, 
McCluskey et a l, 2004). The CiaR/H system has previously been reported to play a role in 
mouse lung colonization (Thioup et a l, 2000) and colonization of the nasopharynx of 
infant rats (Sebert et a l, 2002) and has also been identified as playing a role in a mouse 
model of systemic disease (Marra et a l, 2002a). In this thesis, the relationship between 
HtrA, a stress response protein of the serine protease family, and the CiaR/H system has 
been investigated (see chapter 5).
1.10 Bacterial s tre ss  responses
Exposure to many different, constantly changing stresses is the normal lifestyle of bacteria. 
Stress can be defined as exposure to any environmental situation that results in damage of 
cellular components in the absence of a cellular response. Given the genome expression 
data available for certain bacteria, stress may be defined as a situation that stimulates the
■'4 :
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expression of genes known to respond to a specific environmental condition. Bacterial 
cells respond to alterations in their environment by activating small or large groups of 
genes under the control of a common regulatory protein (Hengge-Aronis, 2000). In their 
attempts to eliminate pathogenic bacteria, host organisms present stressful conditions for 
bacteria, including enviromnents limited in essential nutrients such as iron, suboptimal 
physical conditions such as acidic pH, and attacks of the immune system such as oxidative 
bursts. Pathogenic bacteria have to display rapid responses to these hostile environmental 
conditions including regulation of metabolic factors and exoprotein production 
(Charpentier et a l,  2000). The intriguing mechanisms by which pathogenic bacteria evade 
or cope with these stresses are just beginning to be revealed.
Heat shock or stress proteins (HSPs) are among the most highly conserved and abundant 
proteins found in nature. They are produced by all cells in response to various 
physiological and non-physiological stimuli (Lindquist, 1986). These proteins are being 
extensively studied and are classified into many families. The HSPlOO/Clp family is one 
example of such proteins with a great diversity of function, such as increased tolerance to 
high temperatures, promotion of proteolysis of specific cellular substrates and regulation of 
transcription. HSPIOO proteins are classified on the basis of the presence of either one or 
two ATP-binding domains, on the length of the spacer region separating the two conserved 
nucleotide-binding regions and on the occurrence of specific signature sequences. They are 
divided into two major classes with eight subfamilies within these classes. Members of the 
first class contain two nucleotide binding domains (NBDs) flanked by amino-terminal, 
middle (or spacer) and carboxy-terminal regions. On the other hand, members of the 
second class are shorter in length, containing only a single NBD, which more closely 
resembles the second NBD of class Ï, and the carboxy-terminal region (Schirmer et a l, 
1996).
hi Escherichia coli, a Gram-negative bacterium, members of the Clp family of ATPases 
associate with the ClpP proteolytic subunit to form ATP-dependent proteases that degrade 
certain fusion proteins as well as several phage replication proteins (Gottesman, 1996, 
Gottesman et a l, 1998). Data suggest that the Clp ATPases are not only specificity factors 
that help to present various protein substrates to the ClpP subunit, but they also act as 
molecular* chaperones independently of ClpP. For example, Clp A acts as a chaperone for 
the activation of PI replication protein RepA (Wickner et a l,  1994, Wawrzynow et a l,
1996). Regulation of the E. coli heat shock response has been studied extensively. 
Transcription of E. coli heat shock regulon, consisting of twenty genes, requires the 
subunit of RNA polymerase as well as the minor sigma factor Whereas regulon
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plays a m ^or role in coping with cytoplasmic protein damage, the regulon functions
'I
primarily to protect cells against extracytoplasmic or extreme heat stress (Yura et ah,
A
2000). The cellular concentration of is very low at 30°C, but rises rapidly at 42°C 
because of increases in synthesis, stability, and activity (Bukau, 1993).
'i
Gram-positive bacteria use very different and diverse regulatory strategies depending on ï 
the specific heat shock genes and specific bacteria. For instance, the heat shock response in 
the soil bacterium Bacillus subtilis involves at least three different classes of heat-inducible 
genes distinguished by their regulatory mechanisms (Hecker et a l,  1996). Class I genes 
encode classical chaperones such as DnaK, GroES, and GroEL. Their expression involves 
a a^-dependent promoter and the highly conserved CIRCE (Controlling Inverted Repeat of 
Chaperone Expression) operator sequence, which is the binding site for the HrcA repressor 
(Yuan and Wong, 1995, Schulz and Schumami, 1996, Mogk et a l,  1997). Class II genes 
are the largest class; their expression is induced by heat shock but also by general stress 
conditions such as exposm’e to salt or ethanol, or starvation for glucose, phosphate or 
oxygen (Benson and Haldenwang, 1993). Expression of these genes requires g® factor 
whose synthesis and activity are increased under stress conditions. Class III genes (CtsR 
regulon) were defined as those devoid of CIRCE operator sequence and whose induction 
by heat shock and general stress conditions is a^-independent. These genes encode the 
ClpC and ClpX ATPases as well as the proteolytic subunit ClpP (Msadek et ah, 1994,
Gerth et a l, 1996, Msadek et a l, 1998). ClpP and ClpC have been shown to play essential 
roles within the stationary phase regulatory network of Bacillus subtilis. ClpP is required 
for competence development, motility, degradative enzyme synthesis, growth at high 
temperature and spomlation (Msadek et a l, 1998). ClpC acts as a molecular switch to 
inhibit the activity of ComK, which is a transcriptional activator of competence genes 
(Msadek et a l, 1994, Turgay et a l, 1997). The expression of ClpP and ClpC is negatively 
controlled by the product of the first gene of the clpC operon, referred to as ctsR (Derre et 
a l, 1999b). This control by CtsR appears to be a highly conserved heat shock regulatory 
mechanism in low G+C Gram-positive bacteria.
Clp genes play important roles in the virulence and in vivo survival of several pathogens.
For instance, ClpC was found to be required for intracellular growth, survival, and 
vimlence of Listeria monocytogenes. The ClpC-deficient mutant became highly 
susceptible to various stresses, such as elevated temperature and osmolarity. Growth of the 
mutant was restricted within macrophages. However, The ClpC ATPase was not involved 
in phagocytosis, as bacterial uptake was similar in both wild type and mutant bacteria
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(Rouquette et a l, 1998). In another study, transcription o f dpE  gene of Listeria 
monocytogenes required for prolonged sui*vival at elevated temperature, was found to 
increase in the absence of clpC (Nair et a l, 1999). This was the first example implicating 
regulation of one clp by another. While ClpE expression was controlled by ClpC, ClpC 
expression appeared to be unaffected by the presence or absence o f ClpE. In contrast to a 
clpC mutant, which was susceptible to salt stress, growth of the clpE mutant was 
unaffected. ClpP has been shown to modulate transcription of the adhésion-invasion locus 
{ait) in Yersinia enterocolitica (Pederson et a l, 1997) and patients with leprosy or 
tuberculosis were found to have antibodies specifically directed against mycobacterial 
ClpC (Misra et a l, 1996). Thus, elucidating the regulatory pathways controlling clp gene 
expression is likely to be important for understanding the virulence of pathogenic bacteria 
including the pneumococcus.
S. pneumoniae is carried in the nasopharynx where it experiences changes in temperature, 
pH, and ethanol concentration. This hostile environment may act as a strong stress to the 
pneumo coccus and may influence gene expression of heat shock proteins (HSPs). A 
change in the environmental niche of the host, such as penetration of pneumococci from 
the nasopharynx into the bloodstream, can provoke remarkable morphological changes as 
well as changes in gene expression. For instance, it has been demonstrated that 
pneumococci in the nasopharynx are predominantly of the transparent colony phenotype 
and tend to express less capsule and more choline-binding protein A (CbpA) than those in 
the bloodstream. On the other hand, pneumococci in the bloodstream are predominantly of 
the opaque colony morphology and tend to produce more capsule and less CbpA than those 
in the nasopharynx (Kim and Weiser, 1998, Tuomanen, 1999). Furthermore, S. 
pneumoniae may encounter heat stress after penetration from the nasal mucosa (30 to 
34°C) into the blood and/or meninges (37°C) during the pathogenic process (Lindemann et 
a l, 2002). Such changes in temperature may serve as a key trigger for a rapid, transient 
increase in the synthesis of the highly conserved heat shock proteins (HSPs).
It was found that after a thermal shock, S. pneumoniae response appeared as induction of 
three major HSPs of approximate molecular mass of 80, 72, 62 kDa and the shutdown of 
other proteins (Hamel et a l,  1997). HSP72 is present under normal growth conditions and 
the absolute amounts of it do not significantly increase after heat shock. Although this 
contrasts with what has been reported for most E. coli HSPs, this behaviour was also found 
to occur in other organisms (Engel et a l, 1990). Investigation of protein antigens involved 
in the immune response to S. pneumoniae led to the obserwation that HSP62 and HSP72 
are targets of the immune response (Hamel et a l, 1997). Other pneumococcal stress
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proteins including HSPs, GroEL, ClpL and alcohol dehydrogenase families were also 
identified (Choi et a l, 1999). However, despite their biological importance, little is known 
about the role of molecular chaperones/heat shock proteins in the response of S. 
pneumoniae to environmental stresses.
In response to heat stress, S. pneumoniae was also found to produce ClpC ATPase, which 
belongs to the HSPIOO family of heat shock proteins. Members o f this family have a dual 
function: they manifest chaperone activity on their own and are also involved in targeting 
disposable or damaged proteins for degradation by a protease moiety such as ClpP (Price, 
2000). ClpC could therefore serve to sort damaged proteins, restoring the less impaired and 
presenting the tenninally damaged for destruction by ClpP protease (Gottesman et a l,
1997). Charpentier and colleagues (Charpentier et a l, 2000) reported that insertion 
duplication mutagenesis of the clpC gene in S. pneumoniae revealed a pleiotropic 
phenotype of improved suiwival at high temperature, chain formation, penicillin and 
vancomycin tolerance, and adhesion and transformation deficiency. In this study, when the 
gi'owth rates of the parent strain and the ClpC-deficient mutant were compared at 
temperatures ranging from 37°C to 46°C, the wild type did not grow well at temperatures 
higher than 40°C, whereas the mutant gi*ew well at temperatures up to 44°C. Other studies 
suggest that the ClpC protein plays no role in these processes (Chastanet et a l, 2001, 
Robertson et a l,  2002). The function of ClpP-mediated proteolysis in the stress response 
and vimlence of many Gram-negative and Gram-positive bacteria has been studied 
extensively. ClpP was found to be essential for virulence o f Salmonella enterica serovar 
Typhimurium when examined in both a mouse model and in isolated macrophages (Webb 
et a l, 1999, Yamamoto et a l, 2001b). In L. monocytogenes, dismption of the clpP gene 
reduced haemolytic activity due to the major vimlence factor, listeriolycin O that helps the 
bacteria to escape from the phagosomes of macrophages (Gaillot et a l, 2000). ClpP- 
negative mutants of B. subtilis and Lactococcus lactis were unable to survive heat shock 
and other stress conditions (Gerth et a l, 1998, Frees and Ingmer, 1999). Furthermore, it 
was also shown that ClpP was essential for the growth of Staphylococcus aureus in the 
presence of oxidative stress or at low temperature. The vimlence o f a AclpP mutant of S. 
aureus was severely attenuated when investigated in a murine abscess model (Frees et a l, 
2003). Recent reports have shown the requirement of ClpP protease for thermotolerance, 
development of competence, and vimlence of S. pneumoniae (Chastanet et a l, 2001, 
Robertson et a l,  2002, Kwon et a l, 2003). A part of this thesis was concerned with the 
investigation into the role of ClpC and ClpP, as an example of the ATP-dependent 
proteases, in the stress response and vimlence of the pneumococcus.
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This thesis has also tried to shed some light on HtrA as an example of the ATP- 
independent proteases. Homologues of the high temperature requirement A protein, HtrA 
have been described in a wide range of organisms including bacteria, yeast, plants, and 
humans (Zumbrunn and Tmeb, 1996, Pouting, 1997, Gray et aL, 2000). Some bacteria 
have more than one paralogue of HtrA (Noone et aL, 2001). In all cases, the evidence 
points to a major role for these proteases in helping organisms to survive environmental 
stresses such as elevated temperature, oxidative and osmotic stresses. HtrA is known to be 
involved in the virulence of many Gram-negative bacteria such as Salmonella enterica 
serovar Typhimurium (Baumler et ah, 1994), Brucella abortus (Elzer et a l, 1996), and 
Yersinia enterocolitica (Li et a l, 1996). This protease is also required for full virulence of 
the Gram-positive bacterium Streptococcus pyogenes (Jones et aL, 2001). A HtrA 
homologue has also been identified in Streptococcus pneumoniae (Gasc et aL, 1998) and is 
regulated by the CiaR/H two-component system (Sebert et aL, 2002, Mascher et aL, 2003). 
HtrA was identified as a virulence factor of the pneumococcus in a signature tagged 
mutagenesis screen (Hava and Camilli, 2002).
The aim of this work was to answer the following questions:
• What proteins are involved in the stress response of the pneumococcus?
• Do these proteins affect the regulation of other proteins or metabolic factors?
• Are these proteins necessary for virulence o f S. pneumoniae^
• Are mutations in such stress genes likely to affect growth pattern or virulence? and in 
what way?
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MATERIALS AND METHODS
Materials and Methods
2.1 Bacterial strains and growth conditions
Streptococcus pneumoniae strains used in this study are listed in table 2.1. Bacteria were 
grown on blood agar base number 2 (Oxoid, Basingstoke, United Kingdom) supplemented 
with 5% (vol/vol) defibrinated horse blood (E&O Laboratories, Bonnybridge, United 
Kingdom) (BAB) and in Brain Heart Infusion (BHI). Escherichia coli strains DH5a and 
XL-Gold ultracompetent cells (Stratagene) were grown in Luria- Bertani broth or Luria- 
Bertani (LB) agar plates. Where appropriate, antibiotics were added to the growth media at 
the following concentrations: ampicillin at 50 pg/ml, erythromycin at 1.0 mg/ml for E". coli 
or 1.0 pg/ml for S. pneumoniae and spectinomycin at 200 pg/ml for E. coli or 100 pg/ml 
for S. pneumoniae. Agar plates or broth inoculated with bacteria were incubated at 37 
unless otherwise stated.
2.2 Primers and plasm ids
The oligonucleotide primers used in this study are listed in table 2.2, PCR-Script™ 
plasmid (Stratagene) was used for cloning according to the manufacturers’ 
recommendations. pDL278 plasmid (LeBlanc et a l, 1992) was used as a template to 
amplify the yf^'cLgenerated spectinomycin resistance cassette (used as antibiotic marker in 
some mutants) using primer pair spec up and spec dn (table 2.2). pAL2 plasmid (Beard et 
a l, 2002) was used for expression of HtrA in S. pneumoniae.
2.3 Preparation of glycerol stocks
All pneumococcal strains used in this study were confimied by colony morphology, 
production of a-haemolysis on blood agar plates, Gram stain and sensitivity to 5 |ag of 
ethylhydrocupreine (optochin). Serotypes were confirmed by the Quellung reaction using 
specific antisera against capsular polysaccharide. Glycerol stocks of wild type and mutant 
strains were prepared by growing a single colony of the culture in BHI to mid-log phase 
(O D eoonm  ~ 0.6-0.7). Sterile glycerol was then added to a final concentration of 20 % 
(vol/vol) and 1-ml aliquots of the cultures were frozen at -  80 °C in cryotubes.
62
Materials and Methods
Table 2.1- List of pneumococcal strains used In this study.
Strain Relevant features Reference or source
D39orD39(M A) Serotype 2; NCTC 7466 (Avery et a l, 1944)
D39 (LA) Serotype 2, avimlent strain Laboratory stock '
TIGR4 Serotype 4, clinical isolate (Aaberge et a l, 1995)
R6 Subclone of R36A, derivative of D39 (Smith and Guild,
1979) ?
R800 R6 derivative (Lefevre et a l, 1979) i
0100993 Serotype 3, clinical isolate (Throup et a l , 2000) ■Ï
D39 (MA) AclpC D39 (MA) with replacement of clpC with Ery This work
cassette %
D39 (LA) AclpC D39 (LA) with replacement of clpC with Ery This work
..AÀ.
cassette
R6 AclpC R6 with replacement of clpC with Ery This work ■?
cassette
R800 AclpC R800 with replacement of clpC with Ery This work
4
cassette
TIGR4 AclpC TIGR4 with replacement of clpC with Ery This work "’S
cassette ■•4."Ï
SP 2000 AclpP mutant with Kan cassette (Chastanet et a l.
2001)
D39 AclpP D39 (MA) with replacement of clpP with This work
Kan cassette
TIGR4 AclpP TIGR4 with replacement of clpP with Kan This work
cassette
D39 AhtrA D39 with replacement of HtrA with spec This work
cassette
TIGR4 AhtrA TIGR4 with replacement of htrA with spec This work
cassette
D39 AhtrA/phtrA^ D39AhtrA complemented with pAL2-HtrA This work
cia spc 136b R6 mariner mutant of ciaR (Martin et a l , 2000) i
D39AciaR D39 with mariner insertion in ciaR This work
0l00993AciaR 0100993 with replacement of ciaR with Ery (Tiiroup et a l, 2000)
cassette
D39/pAL2YI D39 with the empty pAL2YI vector This work ■ -,j|
T939lphtrA'^ D39 with pAL2-HtiA plasmid This work
T>39 AciaR/phtrA^ J939AciaR complemented with pAL2-HtrA This work
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Table 2.2- List of oligonucleotide primers used in this study.
Primer Sequence (5’-^ 3’) Used for
ClpC and ClpP work
ClpC a 1 ATGAACTATTCAAAAGCATTG
ClpC a2 TGCAATATCAAATTTTAACTGG
Clp invl GGCGCGCCTATCATGCAAAATCGCATAG
Clpinv2 GGCGCGCCAACTGAAAAAAGCTTATAGACC
Ery 3 GGCGCGCCTAACTATCGTCTTGAGTCCAACCC
Ery 5 GGCGCGCCGTTCATATTTATCAGAGCTCGTGC
MCP1 .for CATACAAGAGGTAGATAGAAAAGG
MCP2.rev TCAAACCAGTGTTTTGAGCAACCT
ClpP for ATGATTCCTGTAGTTATTGAAC
ClpP rev GTTCAATGAATTGTTGGCCATA
AC94 TGACCATGGTTCCAGCTGCTAAAGTTGGC
AC97 GCTACCATGGCAAGCGCCACAAACGATAG
HtrA and CiaR work
Hti A for ATGAAACATCTAAAAACATT
HtrA rev AGATTCTAAATCACCTGAAC
Hti'A invl GGCGCGCCTACGCTATTTTGTCTGTT
Hti'A inv2 GGCGCGCCTTGGGAATCCAGATGGTTAAT
Spec up GGCGCGCCATCGATTTTCGTTCGTGAATA
Spec dn GGCGCGCCTATGCAAGGGTTTATTGTT
htrA C1 AGTTATAATTAAGCTAGTCAG
htrA C2 TGATTCTACACTAACACATCT
HtrAl CTGAATTCATAGGAGGACTATGAAACATC
HtrA2 CTGAATTCAGATTCTAAATCACCTGAAC
pAL2yl CGAAAATTTGTTTGCTTTTTAATGG 
pAL2y2 GGATACATTTCTATTGAGACTGGAT 
MP144 CGAACCAAGCTGGAATATCT
MPI 45 AACCATGTCAGGATCGTAGT
clpC amplification 
clpC amplification 
Deletion of clpC 
Deletion of clpC 
Amplification of 
erythromycin cassette 
Amplification of 
erythromycin cassette 
Confirmation of 
chromosomal insertion of 
interrupted clpC 
Confirmation of 
chromosomal insertion of 
interrupted clpC 
clpP amplification 
clpP amplification 
clpP deletion (Chastanet et 
a/., 2001)
clpP deletion (Chastanet et 
al, 2001)
Amplification of htrA 
Amplification of htrA 
Deletion of htrA 
Deletion of htrA 
Amplification of 
spectinomycin cassette 
Amplification of 
spectinomycin cassette 
Confirmation of 
chromosomal insertion of 
intenupted htrA 
Confirmation of 
chromosomal insertion of 
intenupted htrA 
Cloning of htrA into pAL2 
plasmid
Cloning of htrA into pAL2 
plasmid
htrA orientation in pAL2 
htrA orientation in pAL2 
PCR of ciaR/H. Upstream of 
ciaR (Martin et a l , 2000) 
PCR of ciaR/H. Downstream 
of ciaH (Martin et al, 2000)
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2.4 Preparation of genom ic DNA
Pneumococcal genomic DNA was prepared according to a published protocol (Blue and 
Mitchell, 2003). A single bacterial colony grown on blood agar plate was picked up and 
used to inoculate 10 ml of BHI and incubated overnight at 37 °C. Bacterial cells were 
collected by centrifugation at 5,000 xg at room temperature for 15 min (Sigma laboratory 
centrifuge 4K15), resuspended in 1-ml extraction buffer (10 mM Tris pH 8.0, 100 mM 
EDTA pH 8.0, 20 pg/ml RNAseA, 0.5 % SDS w/vol) and incubated at 37 °C for Ih. 
Proteinase K (Sigma-Aldrich, UK) was added to a final concentration of 100 pg/ml and the 
mixture was further incubated for 3 hours at 50°C. An equal volume of phenol/ 
chloroform/isoamylalcohol (25:24:1 vol/vol, BDH & Fisher Scientific UK. Ltd.) was then 
added and the mixture was gently mixed. Following centrifugation at 13,000 xg for 3 min 
(Eppendorf centrifuge 5417C, Germany), the aqueous layer was removed and DNA was 
precipitated by adding 0.2 volume of 10 M ammonium acetate (Sigma-Aldrich, UK) and 5 
volumes of 100 % ethanol. The mixture was then centrifuged at 13,000 xg for 30 min and 
DNA pellet was left to air dry for 30 - 60 minutes. DNA was resuspended in TE buffer 
(Qiagen) pH 7.4 and stored at -  20 °C.
2.5 Analysis of DNA
DNA samples were analyzed by measuring the OD260nm and OD2gonm (Unicam UV2, 
UV/Vis spectrophotometer) where an OD260nm of 1.0 corresponds to 50 pg/ml of DNA and 
OD260nm/ OD280nm IS 1.8 foi" pui'c DNA. DNA was also analyzed by running on a 1% 
agarose gel (Gibco BRL Life Teclmologies, UK) containing 0.5 pg/ml ethidium bromide 
(Sigma-Aldrich, UK) in TAE buffer. DNA was visualized using an UV transilluminator 
(Spectroline, TVC-312A) and images were taken using a UVP GelDoc system (UVP 
Laboratories).
2.6 DNA techniques and transform ation
2.6.1 Polymerase chain reaction
Genomic DNA was prepared as described above (section 2.4) and specific primers for 
different genes are listed in table 2.2. PCR reactions (100 pi) were set up as follows; 5 pi 
(-500 ng) genomic DNA, 1 pM of each primer (Sigma-Genosys, UK), 10 pi of themiopol
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buffer, 2 \û of 100 mM MgS0 4 , 2 units of Vent® polymerase (all purchased from New 
England Biolabs, UK) and 50 pM of dNTPs (Promega). The reaction volume was made up 
to 100 pi using dHaO. The PCR reactions were heated to 95 °C for 5 min and run through 
35 cycles of (95 °C for 30s, 55 °C for 30s, 72 °C for 1 min) and then heated to 72 °C for 5 
min. Amiealing and extension temperatures were variable and were optimized using a 
gradient program (Hybaid Omnigene PCR machine). PCR products were visualized as 
mentioned above (section 2.5).
2.6.2 DNA purification and cioning
DNA samples to be purified were run in DNA loading buffer (appendix, A3) in 1% 
agarose gels as described previously (section 2.5). 1 kb plus ladder (Promega) was also run 
on the gels to confinn the molecular weight of DNA fragments. DNA bands were excised 
from the gel and purified by using Qiaquick Gel Extraction Kit (Qiagen) according to the 
manufacturer’s instructions. PCR-Script™ Amp SK (+) plasmid (Stratagene, see appendix, 
A l) was used for cloning according to the manufacturer’s recommendations. Genes were 
cloned at the SrfI site as blunt-ended products and the proper orientation of genes was 
confirmed by restriction digestion with the appropriate endonuclease enzymes.
2.6.3 Transformation of E. coli with plasmid constructs
Escherichia coli strains DH5a and XL-Gold ultracompetent cells (Stratagene) were used 
for propagation of plasmid constructs following the manufacturer’s instructions. The cells 
were plated onto LB agar plates with the appropriate antibiotic and also with IPTG and X- 
gal to facilitate the identification of transformed cells by blue/white selection. Cells 
containing vector with no insert form blue colonies while those containing vector carrying 
the insert form white colonies. Single white colonies were picked up and used to inoculate 
LB broth with the appropriate antibiotic and incubated overnight at 37 °C. In some 
experiments, Top 10 electrocompetent cells (hivitrogen) were used for transformation as 
follows; lOO-pl aliquots of competent cells were thawed on ice and 1-5 pi of plasmid DNA 
was added. The tubes were incubated on ice for 20 min. The mixture was then transferred 
to pre-chilled 1-mm-gap electroporation cuvettes (Molecular BioProducts) and the samples 
were electroporated using Gene Pulser^^ (BIORAD) with the following settings; voltage: 
1.5 V, capacitor: 25 pF, resistor: 200 Ohm. A typical time constant with these settings was 
~ 4.6. After electroporation, the cuvettes were placed back on ice, 200 pi of SOC or LB 
medium was added and the contents transferred to microcentrifuge eppendorf tubes and
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incubated at 37 °C for an hour. Different volumes of the cells were then plated onto LB 
agar with the appropriate antibiotic and incubated overnight at 37 °C.
2.6.4 Plasmid preparation and purification
Following overnight incubation, transformed cells were haiwested by centrifligation at 
5,000 xg at room temperature for 5 min (Sigma laboratory centrifuge 4K15). Plasmids 
were isolated from bacterial pellets using the commercially available Qiaprep Spin 
Miniprep Kit (Qiagen). Plasmid DNA concentration and purity was determined as 
deseribed in section 2.5.
2.6.5 DNA sequencing
To confirm that plasmids carry the con'ect inserts, Plasmid DNA samples were sent to the 
MB SU (Molecular Biology Support Unit, University o f Glasgow, UK) for sequencing 
using the appropriate primers. Primers were used at 3.2 pM concentration for sequencing 
reactions. The MB SU sequence faeility used ABI377 and MegaBACElOOO DNA 
sequencers (Amersham Bioscience) and a protocol based on the dideoxy method 
developed by Sanger et al (Sanger et a l, 1977). Sequence homology searches were 
performed using BLAST (Altschul and Lipman, 1990) and the Institute for Genomic 
Research (TIGR, CMR, http://www.tigr.org/) database.
2.7 Construction of pneum ococcal m utants
2.7.1 Strategy for introducing mutation
Isogenic mutants of S. pneumoniae were constructed to study the role played by different 
stress response proteins in the virulence of this organism. The strategy used for making 
mutants is outlined in figure 2.1. The whole gene to be mutated was amplified from the 
pneumococcal cliromosomal DNA (strain D39 unless otheiivise mentioned) using forward 
and reverse primers specific for each gene (table 2.2) and cloned in PCR-Script™ Amp SK 
(+) plasmid (Stratagene). hiternal primers, (table 2.2) were designed to amplify the 5’ and 
3’ends of the gene together with the PCR-Script™ and to create Ascl sites in the resulting 
PCR product. This PCR product was self-ligated to produee a plasmid carrying the 
interrupted gene. The resulting plasmid was purified as described in section 2.6.4 and 
sequenced in-house (MBSU) as described above, using primers T3 and T7 specific for
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PCR-Script™ plasmid to confirm the knockout of the gene. To facilitate the selection of 
transformants, an y45cl-generated antibiotic resistance cassette (either erythromycin or 
spectinomycin) was ligated into this plasmid after digestion with Ascl. The modified 
version of the gene was amplified with PCR and used to transform S. pneumoniae. This 
method was used for making ClpC- and HtrA-null mutants in a serotype 2 background 
(strain D39).
Inv. primer 1
Inv. primer 2
PCR-Script
Gene of interest cloned 
in PCR-Script plasmid
V
1. Inverse PCR
2. Cut with Ascl
3. Self ligation
Ascl Ascl
R
Ascl
Antibiotic cassette
Ascl V
Marker
ligation
Ascl
Antibiotic cassette B
V
PCR and transform 5. pneumoniae 
Figure 2.1- Strategy for making pneumococcal mutants
2. 7.2 Transformation of S. pneumoniae
Transformation of S. pneumoniae strains D39 (serotype 2) and TIGR4 (serotype 4) was 
done by using a modification of an existing method (Lacks and Hotchkiss, 1960). 
Competence stimulating proteins (CSP-1 for D39 and CSP-2 for TIGR4) were used for 
inducing competence in these different serotypes (Pozzi et a i, 1996). Competent cells of
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D39 or TIGR4 were prepared as follows; 200 pi of glycerol stock of cells (previously 
frozen down at ODeoonm -0 .6 )  were used to inoculate 10 ml of CAT medium (Porter and 
Guild, 1976) (see appendix, A3) supplemented with 20 % glucose and 0.5M K2HPO4 
(CAT/GP medium) and incubated at 37 °C until they reached an ODeoonm of 0.3-0.4. Cells 
were then haiwested by centrifugation at 5,000 x g for 10 min at 4 °C (Sigma laboratory 
centrifuge 4K15) and cell pellets were resuspended in CAT/GP medium containing 20% 
glycerol and frozen down at -  80 °C as 100-pi aliquots. Aliquots o f competent cells were 
thawed and diluted 1/10 in CAT/GP medium supplemented with 4% bovine serum albumin 
and O.IM CaCh (CTM medium), and 100 ng of CSP/ml was added. Different amounts of 
transforming DNA (0.5-2 pg) were then added and the cells were incubated at 37 °C for 10 
min and then at 30 °C for 20 min. Transformed cells were selected on BAB plates with 
appropriate antibiotic selection.
2.7.3 Moving mutation from existing mutants
Some of the mutant strains used in this study were made by PCR amplification of the 
mutated genes from existing mutants of different serotypes.
2.7.3.1 ClpP mutants
The AclpP mutants of TIGR4 and the mouse-adapted strain of D39 (D39 MA, table 2.1) 
were constmcted using a AclpP mutant strain, SP2000 (Chastanet et a l, 2001) kindly 
provided by Jean-PieiTe Claverys (Toulouse, France). The mutation was moved by PCR 
amplification of a 1,6-kb fragment con-esponding to the mutated clpP gene carrying a 
kanamycin resistance cassette using primer pair AC94 and AC97 (table 2.2) and using the 
PCR product to transfonn D39 and TIGR4. Transformed cells were selected on agar plates 
containing 250 pg/ml kanamycin.
2 .7 .3.2 CiaR mutants
The AciaR mutant strain cia spc 136b (Martin et a l, 2000) kindly provided by Jean-Pierre 
Claverys (Toulouse, France) was used to move the AciaR mutation into D39 by PCR 
amplification of a 6-kb fragment corresponding to the AciaR mutation using primer pair 
M PI44 and M PI45 (Martin et a l, 2000) (table 2.2) and using it directly to transform D39 
wild type to create D39AciaR. Transforaied cells were selected on agar plates containing 
100 pg/ml spectinomycin.
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2 . 7.4 Confirmation of mutants
To confirm the mutations, genomic DNA was prepared from the transfonned cells grown 
on blood agar plates supplemented with the appropriate antibiotic as described previously 
(section 2.4) and PCR was used to compare the mutated genes to those of the wild types. 
Homologous recombination of mutated DNA into the pneumococcus chromosome resulted 
in an increase/decrease in PCR product size for mutants when compared to the wild type 
copy of the gene. To ensure that the mutations occurred at the correct position of the 
chromosome, mutations were also confirmed by sequencing. Primers flanking the target 
genes were designed to amplify the genes with flanking DNA in the wild types and 
mutants and the PCR products were sent to the MB SU for sequencing as described in 
section 2.6.5. In the correct mutants, the sequence showed the 5’ end of the gene followed 
by the antibiotic resistance marker and the 3 ’ end of the gene whereas, sequence of the 
wild type copy showed the full length of the gene.
To confirm that the observed phenotype of D39 AclpC mutant strain was due to the 
disruption of clpC and not mutations elsewhere in the chromosome the clpC mutation was 
repaired. A 2,578-bp PCR product was amplified from wild-type D39 genomic DNA using 
primer pair MCPl for and MCP2 rev (table 2.2). This fragment contained 30 bases 
upstream of the start codon {ctsR gene) and an additional 115 bases downstream of the stop 
codon for clpC. This PCR product was purified using the Qiagen gel purification kit and 
used directly to transform D39 AclpC strain by homologous recombination. 
Transformation of S. pneumoniae D39 AclpC strain was carried out as described in section
2.7.2. The transformation reactions were screened for transformants by plating onto 
selective plates (with 1 pg/ml erythromycin) and non-selective plates (without antibiotic). 
Colonies that lost erythromycin resistance were selected and checked by PCR and 
nucleotide sequencing for the presence of a complete copy of clpC. The effect o f HtrA 
mutation was confirmed by complementation of HtrA from a plasmid (see below),
2.8 Construction of the plasmid expressing htrA gene in 
the pneum ococcus
htrA was expressed in pAL2 (appendix, A2) plasmid (Beard et a l, 2002) from the 
constitutive promoter of S. pneumoniae aminopterin resistance operon {ami) (Alloing et 
a l, 1990). Primer pair htrAl and htrA2 (table 2.2) was used to amplify htrA with EcoBl 
sites and a Gram-positive Ribosome Binding Site (RBS). This fragment was ligated to the
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ÆcoRI-digested pAL2 caixying the ami promoter to create pAL2-HtrA plasmid. Proper 
orientation of htrA gene in pAL2-HtrA plasmid was confirmed by PCR using primer pair 
pAL2yl and pAL2y2 (table 2.2) and the htrA gene was sequenced using the forward 
primer pAL2yl and the reverse primer htrA2 for further confirmation. A schematic 
representation of pAL2-HtrA is shown in figure 2.2.
fSamHI
Hindlll
■EcoRI
Pam i
htrAEm-R
pAL2-HtrA 
8651 bp
'EcoRI
Cm-R
p15Aori
Hindlll
B a rn m  - 3 5  - 1 0  E coR I  R B S
5 ’ -ggatacgaaaatttgtttgctttttaatggataatgtgatataat-nl4-gaattc-acAGGAGGactATG-3 ’
Figure 2.2- A schematic representation of pAL2-HtrA plasmid.
pAL2-HtrA plasmid used for expression of htrA gene In Streptococcus 
pneumoniae. It was modified from pAL2 plasmid (Beard et al., 2002) as 
explained In the text of this section. Arrows indicate the location and orientation 
of open reading frames. The nucleotide sequence shows the region between the 
ami promoter and the start codon of htrA. The Gram-positive ribosome binding 
site Is shown in bold and uppercase, the htrA start codon Is shown In 
uppercase, and restriction sites are underlined. Em-R, erythromycin resistance 
gene, Cm-R, chloramphenicol resistance gene.
2.9 Complementation with HtrA
The pAL2-HtrA plasmid described above, which carries an erythromycin resistant cassette, 
was used to transform D39AhtrA and D39AciaR mutants to generate the complemented 
strains D39AhtrA/phtrA^ and D39AciaR/phtrA'^ in which HtrA is expressed from the 
plasmid. To test whether the effect of pAL2-HtrA plasmid was solely due to htrA insertion,
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the Æ'coRI-digested pAL2 firagment containing the ami promoter was self ligated to create 
the empty plasmid designated pAL2YI. This plasmid was used to transform D39 wild type 
to generate the D39/pAL2YI strain (table 2.1). Strains complemented with HtrA were 
compared to the knockout strains with a number of assays to confirm that the phenotypes 
of these knockout strains are solely due to HtrA.
2.10 In vitro a ssay s
2.10.1 Determination of bacterial growth
Growth phenotypes of the strains at normal and elevated temperatures were determined by 
measuring optical densities at 600 nm (ODeooum) and the viable counts as described below
2.10.1.1 Growth curves
Aliquots of bacterial standard inocula (glycerol stocks) were quickly thawed at 37 °C in a 
water bath and the same number of viable cells (10^ CFU/ml) of each strain was used to 
inoculate BHI prewarmed at 37 ”C or 40 ‘’C or otherwise stated. At Ih-intervals, samples 
were withdrawn to measure the ODeoonm (Unicam UV2, UV/Vis spectrophotometer) with 
the use o f BHI as a blank.
2.10.1.2 Viable count
To enumerate the number of colony forming units (CPU) o f bacteria in frozen stocks, an 
aliquot of glycerol stock was thawed and 900 pi was removed and centrifuged at 13,000 xg 
(Eppendorf centrifuge 5417C, Gennany) for 3 min to collect cells. The cell pellet was 
resuspended in 900 pi of sterile phosphate buffered saline (PBS). Serial 10-fold dilutions 
in PBS (up to 10^) were made in a 96-well round-bottom plate (Nunclon® surface, Nalge 
Nunc International™). 6 x 20 pi of each dilution were plated onto BAB plates that were 
divided into six segments at the base and the plates were incubated at 37 °C overnight. 
Next morning, the number of bacterial colonies in the plates was counted (a number of 50- 
200 colonies/spot was considered) and the number of CFU/ml was calculated from the 
formula (Average number of colonies x 50 x dilution factor).
For growth phenotype comparison, equal numbers of viable cells (10^ CFU/ml) of each 
strain was used to inoculate BHI prewanned to the desired temperatures and samples were 
withdrawn at Ih-intervals to detennine the viable count as described above.
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2.10.2 Stress experiments
2.10.2.1 Penicillin-induced loss of viability
The penicillin-induced cell lysis of mutant strains and their wild types was studied 
according to the method of Charpentier and co-workers (Charpentier et a l, 2000). 10 ml of 
cultures grown in BHI to ODeoonm - 0 .3  were exposed to 10 times the minimal inliibitoiy 
concentration (MIC) of benzylpenicillin (0.1 pg/ml) and the effect on cell viability was 
recorded by plating samples of penicillin-treated cultures taken at hourly inteiwals on BAB 
as described in section 2.10.1.2.
2.10.2.2 Deoxycholate-induced lysis
Bacterial strains were gi'own in BHI at 37 °C until they reached mid-log phase of growth 
(ODeoonni ~ 0.6-0.7). 10 % (w/vol) of deoxycholate (DOC; Sigma-Aldrich, UK) prepared in 
PBS was added to 5-ml aliquots of each culture to a final concentration of 0.05 %. Viable 
count was determined before the addition of DOC and at different time points following 
treatment with DOC.
2.10.2.3 Sensitivity to hydrogen peroxide
The sensitivity of strains to H2O2 was tested by using the method of Johnson and co­
workers (Jolmson et a l, 1993) with a slight modification. Aliquots of cultures grown to 
ODeoonm -  0.3 were exposed to 40 mM of H2O2 for 5,10 and 15 minutes at room 
temperature and the viable cells were counted by plating onto blood agar plates before and 
after the exposure to H2 O2 and the result was expressed as percentage suiwival.
2.10.2.4 Sensitivity to paraquat
The effect o f the redox compound methyl viologen (paraquat) was studied. A total of 10"^  
cells were exposed to 60 mM paraquat (Sigma-Aldrich, UK) over a period of two hours. At 
various time intervals, samples were taken and the number of viable cells was determined 
by plating onto BAB (Tseng et a l, 2002).
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2.10.2.5 PH tolerance
To study the role of stress proteins in pH tolerance, equal numbers of cells of mutant 
strains and wild types were used to inoculate BHI adjusted at pH 4, 5, 6, 7, 8, and 9. The 
growth was recorded after overnight incubation at 37 °C (Diaz-Torres and Russell, 2001).
2.10.3 Analysis of protein
2.10.3.1 Protein preparation
Bacterial strains were grown in BHI to the desired optical densities at the appropriate 
temperatures. Cell pellets from 20-ml cultures were collected by centrifugation at 5,000 x 
g for 15 min and were resuspended in 1 ml of phosphate buffered saline (PBS). Cell 
suspensions were sonicated 4 times of 30s each with a 13-mm probe (Sonicator, Vibra cell, 
Sonics & Materials Inc.) using a power output of 36W. The tubes containing the samples
2.10.3.3 SDS-PAGE
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was used to 
visualize proteins according to a standard protocol (Sambrook et a l, 1989). After 
assembling the minigel apparatus (BIO-RAD), a 10-12 % separating gel (appendix, A3) 
was poured, overlayed with dHiO and allowed to set. Stacking gel (appendix, A3) was 
then poured on top of separating gel, a 10-well comb was inserted and the gel was left to 
set. While the gel was allowed to set, protein samples in loading buffer (appendix, A3) 
were heated to 95 °C for 5 min. The combs were then removed and protein samples were
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were kept in crushed ice during sonication. The cell debris was removed by centrifugation
j
at 13,000 X g for 10 min.
2.10.3.2 Protein quantitation
Concentrations of total proteins were determined by Bradford assay with the use of bovine 
serum albumin (BSA) as a standard (Bradford, 1976). Different concentrations of BSA 
standard, protein samples or PBS (in triplicates) were mixed with Bradford reagent 
(Sigma-Aldrich, UK) and the absorbances at 280mn (A280) were measured using a Unicam 
UV2, UV/Vis spectrophotometer. A standard cui’ve was created by plotting the average 
readings of standards against their concentrations. The concentration of protein in each 
sample was calculated from this standard cuiwe.
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loaded along with a standard protein ladder (Kaleidoscope Prestained Standards, BIO­
RAD) to determine protein band size. Gels were i*un at 150 V for approximately 90 min 
using a Biorad power pack 300. When protein separation was completed, as indicated by 
migration of the bromophenol blue dye in the loading buffer towards the bottom of the 
gels, the gels were carefully removed from the glass plates and stained with Coomassie 
stain (appendix, A3) for 3-4 hours with shaking. Gels were then destained using destain 
solution (appendix, A3) until protein bands were clearly visible.
2.10.3.4 Western immunoblot
For western blot analysis, equal amounts of total proteins hom  each strain were separated 
on SDS-PAGE as described above and gels were equilibrated in the transfer buffer 
(appendix, A3) for 30 min shaking. Hybond-C nitrocellulose membrane optimized for 
protein transfer (Amersham) and filter paper were cut to the size of the gel and soaked 
along with fibre pads in transfer buffer. The BIO-RAD blotting apparatus was assembled 
as follows; grey side of holder, fibre pad, filter paper, gel, membrane, filter paper, filter 
pad. An ice pack and stiiTer bar were placed in the tank and the protein bands were blotted 
at 100 V for 80 min. The membranes were blocked by transferring them into 3 % skimmed 
milk in Tris-NaCl (appendix, A3) for Ih or overnight. Membranes were then transferred 
into 3 % skimmed milk in Tris-NaCl with 1:1000 dilution of the primary antibody and 
shaken at 37 °C for 2-3 hoiu's before washing four times with Tris-NaCl for 5 min each. 
They were then transferred to 1:1000 dilution of the secondary antibody (anti-mouse or 
anti-rabbit horseradish peroxidase-linked whole antibody, Amersham) in the same solution 
and shaken at 37 °C for 1 h. Membranes were washed as before and transferred to the 
developer solution (appendix, A3) in the dark for 15 min or until bands developed. Blots 
were air dried and scanned.
2.10.4 Haemolytic assay
Pneumolysin activity of the mutant strains was compared to that of the wild type by the 
haemolytic assay, which is based on the ability of pneumolysin to cause lysis of red blood 
cells. 50-pl aliquots of PBS were added to the first-column wells of two round-bottomed 
96-well plates (Nunclon® surface, Nalge Nunc International™) and 50 pi of total protein 
samples prepared as described in section 2.10.3.1 or PBS control were added and two-fold 
dilutions were made across the two plates. 50 pi of 2 % defibrinated sheep red blood cells 
(E&O Laboratories, Bonnybridge, UK) was added to each well and the plates were
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incubated at 37 °C for 30 min and then left at room temperature until blood cells in 
negative wells had settled down. Results were read by visual examination of wells where 
in negative wells, blood cells fomi compact pellets whereas in positive wells pneumolysin 
caused the lysis of cells and therefore prevented pellet formation. The end point was taken 
as the well in which the pellet is half the size of the control wells. The haemolytic units 
were calculated from the number of dilutions required to cause 50 % cell lysis. For 
instance, in the first well, pneumolysin is diluted 1:2 in PBS and further diluted 1:2 when 
blood is added i.e. diluted by a factor of 4. If the first well is the endpoint, so there are 4 
haemolytic units (HU) in 100 pi i.e. 40 HU/ml.
2.10.5 Competence assay
Competent cells of D39 wild type and AhtrA and AhtrA/htrA^ mutants were made as 
described in section 2.7.2 and stored as 100-pl aliquots with 20% glycerol at -  80 °C. To 
compare the ability of the AhtrA and AhtrAfhtrA^ mutants to take up external DNA to that 
of the wild type D39, competent cells were thawed, diluted 1:10 in CTM medium 
described before (section 2.7.2) and 100 ng/ml of competence stimulating peptide (CSP) 
was added. 0.3 pg of pneumococcal genomic DNA confemng kanamycin resistance (hom 
a t^clpP mutant containing kanamycin resistance cassette (Chastanet et a l,  2001) was then 
added and the cells were incubated at 37 °C for 10 min, then at 30 °C for 20 min. 
Transformed cells were incubated on BAB without antibiotic selection for 2 hours at 37°C, 
then 250 pg/ml of kanamycin was added and incubation continued overnight. The 
efficiency of transfonnation was expressed as percentage o f transformants to the total 
number of cells used.
2.10.6 Neuraminidase activity measurement
Neuraminidase activity in different cell fractions (Soluble, insoluble and supernatant) was 
assayed fluorometrically by mixing 10 pi of enzyme sample (total protein extracts), known 
concentrations of purified neuraminidase (positive control) or PBS (negative control) in 
triplicates with 10 pi of 0.35 % (w/vol) of the fluorogenic substrate 2 '-(4-methyl- 
umbelliferyl)-a-D-A-acetylneuranhnic acid (MUAN) (Sigma) in a 96-well plate as 
previously described (Lock et a l, 1988b). The reaction mixture was incubated for 10 min 
at 37 °C, and the reaction was stopped by the addition o f 180 pi of 50 mM sodium 
carbonate buffer, pH 9.6. Fluorescence resulting from the release of 4-methylumbelliferone
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fi-om MU AN was detected using a Perkin-Elmer LS2B fluorimeter at an excitation 
wavelength of 366 nin and an emission wavelength of 446 nni.
2.10.7 Hyaluronidase activity measurement
The hyaluronidase activity was detected using a protocol based on two published plate 
methods (Smith and Willett, 1968, Richman and Baer, 1980) with the use of hyaluronic 
acid (HA) as a standard. Hyaluronic acid (Sigma-Aldrich) was dissolved in water at 8 
mg/ml concentration and 0.8 % agarose (Roche Diagnostics, Germany) was dissolved in 
0.3 M sodium phosphate buffer pH 7.0. 1 ml of HA was mixed with 9 ml of agarose heated 
to 55 °C and the mixture was poured into Petri dishes. After solidification, 3-mm wells 
were punched and emptied. 100 pi of samples or hyaluronidase control (Sigma-Aldrich) 
was then added to the wells and the plates incubated at 37 °C overnight (17-24 hours). 
Wells were then emptied and the surface medium flooded with 10 % (w/vol) of 
cetylpyridinium chloride made up in dHzO and plates left on the bench for 30 min. A clear 
zone around the well suggested substrate degradation and the cloudy background resulted 
from undigested HA precipitation by cetylpyridinium chloride. The clear zones were 
measured in different cell fractions of the wild type and mutant strains and the activity of 
hyaluronidase compared.
2.11 In vivo a ssay s
All animal work was canied out after receiving proper training and under appropriate 
project and personal licenses from the Home Office, UK. Local regulations of the 
University of Glasgow were also abided by.
2.11.1 Mice
Female outbred M Fl mice (25-30 g) were purchased from Harlan Olac, Bicester, UK. 
They were used when they were 9 weeks old as a standard model of pneumococcal 
pneumonia and bacteraemia. They were housed at the Central Research Facility (CRF), 
University of Glasgow, UK. All mice were kept in appropriate cages and provided with 
sterile pelleted food (B&K Universal, North Humberside, England) and water throughout 
the experiments.
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2.11.2 Preparation of standard Inocula
Bacterial strains were passaged through mice to prepare standard inocula before studying 
their in vivo phenotypes. Cells fi‘om 900 pi of glycerol stock of each strain were 
resuspended by centrifugation at 13,000 xg (Eppendorf centrifuge 54170, Germany) for 3 
min. Pellets were resuspended in 900 pi of sterile PBS and diluted to give approximately 
1x10^ CFU/ml. Mice were injected with 200 pi of bacterial suspension (2x 10  ^CPU) into 
the peritoneal cavity using a 1-ml insulin syringe (Microfine, 12.7 mm, Becton Dickinson). 
24 hours (or 48 h for some mutants) following injection, mice were sacrificed by cervical 
dislocation and the chest cavity opened. Blood was collected from the right ventricle of the 
heart using a 23-gauge needle. 10 ml of BHI (+/- antibiotic) was inoculated with 50 pi of 
collected blood and incubated overnight (10-12 h) at 37 °C. Bacteria were collected by 
centrifugation at 5,000 xg at room temperature for 15 min and resuspended in 1 ml of BHI. 
100 pi of this suspension was used to inoculate 20 ml of BHI containing 20 % (vol/vol) 
heat-inactivated PBS (Gibco BRL, Life Technologies, UK) and incubated at 37 °C until 
mid-log phase of gi'owth (OD^ooum 0.6-0.7). Glycerol was added to a final concentration of 
20 % (vol/vol) and cultures kept as 1-ml aliquots at -  80 °C. Viable count of stocks was 
determined as described before (section 2.10.1.2) at least 24 hours following freezing.
2.11.3 Intranasal Infection
Bacterial suspensions were prepared from standard inocula to give 2x 10  ^ CPU/ml. Mice 
were lightly anaesthetized with 1.5 % (vol/vol) halothane (Zeneca Pharmaceuticals, 
Macclesfield, UK) over oxygen (1.5 L/min) using a calibrated vaporizer. Anaesthesia was 
confirmed when mice failed to produce a reflex reaction when gently pinched. The 
infectious dose (Ix 10  ^ CPU/mouse) was administered in 50 pi of bacterial suspension to 
the nostrils of mice held vertically (Kadioglu et al., 2000) using a Proline® pipette (Biohit) 
and mice were laid on their backs until they recovered. Viable counts of bacterial 
suspensions were determined before and immediately after infection as described in 
section 2.10.1.2.
2.11.4 Intra venous Infection
Bacterial suspensions were prepared from standard inocula to give 2x 10  ^ CPU/ml. Mice 
were placed in a ventilated, heated Perspex box for 5 min in order to expose veins and 
were restrained in appropriate apparatus. 100 pi of bacterial suspension was administered
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directly into the bloodstream via the lateral vein using a 1-ml insulin syringe (Microfme, 
12.7 mm, Becton Dickinson). Blood was taken from a separate vein immediately following 
injection to ensure successful infection (KeiT et a l, 2002) and bacteria enumerated as 
described in section 2.10.1.2.
2.11.5 Mice survival and pain scoring
Following infections, mice were obseiwed and the development of symptoms was recorded 
over a period of eight days unless stated otherwise. Symptoms progressed from normal to 
severe with mice showing piloerection (staiTy coat), hunched posture and lethargy. Severe 
infection eventually resulted in mice becoming moribund, indicated by their inability to 
move when encouraged to do so. When showing signs of lethargy or upon becoming 
moribund, mice were humanely euthanized and were considered to reach the endpoint of 
the experiment (Toth, 1997). Mice that sui*vived the course o f infection were assigned an 
arbitrary survival time of 192 h for statistical analysis.
2.11.6 Bacteriological Investigation
2.11.6.1 Bacterial loads in lung airways
At pre-chosen time points after intranasal infection, groups of mice were sacrificed by 
ceiwical dislocation ensuring intact trachea and the skin and muscles surrounding the 
trachea were exposed and the thoracic cavity opened. The trachea was clamped using 
Spencer-Wells forceps (Fisher Scientific Ltd, UK) to prevent backflow of fluid up the 
trachea. For bronchoalveolai' lavage, a 16-gauge nonpyrogenic angiocath (F. Baker 
Scientific, Runcorn, United Kingdom) was inserted into the trachea and the lungs were 
lavaged twice with a total volume of 2 ml of sterile PBS. Viable bacteria in the lung 
airways were counted by plating out serial 10-fold dilutions on BAB (KeiT et a l,  2002) as 
described in section 2.10.1.2.
2.11.6.2 Bacterial loads in lung tissue
Following intranasal infection, lungs were lavaged as mentioned in the previous section. 
Lavaged lungs were removed into 5 ml of sterile PBS and were homogenized with a glass 
handheld tissue homogenizer (Jencons, Leighton Buzzard, United Kingdom). Viable 
bacteria in lung homogenate samples were counted by plating out serial 10-fold dilutions 
on BAB (Kerr et a l,  2002) as described in section 2.10.1.2.
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2.11.6.3 Levels of bacteraemia
At pre-determined time points following intranasal infection, groups of mice were 
sacrificed by ceiwical dislocation and blood samples were collected from the right ventricle 
of the heart after the chest cavity was opened. Following intravenous infection, blood 
samples were taken fi'om peripheral veins. Mice were restrained as described in section 
2.11.4 and a maximum of 100 pi of blood samples was removed hom  the lateral tail veins 
and stored on ice. Enumeration of bacteria in blood samples collected by either method 
was earned out as described in section 2.10.1.2.
2.11.7 Nasopharyngeal colonization assay
Bacteria colonizing the nasopharynx were collected for counting by doing nasopharyngeal 
lavage early (6h-post-infection) and late in infection (48h-post-infection). Groups of MFl 
mice were intranasally infected with 1 xlO^ CFU/mouse as described in section 2.11.3. At 
the indicated time points, mice were sacrificed and the nasopharynx was washed by 
injecting 1-ml of sterile PBS into the trachea and collecting the fluid coming from the 
nares. The nasopharyngeal washes were then plated onto BAB with 20 pg/ml of neomycin 
to limit the growth of other bacteria.
2.11.8 Histological analysis
Mice were infected intranasally as described in section 2.11.3. At time points following 
infeetion animals were saerificed and their trachea exposed. The trachea was clamped as 
described in section 2.11.6.1 and inflated with 1ml of foimal saline (appendix, A3) using a 
catheter. Using a second set of forceps, the trachea was clamped just below catheter to 
keep the lung inflated. The first clamp and catheter were removed and the trachea was 
clamped just above the heart and lung using the first elamp. The second clamp was then 
removed and trachea was carefully cut above the first clamp to free the heart and lung and 
then pulled up. The heai1/lung was placed into formal saline and covered with a piece of 
tissue paper to keep the inflated lungs submerged in formal saline. After 24 hours, the 
lungs were taken out and the heart carefully dissected away and discarded. The lungs were 
placed in new fonnal saline until ready for further processing. Following fixation, the 
lungs were embedded in paraffin and blocked by utilizing standard histological protocols. 
Lung blocks were sectioned at 5 pm prior to staining with hematoxylin and eosin (BDH 
Laboratory supplies, Poole, United Kingdom) (Kerr et a l,  2002). Lung tissue seetions
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were examined by microscopy and the number o f areas at the pleural interface that were 
swollen with recruited inflammatory cells (pleurisy) as well as the number of perivascular 
alterations were scored in individual mice (Kerr et a l, 2002).
2,11.9 Measurement of immune modulators
At pre-deteimined time points following intranasal infection, as described in section 
2.11.3, mice were sacrificed and the thoracic cavity opened up to expose the lungs. 
Broncho alveolar lavage was done as described in section 2.11.6.1, but the fluid was snap- 
frozen by immersion in liquid nitrogen. Lungs were then removed, wrapped in aluminium 
foil, and snap-frozen in liquid nitrogen. Samples were then stored at - 80 °C until further 
processing. Upon thawing, the whole lungs were homogenized as described in section
2.11.6.2. Homogenates were centrifuged at 1,600 x g for 30 min at 4 °C (Sigma laboratory 
centrifuge 4K15). The supernatants were then centrifuged at 5,000 x g at 4 °C, filter- 
sterilized using 0.2 pM filter (Gelman Sciences, Northampton, United kingdom), and 
stored at -  80 °C. Upon thawing, lavage fluids were centrifuged at 17,900 x g for 3 min.
2.11.9.1 Measurement of IL-6
IL- 6  was measured by Enzyme-linked immunosorbent assay (ELISA) by utilizing 
commercially available antibody pairs. Flat-bottomed 96-well maxisorb™ plates (Life 
Teclmologies) were coated with 50 pi per well of a 2 pg/ml preparation of purified anti­
mouse mAh (Phanningen Cat. No. 554400, Becton Dickinson) in coating buffer (appendix, 
A3), sealed with cling film to prevent evaporation and incubated at 4 °C overnight. Wells 
were then emptied and unbound areas blocked by the addition o f 2 0 0  pi of blocking buffer 
(appendix, A3) and incubation at room temperature for 2 hours. Blocking buffer was 
removed from all wells and the plates were washed three times with PBS/0.05% tween 20 
(Polyoxyethylenesorbitan monolaurate) (wash buffer). The recombinant murine IL- 6  
standards (Phanningen Cat. No. 19251V) were prepared in blocking buffer/tween 
(appendix, A3) in the range of 1000 pg/ml to buffer only. Lavage fluids and lung 
homogenates prepared as described above were diluted 1:2 and 1:5 respectively in 
blocking buffer/tween prior to the addition of 1 0 0  pi of standard or sample in duplicates. 
Plates were then incubated at room temperature for 2 h or for 16 h at 4 °C. Plates were 
washed four times with wash buffer, 1 0 0  pi of 1 pg/ml solution of biotinylated anti-mouse 
mAb to IL - 6  (Phanningen Cat. No. 18082D, Becton Dickinson) was added and the plates 
were incubated for an hour at room temperature. Following four times of washing, 100 pi
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of 1:200 dilution of streptavidin-HRP (Genzyme Cat. No. 80-3546-03) was added and 
incubated for 30 min at room temperatui*e. After five washes with wash buffer, plates were 
developed with 100 pi of ELISA substrate (appendix, A3). Plates were incubated in the 
dark at room temperature for 30 min and the reaction stopped by addition of 100 pi of IM 
sulphuric acid. The A45 0  was detennined by reading the plates on a Dynatech MRX ELISA 
plate reader with correction set at A5 7 0 .
2.11.9.2 Measurement of TNF-a
TNF-a levels were measured by using TNF-a ELISA kit, OptEIA™ mouse TNF-a set 
(Pharmingen cat. no. 555268). Plastic flat-bottomed 96-well maxisorb™ plates (Life 
Technologies) were coated overnight at 4 °C with anti-mouse TNF-a capture antibody, 
diluted 1:350 in coating buffer (appendix, A3). Wells were washed three times with wash 
buffer (appendix, A3) and blocked with 200 pi of assay diluent (appendix, A3) for an hour 
at room temperature. TNF-a standards were prepared in assay diluent using two fold 
dilutions to concentrations ranging between 15.6 to 1000 pg/ml and assay diluent used as 
zero standard. Wells were washed three times, 100 pi of samples or standards was added 
and plates were sealed and incubated at room temperature for 2 hours. Wells were washed 
five times and 100 pi of working detector (biotinylated anti-mouse TNF-a detection 
antibody 1:350) was added and plates were sealed and incubated for an hour at room 
temperature. Wells were washed seven times, 100 pi of substrate solution (appendix, A3) 
was added to each well and the plates incubated in the dark for 30 min. reactions were 
stopped by adding 50 pi of 1 M phosphoric acid and absorbance (A450 ) read using 
Dynatech MRX ELISA reader with correction set at A5 7 0 .
2.12 Proteomic analysis
I performed the proteomic analysis of D39 àhtrA mutant in collaboration with Dr. Fran 
Mulholland at the histitute of Food Research (IFR), Norwich, UK.
2,12.1 Préparation of protein extracts
s. pneumoniae cultures were grown in BHI (100 ml) to an ODeoonm of 0.4 then haiwested 
hy centrifugation at 6,700 x g (Sigma laboratory centrifuge 4K15) for 15 min at room 
temperature and washed twice with cold PBS buffer, pH 8.0 (10 mM Na2HP0 4 , 1 mM 
KH2PO4 , 140 mM NaCl, 3 mM KCl). The pellets were kept at -80  °C. Frozen pellets from
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the 100-ml cultures were defrosted and resuspended in 4.67 ml Solution 1 (10 mM SDS, 
200 mM DTT, 28 niM Tris base, 20 mM Tris-HCl) and 330 i^l Solution 2 (24 mM Tiis- 
base, 0.47 M Tris-HCl, 50 mM MgClz, 10 mg/ml RNAse, 10 mg/ml DNAse in 5 mM 
CaCh). Total extracts were prepared by passing cells through a French pressure cell, One 
Shot Benchtop Cell Disrupter (Constant Systems Ltd, Warwick, UK) at 12,000 Ib/in^ four 
times keeping samples on ice between cycles. Cell debris was removed by centrifugation at 
13,200 X g for 15 min. the supernatant was then aliquoted and stored at -80 °C. Protein 
concentrations in the extract were measured by using Plus One Protein Quant kit 
(Amersham Biosciences).
2.12,2 Two-dimensional electrophoresis
2.12.2.1 First dimension
Bacterial lysates containing 50 pg of proteins prepai*ed by the method described in the 
previous section were analysed in individual gels. The proteins were separated in the first 
dimension using pHaser system (Genomic solutions, Aim Arbor, Michigan, USA) and 
immobilized pH gi'adient gel strips (IPG) pH 4-7 (Amersham Phamiacia, Uppsala, 
Sweden) as recommended by the manufacturers with minor modifications. Proteins were 
mixed with lysis buffer (7 M urea, 2 M thiourea, 4 % CHAPS, 40 mM Tris-base) to a final 
volume of 50 pi, and 350 pi of rehydration buffer (7 M urea, 2 M thiourea, 2 % CHAPS, 2 
% IPG buffer pH 4-7 (Amersham Pharmacia), 18.2 mM DTT, bromophenol blue). Gel 
strips were rehydrated with the total 400 pi overnight at 21 °C. Electrode wicks were put 
under the ends of the strips to allow better isoelectric focusing (lEF) and the strips were 
covered with dry strip cover fluid (Amersham Pharmacia) and the gel strips were run for 
24 hours. The gel strips were rinsed with MilliQ water and equilibrated in filtered 
equilibration buffer (56 % vol/vol Tris acetate equilibration buffer pH 7.0 (Genomic 
solutions), 5 % SDS, 6  M Urea, 30 % glycerol) containing 52 mM DTT for 30 min and 
after that in filtered equilibration buffer containing 1.35 M iodoacetamide for another 30 
min.
2.12.2.2 Second dimension
The proteins were separated in the second dimension on 10 % duracryl gels. Gels were cast 
according to the protocol (Investigator™ 2-D Electrophoresis System, operating and 
maintenance manual), except that glass plates were sealed with silicon (low modulus 
silicon sealant, ARBO, Adshead Ratcliff & Company Ltd, Derbyshire, England). The
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silicon was allowed to dry for at least one day. Gels were kept at 4 °C for one week to one 
month before use. Second dimension gels were run according to the protocol 
(Investigator^^ 2-D Electrophoresis System, operating and maintenance manual) using 
cathode buffer (top miming buffer; 0.2 M Tris, 0.2 M Tricine, 0.4 % SDS) and anode 
buffer (bottom miming buffer; 25 mM Tris/acetate) and the bivestigator system of 
Genomic solutions. Second dimension gels were taken out o f the cold room and their wells 
rinsed with top ruiming buffer several times using squeeze wash bottle and the wells were 
left full with top mmring buffer. A ring gasket with a silicone half moon gasket was put at 
each end round each gel cassette. First dimension gel strips were then placed in the well of 
the gel cassette and pushed gently to ease air bubbles away making sure all strips were 
inserted in the same orientation. Four gels were placed into each gel tank and the tank was 
sealed. The upper tanlc was filled with top buffer until the gasket rings were fully covered 
and the upper tank was placed into the lower tank unit and filled with top buffer until the 
gels were completely covered taking care not to disturb the strips resting on top of the 
second dimension gel. The gels were run for about four hours.
2.12.3 Staining, imaging and anaiysis
After separation, gels were stained with Sybro Ruby (Molecular Probes) according to the 
manufacturer’s recommendations. The gels were taken out of the tank and the glass plates 
were opened. Whilst still on the plates, the sides of the gels where no protein should be 
located were cut off. Gels were cai*efully lifted off the plates and placed into boxes 
containing 400 ml of Sybro Ruby Fix solution (40 % methanol and 10 % acetic acid in 
MilliQ water) and gels were left for at least one hour on a shaker. The fix solution was 
discarded and 330 ml o f Sybro Ruby stain was added in the dark, boxes were put into black 
plastic bags to avoid light and gels left for at least 90 min on a shaker. The Sybro Ruby 
was removed and 400 ml of the destain solution (10 % methanol and 6  % acetic acid in 
MilliQ water) was added and the boxes were covered again with black bags and left on the 
shaker for about one hour. The proXPRESS Proteomic Imaging System (Perkin Elmer, 
UK) was used for imaging. Gel images were analyzed using the ProteomeWeaver 
software.
2.12.4 Mass spectrometric anaiysis
Protein spots of interest were picked up for analysis using ProPick Spot Picker (Genomic 
Solutions). Protein spots were washed tbi'ee times for 20 min in 100 pi solution A (freshly
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prepared 80% (vol/vol) 50 ixiM ammonium bicarbonate, 20% (vol/vol) acetonitrile). The 
gel plugs were washed in 100 pi acetonitrile for 10-15 min and air dried for 10 min. For 
trypsin digestion, 5 pi of sequencing gi’ade porcine modified trypsin (lyophilized, 
Promega) containing 50 ng of trypsin in 10 mM ammonium bicarbonate, was added and 
the plugs incubated at 37 for 2-4 hours. Trypsin was inactivated by adding 5 % formic 
acid and the plugs were incubated at 37 °C for 20 min, flash frozen and stored at -80  °C.
For matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI- 
TOF-MS) analysis, the spots were analyzed by the John Imies Centre Protein Sequencing 
Facility. Peptide peak lists were searched against all bacteria databases at 
(http://www.matrixscience.com/).
2.13 Microarray analysis
Extra care was taken while working with RNA to avoid RNA degradation by RNases. 
Powder-free gloves were worn at all times to prevent contamination by RNases present on 
the skin and to avoid contamination of the array with dust particles. Before preparing or 
working with RNA, bench area, pipettes, glassware and gloves were treated with 
RNaseZap® RNase Decontamination Solution (Ambion Ltd, UK) to remove any RNase 
contamination. Filter tips (Greiner Bio-One Ltd, Gloucestershire, UK) were used for 
pipetting all liquids during this work.
2.13.1 Extraction of RNA
Bacterial strains were grown in BHI at the desired temperatiues until they reached the mid- 
logarithmic phase o f growth (ODeoonm ~ 0.6). Cells from 1 0 -ml cultures were collected by 
centrifugation at 5000 xg for 5 min at room temperature (Sigma laboratory centrifuge 
4K15) and snap-frozen in liquid nitrogen to preserve RNA as quickly as possible. 
RNeasy® Midi Kit (Qiagen) was used to prepare RNA according to the protocol of the 
manufacturer with slight modification. All reagents were provided with the kit unless 
mentioned otherwise. Bacterial cell pellets were resuspended in 200 pi of lysis buffer, 15 
mg/ml of lysozyme (Sigma-Aldrich, UK) in TE buffer (10 mM Tris pH 8.0; 1 mM EDTA 
pH 8.0) and vortexed for 30 seconds. Suspensions were then left at room temperature for 
10 min with vortexing every 2 min. 700 pi of RLT buffer containing P-mercaptoethanol 
(10 pi o f p-mercaptoethanol per 1-ml RLT buffer, freshly prepared prior to use) was added 
and mixed by vortexing. This mixture was transfemed to cryotubes containing acid-washed
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glass beads (106 jam, Sigam-Aldrich, UK) and bacterial cells disrupted using a HYBAID 
RiboLyser™ Cell Disrupter (Hybaid Ltd, Middlesex, UK) four times of 20s each. The 
tubes were then centrifuged for 30s at 13,000 xg to remove the glass beads and the 
supernatants were transferred to 15-ml tubes. 3.2 ml of RLT buffer containing P- 
mercaptoethanol was added and tubes vortexed. 4 ml of 70% ethanol (prepared using 
RNase-free water) was added, mixed and applied to the columns and the columns were 
centrifuged at 5000 xg for 5 min at room temperature. The flow-through was discarded and 
the columns washed by adding 4 ml of RW l buffer and centrifuged at 5000 xg for 5 min, 
then by adding 2.5 ml of RPE buffer and centrifuged at 5000 xg for 2 min and a final wash 
by adding 2.5 ml of RPE buffer and centrifuged at 5000 xg for 5 min before elution. 
RNeasy eolumns were transferred to new 15-ml tubes and RNA was eluted by adding 150 
pi of RNase-free water, let stand for 1 min and centrifuged at 5000 xg for 3 min and then 
for a second time using the first eluate to increase the final concentration of RNA.
2.13.2 Analysis of RNA
Total RNA concentrations were determined using a NanoDrop® ND-1000 UV/Vis 
spectrophotometer (NanoDrop® Technologies, USA). The RNA samples were also 
checked for integrity and concentration using the RNA 6000 Nano assay with the Agilent 
2100 Bioanalyzer (Agilent Technologies, UK) according to the protocol of the 
manufacturer.
2.13.3 Array design and storage
The pneumococcal genome microarray slides were designed at the Pathogen Functional 
Genomics Resource Centre at TIGR (http://www.tigr.org/). They consist of PGR products 
representing segments of 2131 ORFs from S. pneumoniae strain TIGR4 in addition to 118 
unique ORFs fi*om strains R6  (37 ORFs) and G54 (81 ORFs), which are not present in the 
TIGR genome. They also contain 10 control spots printed at various locations. The slides 
were printed on 96 grids with each grid containing 7 columns and 14 rows. Slides were 
stored in a plastic slide box at room temperature in a dessicator containing a bottom layer 
of anhydrous calcium sulphate. Slides were kept away fi'om dust and were handled with 
extreme care to prevent scratching or rubbing that may damage the printed DNA.
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2.13.4 AminoallyNabelled cDNA synthesis
10 jag o f RNA was mixed with 2 jul of 3 mg/ml random hexamer (Invitrogen) and the 
volume was brought to 18.5 |al using DEPC water (Ambion), The mixture was incubated at 
70 °C for 10 min, cooled on ice for 30s and centrifuged briefly to bring down any 
condensation. Incubation was continued at room temperature. RNA/primer mix was mixed 
with 6  p.l 5x first strand buffer, 3 p,l of 0.1 M DTT, 1.2 pi o f 12.5 mM dNTP/aa-UTP 
labelling mix (Ambion), and 2 pi of 200 U/pl of Superscript II RT (Invitrogen), to a final 
volume of 30.7 pi. The mixture was incubated at 42 °C overnight (~ 16 hours). The first 
strand synthesis reaction was stopped by adding 10 pi of 0.5 M EDTA (Ambion) and 10 pi 
of 1 M NaOH to hydrolyze RNA in the cDNA/RNA mixture. The mixture was incubated 
at 65 °C for 15 min and 25 pi of 1 M Tris, pH 7.0 (Ambion) was added to neutralize pH. 
The unincorporated aa-dUTP and hee amines were removed using a modification of the 
Qiagen protocol for their PCR purification kit. The cDNA reaction was mixed with 400 pi 
of PB buffer (Qiagen) and transferred to a Qiaquick column, centrifriged at 13,000 xg for 1 
min and the collection tubes were emptied. The columns were washed with 750 pi of 
phosphate wash buffer (5 mM KPO4 pH 8.0 and 80 % ethanol in MilliQ water) and 
centrifuged at 13,000 xg for 1 min. The collection tubes were emptied and the columns 
were centrifuged for an additional 1 min. The cDNA was eluted twice with 30 pl-each of 
phosphate elution buffer (4 mM KPO4 pH 8.0 in MilliQ water). The final elution volume 
(60 pi) was transferred to open tubes and dried down in a speed vac (Savant DNA 110 
Speed Vac, Global Medical Instruments, USA) for 1 hour.
2.13.5 Cy3/Cy5 labelling of cDNA
All reaction tubes were wrapped in foil and kept sequestered from light as much as 
possible to prevent photobleaching of the Cy-dyes. The aminoallyl-labelled cDNA was 
resuspended in 4.5 pi of 0.1 M of freshly prepared sodium carbonate (Fisher) buffer pH 9.3 
(0.53 gm of Na2C0 3  in 50-ml MilliQ water, lower pH to 9.3 using HCl) by pipetting up 
and down for several minutes. 4.5 pi of the appropriate Cy-dye, Cy3 or Cy5 (Amersham 
Bio sciences) was added and the mixture incubated for 2 hours at room temperature in the 
dark. After coupling was complete, 35 pi of 100 mM sodium acetate pH 5.2 (1 ml of 3 M 
NaOAc pH 5.5, Ambion, in 29 ml of MilliQ water) was added and the fi'ee dye was 
removed using the Qiagen purification protocol. The cDNA reaction was mixed with 250 
pi of PB buffer (Qiagen), transfemed to Qiaquick columns and centrifriged at 13,000 xg for
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1 min. The columns were washed with 750 |.il of PE buffer (Qiagen) and centrifuged as 
above and for an additional 1 min. The dye-labelled cDNA was eluted twice with 50 |il 
each of EB buffer (Qiagen). The incorporation of the Cy-dye into the cDNA was measured 
in 1-jul sample using the NanoDrop® ND-1000 UV/Vis spectrophotometer (NanoDrop® 
Technologies, USA). The final elution volume (100 |al) was transferred to open tubes and 
dried down in a speed vac (Savant DNA 110 Speed Vac, Global Medical Instruments, 
USA) for 2 hours.
2.13.6 Hybridization of cDNA probes to array
2.13.6.1 Pre-hybridization
It is extremely important that slides be perfectly clean to prevent background staining. The
printed slides were placed with their labels up and their printed side down in a Coplin jar 
containing 60 ml of prehybridization buffer (15 ml of 2 0 x SSC (Ambion); 600 p,l of 10 % 
SDS (Ambion); 0.6 gm of BSA fraction V powder (Sigma); 44.4 ml o f MilliQ water) 
preheated at 42 °C and incubated for at least an hour at 42 °C. The slides were removed 
from the Coplin jar by carefully gripping them by the label using forceps and placed in the 
slide holder of a glass-staining dish filled with MilliQ water. The entire staining dish 
apparatus was placed on top of a rotor shaker (Edmund Biihler KM-2 shaker) and shaken 
for 2 min. The water was changed every 2 min until ~ 2 L o f wash water was used. The 
slides were then washed with isopropyl alcohol (Fisher Scientific) for 2 min on the rotary 
shaker. The slides were put into a clean centrifuge with a flat plate-holder lined with paper 
towel and centrifuged at 700 rpm for at least 10 min for drying.
2.13.6.2 Hybridization
The slides were used immediately following prehybridization to ensure optimal 
hybridization efficiency. The Ix hybridization buffer (500 |,il of formamide (Sigma), 250 
|al of 2 0 x SSC; 10 pi of 10 % SDS, 75 pi of 10 mg/ml sheared salmon sperm DNA 
(Ambion) and 165 pi MilliQ water) was prepared and filtered using 0.22 pM filter (Fisher 
Scientific) just prior to use. The labelled probes prepared as described in section 2.13.5 
were resuspended in 30 pi of hybridization buffer by finger flicking for about 1 min and 
the mixture was heated to 95 °C for 5 min. The suspension was mixed by finger flicking 
for an additional minute and heated again at 95 °C for another 5 min. The inicroaiTay slides 
were placed between the two plastic teeth in the bottom half of a hybridization chamber
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(Coming) and the entire labelled probe mixture was applied onto the printed area of the 
slides keeping air bubbles to a minimum. A glass cover slip 24mm x 60mm was dusted 
with compressed air and placed over the slide printed area and any large bubbles were 
worked towards the edge by gently pressing the cover slip surface. 2 0  pi of unused 
hybridization buffer were added to the small wells at each end of the hybridization 
chamber. The chamber was then sealed with the metal edge bars, wrapped in aluminium 
foil and incubated at 42 °C for 16-20 hours (GeneChip® Hybridization oven 640).
2.13.6.3 Post-hybridization
The low stringency buffer (100 ml of 2 0 x SSC, 10 ml of 10 % SDS, 890 ml of MilliQ 
water) was prepared and preheated to 55 °C. The slides were removed from the chamber 
and submerged in a Pyrex glass dish (Fisher Scientific) filled with the low stringency 
buffer. The slides were shaked to loosen the cover slip until it slid fiee of the slide surface 
and the slides were washed vigorously for an additional 1 min. The buffer was changed 
and slides washed for another 5 min followed by 5-min wash using medium stringency 
buffer (5 ml of 2 0 x SSC, 10 ml of 10 % SDS, 985 ml of MilliQ water) and then with final 
5-min wash with high stringency buffer (5 ml of 2 0 x SSC, 995 ml of MilliQ water). The 
slides were dried by centrifugation as mentioned before (section 2.13.6.1) and kept in dark 
until ready for scanning.
2.13.7 Scanning array and data processing
For each strain, two or three independent RNA preparations were analyzed using the 
microanays. Hybridized slides were scaimed using a ScanArray™ Express microarray 
scanner (Packaid Bioscience, Biochip Technologies) according to the manufacturer’s 
instructions and the median pixel intensity values for each element on the array were 
quantified using Quantarray™ (Packard Bioscience). The data was further analyzed using 
GeneSpring™ 6.0 (Silicon Genetics). The Lowess intensity-dependent normalization was 
used to perfonn per spot and per array normalization and the cross-gene en'or model was 
based on the replicate measurements for each strain. Statistically significant differences 
were defined as those with a f-test P-value of less than 0.05 and ratio change threshold of 
at least 2  standard deviations compared to the median ratio for each strain.
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2.13,8 RT-PCR
RNA was extracted from cultures gi-own in BHI to ODeoonm of 0.6 using an RNeasy midi 
kit (Qiagen) as described in section 2.13.1. The synthesis o f cDNA was canied out using 
ThermoScript™ RT-PCR system (Invitrogen). The reverse transcription reactions were 
prepared by combining the following in 0.5-ml eppendorf tubes; 50 ng of random 
hexamers, 5 pg of RNA, 2 pi of 10 mM dNTP mix. The reaction volmnes were adjusted to 
12 pi using DEPC-treated water and tubes incubated at 65 °C for 5 min to denature RNA 
and primers. The 5x cDNA synthesis buffer was vortexed briefly just prior to use. The 
following were then added to the reaction mixtures; 4 pi of 5 x cDNA synthesis buffer, 1 pi 
of 0.1 M DTT, 1 pi of RNaseOUT™ (40U/pl), 1 pi of DEPC-treated water, and 1 pi of 
ThennoScript™ RT. A reaction without ThermoScript™ RT was used as a negative 
control. The reactions were then transferred to a thermal cycler and incubated at 25 °C for 
10 min followed by 30 min at 50 °C. The reverse transcription reactions were terminated 
by incubating them at 85 °C for 5 min, 1 pi of RNase H was then added and tubes 
incubated at 37 °C for 20 min to get ride of any residual RNA and the cDNA synthesis 
reactions were stored at -20 °C. 5 pi of each cDNA reaction was used as a DNA template 
in PCR reactions, which were canied out using Vent® polymerase (Promega) as described 
in section 2 .6 . 1  and the results analyzed by agarose gel electi’ophoresis.
2.14 Statistical anaiysis
Statistical analyses were carried out using StatView 4.1 (Abacus Concept). Survival times 
and comparisons of cytokine levels were analyzed by using nonparametric Mann-Whitney 
U analysis. Cytokine levels were expressed as the median ± the median absolute deviation 
(MAD) (KeiT et a l, 2002). Bacteriology results were expressed as geometric mean ± 
standard error of the mean (SEM). Bactériologie assay results below the detection limits of 
the viable count assays (log 1.92 units per ml of blood and log 0.92 unit per ml of lung 
lavage fluid or lung homogenate samples) were ascribed values just below the detection 
limits (log 1.91 and 0.91, respectively). Comparisons of bacterial loads in the time course 
bacteriology experiments were performed using an unpaired r-test. Comparisons of 
bacterial loads at different time points within a group were caixied out using the analysis of 
variance (ANOVA) with the Bonferroni post hoc test. The inter-group variation was 
controlled for by ensuring no statistical differences in any parameter between wild type 
and mutant-infected mice immediately following infection. In all analyses, a jo-value less 
than 0.05 was considered statistically significant.
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ROLE OF CLPCP PROTEASE IN THE 
PNEUMOCOCCAL STRESS RESPONSE, RESULTS
_
ClpCP Results
Upon exposure to stress conditions, particularly heat shock, bacteria respond by mediating 
a cascade of events leading to the synthesis of a unique group of proteins called heat shock 
proteins (HSPs). The production of these proteins represents a protective cellular response 
to cope with the stress-induced damage of proteins. HSPs are highly conserved in both 
prokaryotes and eukaryotes (Lindquist, 1986, Craig et a l,  1993, Hendrick and Haiti, 
1993). Many HSPs are molecular chaperones or ATP-dependent proteases and play major 
roles in protein folding, repair, and degradation under normal and stress conditions 
(Gottesman, 1999, Wickner et a l, 1999).
The ATP-dependent caseinolytic protease, ClpCP consists of an ATPase specificity factor, 
ClpC, which is a member of HSPlOO/clp family (Schirmer et a l, 1996) and a proteolytic 
subunit, ClpP, which by itself represents a unique family of serine proteases (Maurizi et 
a l,  1990). Both clpC and clpP genes are members of class III group of heat shock genes 
and their expression is negatively controlled by the class three stress gene repressor, CtsR 
(Derre et a l, 1999b). The presence of ClpC, ClpP and other Clp proteases in bacterial cells 
is fundamental for stress suiwival as mutations in some clp genes results in organisms 
unable to grow in the presence of stress conditions (Squires and Squires, 1992, Kmger et 
a l, 1994, Gerth et a l,  1998, Spiess et a l, 1999, Chastanet et a l ,  2001). The ClpC protein, 
also identified as MecB (Msadek et a l,  1994) in Bacillus subtilis, was reported to be 
essential for growth at high temperature, cell division, sporulation and also to act as a 
negative regulator o f ComK synthesis preventing late competence gene expression 
(Msadek et a l,  1994, Kiviger et a l, 1997, Turgay et a l,  1997, Nanamiya et a l, 1998). 
ClpC was implicated in the virulence of Listeria monocytogenes by promoting early 
bacterial escape from the phagosomal compartment of macrophages (Rouquette et a l, 
1996, Rouquette et a l,  1998). It was also involved in the invasion of hepatocytes in vivo 
during infection by modulating the invasion virulence factors (Nair et a l, 2000b). The role 
of ClpP-mediated proteolysis in the stress tolerance and virulence of Gram-negative and 
Gram-positive bacteria has been the subject of many recent studies. In Salmonella enterica 
serovar Typhimurium, ClpP was found to be necessary for vimlence when examined in 
both a mouse model and in isolated macrophages (Webb et a l,  1999, Yamamoto et a l,  
2001b). ClpP-null mutants of B. subtilis and Lactococcus lactis were impaired for survival 
during heat shock and other stress conditions (Gerth et a l, 1998, Frees and Ingmer, 1999). 
In L. monocytogenes, dismption of the clpP gene reduced the haemolytic activity due to 
the major virulence factor, listeriolysin O that helps the bacteria to escape from the 
phagosomes of macrophages (Gaillot et a l, 2000). It was also reported that ClpP was 
important for the growth of Staphylococcus aureus in the presence o f oxidative stress or at
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low temperature. The virulence of a ÀclpP mutant of S. aureus was severely attenuated 
when investigated in a murine abscess model (Frees et a l, 2003).
During the course of this study, a number of reports about the role of pneumococcal ClpC 
have been published but the contribution of ClpC to the autolysis and expression of 
competence genes and vimlence factors is still debated (Charpentier et a l, 2000, Chastanet 
et a l, 2001, Robertson et a l, 2002). ClpC has been reported to play a role in thermal 
tolerance, control of autolysis and chain formation in the pneumococcus (Charpentier et 
a l, 2000) while other studies suggest that the protein plays no role in these processes 
(Chastanet et a l, 2001, Robertson et a l,  2002), Chaipentier and eo-workers (Chaipentier 
et a l, 2000) also reported that ClpC plays a major role in processes related to the virulence 
of the organism including adherence to hiunan cells and production o f known vimlence 
factors such as pneumolysin, LytA, CbpA and other choline-binding proteins. This study 
suggests that ClpC may play a major role in the vimlence of the pneumococcus. A 
signature-tagged mutagenesis screen identified ClpC as a vimlence factor in the 
pneumococcus (Polissi et a l, 1998). However, it was showed that ClpC null mutants of the 
pneumococcus are not greatly affected in their virulence (Robertson et a l, 2002). Recent 
studies have agieed on the requirement of ClpP for thennotolerance, development of 
competence, and virulence of Streptococcus pneumoniae (Chastanet et a l, 2001, 
Robertson et a l,  2002, Kwon et a l, 2003).
The study presented here was undertaken to define the role played by ClpC and ClpP in the 
stress response and virulence of S. pneumoniae. Isogenic mutants of pneumococcal strains 
lacking either ClpC or ClpP genes were constructed and analyzed in vitro and in vivo.
3.1 Characterization of CipC and ClpP proteins
3.1.1 ClpC
Proteins of the Clp ATPase family are highly conserved and ubiquitous in prokaryotes and 
higher organisms and are classified into two classes based on the presence of either one or 
two ATP binding domains as well as on the occurrence of specific signature sequences 
(Gottesman et a l,  1990a, Schiimer et a l, 1996). ClpC belongs to class 1 Clp ATPase 
proteins, members of which contain N-tenninal and C-teiminal domains, two highly 
conserved ATP binding domains and a variably sized middle domain (Ingmer et a l, 1999). 
Analysis of the complete genome sequence of Streptococcus pneumoniae strain TIGR4
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(The Institute for Genomic Research at http://www.tigr.org/) revealed a single copy of the 
gene for ClpC. The 2.433 kb gene encodes for an 810-amino-acid protein with a molecular 
weight of 90.2 kDa and a pi of 5.82. The pneumococcal ClpC protein shares sequence 
similarity with ClpC/MecB of B, subtilis (47.2% identity) and the ClpC ATPases of 
Lactococcus lactis (53.4% identity). The amino acid alignment with other prokaryotic 
ClpC ATPases showed that the structural organization of the pneumococcal ClpC is typical 
for proteins of this family. ClpC contains the two nucleotide-binding regions ATP-binding 
1 (amino acids 206-436) and ATP-binding 2 (amino acids 474-667), harbouring the 
characteristic ATPase A and B boxes. These two domains are separated by a spacer region 
of 37 amino acids (amino acids 437-473) and enclosed between a leader sequence of 205 
amino acids at the N-terminus and a trailer sequence of 143 amino acids at the C-terminus. 
Figure 3.1 shows the amino acid alignment for the pneumococcal ClpC with those of B. 
subtilis and L, lactis.
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Figure 3.1- Multiple sequence alignment of ClpC protein from some Gram-positive bacteria
Alignment of the S. pneumoniae ClpC amino acid sequence with those of B. 
subtills and L. lactis. Amino acid sequences were aligned using ClustalV 
Method (MegAlign, DNASTAR Inc.). Numbers indicate positions in the amino 
acid sequence, identical residues are shaded. The characteristic nucleotide- 
binding domains, ATP-1 (amino acids 206-436) and ATP-2 (amino acids 474- 
667), are boxed. The 37-amino-acid spacer region separates the two ATP 
binding domains (amino acids 437-473).
3.1.2 ClpP
The S. pneumoniae genome has recently been shown to contain only a single copy o f clpP 
(Hoskins et a i,  2001). The 588 bp gene encodes for a 196-amino-acid protein with a 
molecular weight of 21.3 kDa and a pi of 4.49. The pneumococcal ClpP protein shares
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amino acid identity with that of Bacillus subtilis and Lactococcus lactis^ 85.1 % and 58.9 
% respectively. The high degree of identity over the entire length of the aligned sequences 
(figure 3.2) indicates that S. pneumoniae ClpP is a member of the unique family of serine 
proteases (Maurizi et al., 1990). The serine-96 residue, the histidine-121 residue and the 
aspartate-172 residue, which constitute the catalytic triad o f the serine protease, are 
conserved (figure 3.2).
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Figure 3.2- Multiple sequence alignment of ClpP protein from some Gram-posltlve bacteria.
Alignment of the S. pneumoniae ClpP amino acid sequence with those of B. 
subtilis and L. lactis. Amino acid sequences were aligned using ClustalV 
Method (MegAlign, DNASTAR Inc.). Identical residues are shaded. The
conserved catalytic Ser®®, HIs^ ^^ and Asp residues (S. pneumoniae
numbering) are underlined.
3.2 Construction of m utants
3.2.1 ClpC mutation
The clpC gene of S. pneumoniae strains D39, R6, R800 and TIGR4 was disrupted by the 
introduction of an erythromycin resistance cassette into the gene. The whole clpC gene was 
amplified from the chromosomal DNA of a laboratory-adapted strain of D39, D39(LA), 
using primers ClpC al and ClpC a2 (table 2.2) and cloned into PCR-Script™ cloning 
vector (Stratagene). Internal primers, Clp invl and Clp inv2 (table 2.2) were designed to 
carry out inverse PCR for removing the middle region of clpC creating Asc\ restriction 
sites in the resulting PCR product. ^5cl-generated erythromycin cassette, using Ery3 and 
Ery5 primers (table 2.2), was ligated to the inverse PCR product to be used as a selection 
marker.
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Figure 3.3- Introducing cIpC mutation In S. pneumoniae.
3.2.1.1 Confirmation of inverse PCR product
The product of the inverse PCR described above was 3.6 kb. This PCR product was gel 
purified using a Qiagen gel purification kit, self ligated and transformed into E. coll cells. 
The transformed cells were selected by plating onto LB agar with 50 pg/ml of ampicillin 
and the plasmid was recovered from cultures grown overnight on LB broth with ampicillin 
using a Qiagen miniprep kit. The knockout of clpC was then confirmed by restriction 
digestion and PCR. Digesting the resulting plasmid with EcoRl and Ascl resulted in a 300- 
bp band and a 3.3 kb band (figure 3.4 B) confirming the diagrammatic representation 
shown in Figure 3.4. When primer pair clpC al and clpC a2 was used, the PCR product 
was about 700 bp and when primer pair T3 and T7 used, the product was about 750 bp 
(figure 3.4 C). The PCR products again confirm the orientation shown in the upper panel 
of figure 3.4.
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Figure 3.4- Inverse PCR and confirmation of product.
Agarose gel electrophoresis of the Inverse PCR product and Its purification In 
(A) lanes 2 and 3 respectively, confirmation of self-llgated Inverse PCR product 
by restriction digestion with AscI and EcoRI In (B) and confirmation of self- 
llgated Inverse PCR product by PCR using primer pairs, (T3 and T7) and (cIpC 
a1 and cIpC a2) In (C). Band sizes as Indicated on the gel pictures. The DMA 
marker used Is the 1 kb plus ladder.
3.2.1.2 Marker ligation
To facilitate the selection of transformants, an /fjcl-generated erythromycin cassette was 
ligated to the plasmid described above after being digested with Ascl and the new plasmid 
was cloned into E. coli cells. The transformed cells were selected by plating onto LB agar 
with 1 mg/ml of erythromycin and the plasmid was recovered from cultures grown 
overnight on LB broth with erythromycin using a Qiagen miniprep kit. The ligation of the 
erythromycin cassette was confirmed by PCR and restriction digestion. Using the primer 
pair clpC al and clpC a2 resulted in 1.7-kb DNA frgment (figure 3.5 A) and digestion of 
the plasmid with Ascl released the 1 kb fragment corresponding to the erythromycin gene 
(figure 3.5 B).
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Figure 3.5- Confirmation of marker ligation in the knockout plasmid.
Agarose gei eiectrophoresis of PCR product using primer pair cIpC a1 and cIpC 
a2 (1.7 kb) in (A) and digestion of the knockout plasmid with Ascl in (B). In (B), 
lane 2, uncut plasmid. Lane 3, Asci-cut piasmid. The DNA marker used is the 1 
kb plus ladder.
3.2.1.3 Transformation of pneumococcal strains
The modified version of clpC contains the erythromycin cassette in the middle of about 
350 bases of the original gene copy at each end of the gene, which was used for 
homologous recombination. This construct was amplified out of the plasmid using primers 
ClpC al and ClpC a2 primers and used to transform a laboratory-adapted strain of D39, 
termed D39(LA) and mutants were selected by growth on 1 pg/ml erythromycin. Mutation 
was confirmed by using diagnostic primers MCPl for and MCP2 rev (table 2.2) which 
amplify a 2.6 kb fragment in the D39(LA) wild type and a 1.9 kb fragment in the D39(LA) 
AclpC mutant (figure 3.6 A). It was also confirmed by nucleotide sequencing and the 
growth of the pneumococcus on erythromycin. This mutation was moved into strains R6 
and R800 to test whether the phenotype resulting from clpC deletion in these strains is 
consistent with phenotypes reported by other groups (Charpentier et al., 2000, Chastanet et 
al., 2001, Robertson et al., 2002). The clpC mutation was also moved into TIGR4 and a 
mouse-adapted strain of D39, termed D39(MA) to be used in the in vivo studies. 
Confirmation of clpC mutation in these strains is shown in figure 3.6 B.
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Figure 3.6- Confirmation of ClpC mutation in some pneumococcal strains.
Agarose gel electrophoresis of PCR products using primer pair MCP1 for and 
MCP2 rev for confirmation of c/pC mutation in D39(LA) strain in (A) and in other 
strains in (B). PCR products using this primer pair were 2.6 kb fragment in the 
wild type and 1.9 kb fragment in the mutant. The DNA marker used is the 1 kb 
plus ladder.
3.2.2 CIpP mutation
A clpP mutant strain, SP2000 (Chastanet et a i, 2001) was generously provided by Jean- 
Pierre Claverys (CNRS-Université Paul Sabatier, Toulouse, France) as a ligation between 
-500 bp fragments upstream and downstream from clpP gene and a kanamycin resistance 
(Kmr) gene. This mutant was used to construct AclpP mutants of TIGR4 and the mouse- 
adapted strain o f D39, D39(MA), by PCR amplification o f a 1.6 kb fragment 
corresponding to clpP mutation carrying kanamycin resistance cassette using primer pair 
AC94 and AC97 (table 2.2). This PCR product was used to transform D39 and TIGR4. 
Transformed cells were selected on 250 pg/ml kanamycin. The introduction of mutation in 
TIGR4 and D39 was confirmed by PCR using clpP specific primers, clpP for and clpP rev 
(table 2.2) and primer pair AC94 and AC97 (Chastanet et a l, 2001). Using primer pair 
clpP for and clpP rev gave a 600 bp fragment in the wild type and about a 1.4 kb fragment 
in the mutants. The product of PCR when using primers AC94 and AC97 was about 1.4 kb 
in the case of the wild type, while in case of the mutants resulted in a 1.6 kb fragment 
(figure 3.7).
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Figure 3.7- Confirmation of c/pP mutation in TIGR4 and D39.
Agarose gel eiectrophoresis of PCR products for confirmation of c/pP mutation 
in TIGR4 and D39 strains. Lanes 1-3, using primer pair clpP for and clpP rev,
Lane 1, D39 wild type c/pP (600bp). Lane 2, D39Ac/pP mutant (-1.4 kb). Lane 3, 
TIGR4Ac/pP mutant (-1.4 kb). Lanes 4-6 using primer pair AC94 and AC97. Lane 
4, D39 wild type (-1.4 kb). Lane 5, D39Ac/pP mutant (-1.6 kb). Lane 6, 
TIGR4Ac/pP mutant (-1.6 kb). In the diagram, solid arrows represent cIpP for 
and cIpP rev and dashed arrows represent AC94 and AC97.
3.3 In vitro analysis of mutants
3.3.1 Growth measurements ofAclpC mutants
3.3.1.1 By optical density
ClpC has been shown to play an essential role in growth at high temperatures, presumably 
due to its role in the degradation of misfolded and damaged proteins generated by heat 
stress. The ability of AclpC mutants to grow at different temperatures was studied. 1x10* 
CFU/ml of each strain was used to inoculate BHI prewarmed at 37 and 40°C and incubated 
at the indicated temperatures. At 30-min intervals, samples were withdrawn to measure the 
optical density at 600 nm (ODeoonm). The growth of D39(LA) AclpC mutant was reduced 
compared to that of the wild type at 37 °C as measured by optical density. This difference 
was in growth rate rather than total growth as both mutant and wild type strains reached the 
same stationary phase ODeoonm (figure 3.8). The slower growth of the mutant was not
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observed at higher temperature (40 °C), as the growth of both wild type and mutant 
organisms was very similar (figure 3.8). In addition, the t^clpC mutant organism did not 
undergo autolysis after entering the stationary phase of gi'owth both at 37 and 40 °C 
compared to the wild type (figure 3.8).
3.3.1.2 By viable counting
To confirm the lack of autolysis in the Ac/pC mutant, the viable counts of all wild type 
strains, laboratory-adapted D39(LA), mouse-adapted D39(MA), R6, R800 and TIGR4 
were compared to their I^clpC mutants over time. There was no defect in growth at 40 °C 
suggesting that ClpC is not involved in the heat stress tolerance of the pneumococcus. 
However, both at 37 and 40 °C, the AclpC mutants of both the laboratory-adapted strain 
D39(LA) and the mouse-adapted strain D39(MA) maintained cell viability after reaching 
the stationary phase of growth compared to their parent strains which tended to undergo 
autolysis rapidly when a certain cell density had been reached (figure 3.9). This 
observation of the maintenance of viability was not recorded in the AclpC mutants of R6, 
R800 and TIGR4 strains (data not shown).
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Figure 3.8- Representative growth curves of D39(LA) and Its Ac/pC mutant at 37 and 40 °C.
10® CFU/ml of each strain was used to inoculate BHI prewarmed at the Indicated 
temperatures and samples were taken at 30 mln-lntervals to measure the optical 
density at 600 nm (ODeoonm)-
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F ig u re  3 ,9 - R e p r e s e n ta t iv e  g r a p h s  o f in vitro  g ro w th  o f  D39(LA) a n d  D39{MA) w ild  ty p e s  a n d  
th e ir  AclpC  m u ta n ts  a t  37  °C a n d  40  °C.
10® C F U /m l o f e a c h  s t r a in  w a s  u s e d  to  in o c u la te  BHI p r e w a r m e d  a t  th e  in d ic a te d  
t e m p e r a tu r e s  a n d  s a m p le s  w e re  ta k e n  a t  1 h - in te rv a ls  to  m e a s u r e  th e  v ia b le  
b a c te r ia l  c o u n t  o n  BAB p la te s .  T h e  g ro w th  o f  AclpC  m u ta n t s  w a s  s im ila r  to  th a t  
o f  th e  w ild  ty p e s  a t  b o th  t e m p e r a tu r e s .  H o w ev er, th e  m u ta n t  s t r a i n s  m a in ta in  
v ia b ility  in  th e  s ta t io n a r y  p h a s e  o f  g ro w th  i.e. th e  a u to ly s i s  r a te  o f  th e  AclpC  
m u ta n t s  w a s  v e ry  m u c h  r e d u c e d  c o m p a r e d  to  th a t  o f  th e  w ild  ty p e s .
3.3.2 Effect ofclpC deletion on morphology
Cell morphology of cultures grown at different optical densities was examined by light 
microscopy of the Gram-stained samples. The Ac//?C mutants of both D39 strains grew in 
long chains of bacterial eells rather than the typical diplococcus form of S. pneumoniae 
(figure 3.10). No chains longer than 10 organisms were observed in the wild type cultures 
while at least one chain of this length or greater was seen in 12 randomly selected fields in 
the mutant cultures as shown in figure 3,10. Appearance of these chains suggests an 
impainnent in cell separation, which is believed to be induced by the autolytic action of 
autolysin A (LytA) (Briese and Hakenbeck, 1985, Novak et a l,  1999).
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D39 \clpC
Figure 3.10- Effect of c/pC deletion on the morphology of the pneumococcus.
The mutant strains of both D39(LA) and D39(MA) grow In long chains of 
bacterial cells compared to the characteristic diplococcus form of 
Streptococcus pneumoniae. Samples of the same optical density were 
withdrawn, Gram stained and examined by light microscopy. Magnification 
xiOGG.
3.3.3 Penicillin-induced loss of viability
To further investigate the phenomenon of less autolysis in the diclpC mutant, the penicillin- 
induced autolysis of AclpC mutants and their wild types was studied (figure 3.11). This 
assay was carried out by exposing cultures grown to an ODeoonm of ~ 0.3 to 0.1 pg/ml (lOx 
the MIC) of benzylpenicillin at 37 °C and the viable bacteria were counted by plating 
samples of the cultures onto BAB plates at 1 -hour intervals over a period of six hours. The
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àclpC  mutant of D39(LA) strain showed a small decline in viable count over a six-hour 
period of exposure to penicillin while its parent strain lost viability over time and no viable 
cells were recorded after six hours of exposure to the antibiotic. The àclpC  mutant of the 
D39(MA) strain also maintained viability in the presence of penicillin but, surprisingly, its 
parent strain showed no penicillin-induced autolysis (figure 3.11). The TIGR4 wild type 
and TIGR4 àclpC  mutant were also penicillin resistant (data not shown). Similar to their 
parent strains, R6 AclpC and R800 AclpC mutants underwent autolysis when treated with 
penicillin (data not shown).
■ D39(LA)WT 
□ D39(LA) Ac/pC
Time (h)
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□ D39(MA)
2 3 4
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Figure 3.11-Penicillin-Induced loss of viability assay for c/pC mutants and wild types.
Peniciiiin-induced autolysis of AclpC mutants compared to their wild types. 
Cultures grown to OD -  0.3 were exposed to 0.1 pg/mi of benzylpenicillin and 
the viable bacteria were counted on BAB plates at Ih-intervais over a six-hour 
period.
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3.3.4 Role of ClpC In the release of LytA and Ply
It is believed that the toxin pneumolysin is released upon lysis o f pneumococcal cells by 
the influence of autolysin A (Tomasz, 1984). The decreased rate of autolysis in the Ac//?C 
mutant encouraged the investigation of the effect of the clpC deletion on LytA and Ply 
release. Proteins in the cellular fraction and those in the culture supernatant of the mouse- 
adapted strain D39(MA), which was chosen for the in vivo analysis, and its AclpC mutant 
grown in BHI for 11 hours at 37 °C were separated, transferred to nitrocellulose 
membranes and reacted with antisera to LytA and Ply. LytA was not detected in the 
supernatant of AclpC mutant but found in that of the wild type and in the cellular fraction 
of both strains. Ply was detected in the wild type and the mutant both in the cellular 
fraction and the supernatant. However, the amount of the toxin was less in the supernatant 
of the AclpC mutant (figure 3.12). This again suggests a role of ClpC in the autolysis of 
some strains and serotypes of S. pneumoniae.
LytA
Ply
Cellular fraction Supernatant
D39WT D39Ac//?C D39WT D39Ac(pC
—  -
Figure 3.12- Western blot analysis of LytA and Ply in the D39(MA) WT and its AclpC mutant.
Total proteins in the cellular fraction and in the culture supernatant were 
separated by SDS-PAGE, transferred to nitrocellulose membranes and reacted 
with antisera specific to lytA and Ply. The amount of LytA and Ply produced was 
not affected by cIpC deletion but the amount of Ply released to the supernatant 
upon cell lysis was much less in the mutant compared to that of the parent 
strain. In addition, no LytA was detected in the supernatant of D39 AclpC 
mutant.
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3.3.5 Growth phenotype of AclpP mutants
The requirement of the pneumococcal ClpP for resistance to heat stress was reported 
before in the R6 and D39 strains (Chastanet et al,, 2001, Robertson et a l, 2002). To 
address the question of whether the ClpP protein is required for stress tolerance, the ù^clpP 
mutants generated in this study were assessed for altered phenotypes with respect to high 
and low temperatures. The role of ClpP in D39 and TIGR4 strains was investigated by 
growing equal numbers of viable cells of the wild types and their AclpP mutants in BHI at 
30, 37 and 40 °C and recording the optical density at 600mii at time intervals (figure 3.13). 
The growth of both mutants at 37 °C was very much similar to that of their wild types. 
However, the AclpP mutants of both strains were unable to gi’ow at 40 °C, The D39 AclpP 
mutant was less able to grow at 30 °C than its D39 parent strain while the AclpP mutant of 
TIGR4 and its wild type strain were identical in their growth at this lower temperature 
(figure 3.13). The reduced growth rate of D39 AclpP mutant at 30 °C has been reported 
previously (Robertson et al., 2002).
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Figure 3.13- Representative growth curves of D39 and TIGR4 parent strains and their AclpP 
mutants at different temperatures.
10° CFU/ml of each strain was used to inoculate BHI prewarmed at the indicated 
temperatures and samples were taken at Ih-intervais to measure the ODeoonm- 
The AclpP mutants of both strains were impaired for growth at 40 *C and the 
growth of D39 AclpP mutant was less than that of the D39 wild type at 30 ®C.
3.3.6 Response of mutants to oxidative stress
The proteolytic activity of ClpP is required by bacterial cells to prevent the accumulation 
of misfolded or damaged proteins resulting from different stress conditions (Frees and 
Ingmer, 1999, Kruger et a i, 2000). To study the role of ClpC and ClpP in the oxidative 
stress tolerance, the sensitivity of AclpC and AclpP mutants to hydrogen peroxide were 
compared to their parent strain D39(MA). As reported before (Robertson et a l, 2002), the 
AclpP mutant was more sensitive to peroxide than the wild type (figure 3.14). On the other 
hand, the response of AclpC mutant to peroxide was very much similar to that of the wild 
type (figure 3.14) suggesting that ClpC does not play a role in pneumococcal resistance to 
oxidative stress. The contribution of ClpC to pH tolerance was also investigated. No
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differences were recorded between D39 WT or AclpC mutant in growth at different pHs 
suggesting that ClpC has no influence on the acidic tolerance o f the pneumococcus (data 
not shown).
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Figure 3.14- Peroxide sensitivity assay for D39 wild type and its AclpC and AclpP mutants.
40 mM of H2 O2 were added to 1-ml aliquots of culture grown to ODeoonm of -  0.3 
and left at room temperature for 15 min. Viable counts were performed on BAB 
plates before and after the addition of peroxide and the % survivals were 
calculated. Values expressed are the mean (SEM) of three independent 
experiments. *, p< 0.05 lower survival for AclpP mutant than wild-type.
3.4 In vivo analysis of m utants
3.4.1 ClpC mutants
The effect of ClpC on the rate of autolysis and thereby the release of pneumolysin 
suggested that ClpC might play a role in the virulence of the pneumococcus. Murine 
models of pneumonia and bacteraemia were used to investigate the contribution, if any, of 
ClpC to the pathogenesis of pneumococcal disease.
3.4.1.1 Intranasal infection
Groups of MFl mice were infected intranasally as described in the Materials and Methods 
section. After administering the infectious dose (10  ^CFU/mouse), mice were observed and 
the development of symptoms was recorded over a period of two weeks. All mice infected 
with D39AclpC mutant succumbed to the infection at the same rate and had similar 
survival times to those infected with the D39 wild type (figure 3.15).
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Figure 3.15- Survival of MPI mice after intranasal infection with D39 WT or its c/pC mutant.
Mice infected intranasally with 10° CFU/mouse of D39 or D39 AclpC (n=5). The 
results are given as the percentage of mice survival over time.
3.4.1.2 Bacteriological investigation
The bacterial loads of the D39Ac/pC mutant compared to the D39 wild type in the lung 
airways, lung tissue and blood after intranasal infection was studied at 0, 6, 12, 18, 24, and 
48 h following challenge. Both the wild type and mutant strains were cleared from the lung 
airways (figure 3.16A). However, the bacterial counts of D39Ac/pC mutant in the lung 
tissue were significantly lower than those of the D39 wild type 12, 18, 24, and 48 hours 
post-infection (figure 3.16B). In the bloodstream, the wild type organism grew to levels of 
about 10^  CFU/ml while the D39Ac/pC mutant caused a transient bacteraemia in mice 24 
hours post-challenge and then started to clear after 48 h (figure 3.16C) where the blood 
concentration of AclpC mutant was significantly lower than that of the wild type.
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Figure 3.16- Bacterial loads of D39 WT or D39Ac/pC after Intranasal Infection.
Effect of ClpC on the virulence of the pneumococcus. (A) Bacterial counts In the 
lung airways. (B) Bacterial counts In the lung tissue. (C) Bacterial counts In 
blood. Bacterial counts were performed on BAB plates at different time points 
after Intranasal Infection with 10° CFU/mouse of each strain (n=5). Dashed line 
represents limit of detection of the assay. *, p <0.05 lower bacterial loads for 
D39Ac/pC mutant than for D39 wild type.
3.4.1.3 Bacterial loads In sequential blood sampling
Because the data in figure 3.16C are derived from groups of animals sacrificed at each time 
point, it is not possible to determine the extent of transient bacteraemia in individual 
animals. To measure the levels of transient bacteraemia caused by the D39Ac/pC mutant 
organisms, the number of bacteria in blood of individual mice was followed at different 
time points after intranasal infection by counting bacteria in blood samples taken by 
sequential tail bleeding (figure 3.17). Again, the mutant organisms grew to levels of about 
10“* CFU/ml 24 h post-challenge and then cleared after 48 h while the wild type organisms 
grew dramatically (figure 3.17). Results from the experiment in figure 3.16C are not 
significantly different from those in figure 3.17.
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Figure 3.17- Bacterial count in blood taken by tail bleeding after intranasal infection.
Bacterial counts were performed on BAB plates at different time points after 
intranasal infection with 10° CFU/mouse of each strain (n=5). Dashed line 
represents limit of detection of the assay. *, p <0.05 lower bacterial loads for 
D39Ac/pC mutant than for D39 wild type.
3.4 .1 .4  In travenous in fection
To determine whether the ClpC role was specific for the lung, wild type and mutant 
organisms were injected directly into the bloodstream to by-pass the respiratory tract. MFl 
mice were given 1x10  ^CFU/mouse and both survival of mice and bacterial loads in blood 
were determined. There were no statistically significant differences between the D39 
AclpC mutant and its parent strain in the ability to cause death in mice when given 
intravenously. All mice in both groups succumbed to the infection by 34 h post challenge. 
The median survival time for D39-infected mice was 24 hours and that for D39Ac/pC- 
infected ones was 31 hours.
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Figure 3.18- Survival of MPI mice after intravenous infection with D39 WT or its Ac/pC 
mutant.
Mice infected intravenously via lateral tail veins with 10  ^ CFU/mouse of D39 or 
D39 Ac/pC (n=5). The results are given as the percentage of mice survival over 
time.
The bacterial loads of both strains in blood were also followed over time. Blood samples 
were taken by sequential tail bleeding at 0, 12, 24 and 31 hours after intravenous infection 
and the bacterial counts were determined by plating serial 10-fold dilutions onto BAB 
plates. Both the wild type and mutant organisms grew to a level of more than 10^  CFU/ml 
by 12 hours post-challenge and grew dramatically thereafter causing the death of 60% of 
the D39-infected mice and 20% of D39Ac/pC-infected mice by 24 hours. However, 80% of 
mice in both groups died by 31 hours and no mice in either group survived the challenge 
more than 34 hours post-infection. The log CFU/ml of both strains at these time points is 
given in table 3.1. There were no statistically significant differences at 0 h and 12 h time 
points and the death of mice 24 h and 31 h post-challenge did not allow any more 
statistical analysis.
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Table 3.1- Bacterial counts in blood after intravenous infection with D39 WT or D39Ac/pC 
mutant.
M ou se_____________ Bacterial loads at indicated time (logio CFU/ml)
no. Oh 12h 24h 31h
D39 Ac/pC D39 AclpC D39 AclpC D39 AclpC
1 5.06 4.97 6.49 6.28 9.04 — — ——
2 4.99 4.95 7.11 6.34 7.77 '—
3 4.86 5.08 7.25 6.18 '— 7.86 — ——
4 5.08 5.00 7.51 6.48 —— 8.25 —
5 4.72 4.83 6.34 6.28 7.49 6.86 9.63 9.39
Mice were bled 0 h, 12 h, 24 h and 31 h after intravenous infection and the viable 
count was determined by plating on BAB plates. - ,  Dead mouse.
3.4.1.5 Histological analysis
Tissue histology of lungs infected with wild type and those infected with D39Ac/pC 
mutant organisms was examined in order to determine the host response to both strains. 
Mice were sacrificed 48 h after intranasal challenge and their lungs removed, fixed, 
sectioned and stained. Sections were examined for the influx of inflammatory cells into the 
lungs by light microscopy and the number of pleurisy, areas at the pleural interface that 
were swollen and congested with recmited inflammatory cells and also the number of 
perivascular alterations were scored. The results are shown in table 3.2. Statistical analysis 
of these scores revealed no significant differences between lungs infected with the wild 
type organism and those infected with the mutant strain suggesting that the host response 
to D39 Ac/pC mutant was not altered and that the mutant organisms caused the same effect 
on lungs of infected mice as that caused by the wild type.
Table 3.2- Histological scores of lungs from mice infected with wild type 039 or AclpC 
mutant organisms.
Mouse D39 WT-lnfected lungs D39 Ac/pC-infected lungs
no. Pleurisy Perivascular
alterations
Total Pleurisy Perivascular Total 
alterations
1 10 12 22 2 6 8
2 0 25 25 6 22 28
3 2 1 3 2 10 12
4 0 0 0 1 1 2
5 4 42 46 5 0 5
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3.4.1.6 Analysis of TIGR4Ac/pC mutant
To examine the role of ClpC in the vimlence of other pneumococcal strains, a kclpC  
mutant of the serotype 4 strain TIGR4 was constmcted and compared to its parent strain 
for the ability to cause disease in mice. Groups of MFl mice (five each) were infected 
intranasally with Ix 10  ^ CFU/mouse of either the wild type or the mutant organisms and 
the symptoms of pneumococcal disease were followed over a period of four' days. Mice, 
which reached the moribund state, were hiunanely sacrificed and their survival times 
recorded. Mice infected with the TIGR4 wild type strain succumbed to the infection 
slightly faster than those infected with the mutant strain. Statistical analysis revealed that 
the median suiwival time of TIGR4 wild type-infected mice was 48 hours and that of the 
mutant-infected mice was 72 hours, however, this difference was not significant. The 
results are represented in figure 3.19,
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Figure 3.19- Survival of MFl mice after intranasal infection with TIGR4 WT or its Ac/pC 
mutant.
Mice infected intranasally with 10^  CFU/mouse of T1GR4 WT or TIGR4 Ac/pC 
(n=5). The results are given as the percentage of mice survival over time.
3.4.2 ClpP mutants
ClpP negative mutants of the serotype 2 strain D39 were reported to be attenuated in a 
mmine intratracheal (Robertson et a l, 2002) and intraperitoneal (Kwon et a l, 2003)
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models of infection. In this study, the virulence of àclpP mutants of D39 and TIGR4 was 
tested in our pneumonia model. None of the mice in the D39-infected gi'oup survived 
(median survival time; 51 h) while D39 AclpP infected mice did not show any symptoms 
of illness (median survival time: 336 h) and suiwived until the end of the experiment 
(figure 3.20A). The virulence of TIGR4 AclpP mutant was significantly reduced (median 
survival time: 54 h) compared to that of the TIGR4 wild type (median survival time: 28 h) 
although no TIGR4 Ac/pP-infected mice survived the challenge (figure 3.2GB).
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Figure 3.20- Effect of clpP deletion on the virulence of pneumococcal D39 and TIGR4 
strains.
Survival of MFl mice infected intranasally with 10® CFU/mouse (n=5) of D39 or 
D39 AclpP in (A) and TIGR4 or TIGR4 AclpP mutant in (B). The D39 AclpP mutant 
was completely avirulent while the TIGR4 AclpP mutant was less virulent than 
the TIGR4 WT. *, p<0.05 shorter survival times for D39 and TIGR4 wild types 
than for AclpP mutants.
In addition, the nmnber of bacteria in the lung aii*ways, lung tissue and blood of mice 
infected with either D39 wild type or the D39AclpP mutant was investigated at 24h and 
48h post-infection with Ix 10  ^ CFU/mouse. The bacterial number in the lung tissue and
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blood of the D39Ac//?P mutant-infected mice was significantly less than that in mice 
infected with D39 wild type 24 h and 48 h post-challenge (figure 3.21). There was no 
significant difference in the number of bacteria in the lung lavage at either time points 
(figure 3.21).
D39 WT □ D39Ac(pP
lav. 24h lung blood lav. 48h lung blood 
horn. 24h 24h horn. 48h 48h
Figure 3.21- Bacterial loads of D39 wild type and its AclpP mutant.
Viable counts of D39 wild type and its AclpP mutant in the lung lavage, lung 
tissue homogenate, and blood 24 h and 48 h after intranasal infection with 10 
CFU/mouse of each strain (n=5). Dashed line represents the limit of detection of 
the assay for blood samples. *, p<0.05 lower bacterial loads for AclpP mutant 
than for D39 parent strain.
3.5 Confirmation of the roie of CipC
Recently, complementation of the clpP mutation has been reported by Robertson and co­
workers (Robertson et al., 2002). This report stated that the growth of the ^clpP/clpP^ 
merodiploids was indistinguishable from that of the R6 and D39 parent strains on different 
media at 30, 37, and 40 °C and, therefore, concluded that the loss of clpP function alone is 
responsible for all of the observed growth defects at reduced and elevated temperatures. 
Because ClpP data in the study presented in this chapter agree with the previous reports, 
only confirmation of the ClpC role has been sought.
In order to confirm that the construction of the clpC mutation did not have a polar effect on 
expression of downstream genes, the expression levels of these genes were examined using
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microarrays. Genes downstream from clpC include the response regulator and the histidine 
kinase genes of the two-component system number six (SP2193 and SP2192, respectively), 
a conserved hypothetical protein (SP2191) and the choline binding protein A gene 
(SP2190). Organization of the clpC gene as published on the TIGR website 
(http://www.tigr.org/) is shown in figure 3.22.
RR-06
HK-06
clpC
SP2194
Figure 3.22- Organization of the c/pC gene locus.
Adapted from TIGR website at (http://www.tigr.org/). RR-06, Response regulator 
of the two-component system number 06. HK-06, Histidine kinase of the two- 
component system number 06. HP, hypothetical protein. CbpA, Choline binding 
protein A.
The clpC mutation was also reverted by transforming the D39Ac/pC mutant with a wild 
type copy of clpC and screening the transformation reaction for colonies that lost the 
erythromycin resistance. The revertant strain was then analyzed both in vitro and in vivo.
3.5.1 Microarray analysis
The pneumococcal genome microarray slides (2"*^  version) designed at the Pathogen 
Functional Genomics Resource Centre at TIGR (http://www.pfgrc.tigr.org/) were used in 
this analysis. The full genome array consists of amplicons representing segments of 2131 
ORFs from S. pneumoniae reference strain TIGR4 spotted in quadruplicate on glass slides. 
Also, the array contains an additional 563 ORFs from strains R6 (164) and G54 (399).
3.5.1.1 RNA preparation, analysis and hybridization
The bacterial RNA was extracted from cultures grown in BHI at 37 °C to an ODôoonmof 0.6 
using RNeasy® Midi (Qiagen) columns according to the manufacturer’s protocol. 
Preparation of RNA under these conditions yielded 2.3 pg/pl of wild type RNA and 1.8 
pg/pl of the mutant RNA. The concentrations of RNA were determined using NanoDrop® 
ND-1000 UV/Vis spectrophotometer (NanoDrop® Technologies, USA). Because it is 
essential for the microarray analysis to have a high quality RNA, the RNA samples were 
also tested for integrity and concentration using the agilent technology. Figure 3.23 shows
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the results of this analysis, which clearly indicates the purity, and integrity of RNA 
samples.
The RNA was reverse transcribed and labelled with Cy3 or Cy5 probes (Amersham 
Pharmacia) by using the aminoallyl labelling method. Denatured probes were then 
hybridized to the glass slides and the hybridized slides were scanned using a laser scanner. 
The microarray data was analyzed to get the global gene expression levels.
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Figure 3.23- Analysis of RNA samples prepared from D39 WT and D39 Ac/pC mutant.
The RNA was prepared from cultures grown In BHI at 37 °C to OD600 ~ 0.6 using 
Qiagen RNeasy® Midi Kit. RNA samples were checked for Integrity and 
concentration using RNA 6000 Nano assay with the Agilent 2100 Bioanalyzer.
Since the labelling efficiencies of Cy3 and Cy5 can be different, as reported previously (Ye 
et a/., 2001), a dye-swapping experiment was performed to eliminate any artificial effect in 
labelling, as well as to provide an independent means to verify the results for the first chip. 
The data from the dye-swapping experiments in this study agreed very well, indicating that 
the two dyes labelled consistently. Statistically significant differences were defined as
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those with a t-tcst P-value of less than 0.0001 and a ratio change threshold of at least 2 
standard deviations compared to the median ratio for each strain.
3.5.1.2 Array results
The scatter plot in figure 3.24 represents the relationship between the average spot 
intensities of the wild-type control cells (X-axis) and D39Ac//?C mutant cells (Y-axis). This 
simple procedure provided a general idea of the data and confirmed that most of the gene 
spots fell along the diagonal lines and were similarly labelled. The spots that were not on 
the diagonal lines were candidates for genes with changes in their expression levels.
D39 WT
Figure 3.24- Representative scatter plot comparing gene expression in the D39Ac/pC mutant 
to that of the wild type D39.
Labelled cDNA samples were hybridized to the probes on the array and 
scanned. Data were analyzed using the Genespring^ software. The plot 
illustrates the spot intensities of all genes detected for the wild type on the X- 
axis and the mutant on the Y-axis. Yellow spots (within the diagonal lines) 
indicate similar expression level, red spots (above the diagonal lines) indicate 
up-regulated genes and blue spots (below the diagonal lines) indicate down- 
regulated genes in the mutant strain compared to wild type strain.
Analysis of microarray data revealed that the expression of genes downstream from clpC 
was not affected by the disruption of clpC gene (table 3.3). Analysis of the levels of RNA
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in the region showed that the only transcript level significantly altered in this region is that 
ofClpC.
Table 3.3- Levels of expression of c/pC and downstream genes in the D39Ac/pC mutant 
compared to the wild type as determined by microarray.
Gene" Spot
Intensity
ratio*
p-value'' Annotation'^
SP2194 0.25 4.7E-05 ATP-dependent Clp protease, ATP-binding subunit
SP2193 1.23 0.254 DNA-binding response regulator
SP2192 1.55 0.003 Sensor histidine kinase
SP2191 1.25 0.033 Conserved hypothetical protein
SP2190 1.20 0.269 Choline binding protein A
a, Gene designation of microarray ORFs which match the TIGR designations 
(http://www.tigr.org). b, Mutant/wild type intensity ratios as determined in 
microarray experiments, c, p-value represents the mean p-value calculated from 
individual f-tests of intensity changes between the wild type and mutant. A p- 
value of less than 0.0001 is considered significant for up- or down-regulated 
genes, cf, Annotations as published in TIGR4 genome (http://www.tigr.org).
3.5.1.3 Regulation of gene expression by CIpC
Besides confirming that clpC mutation was done in a proper way with no downstream 
polar effects, the array results also identified some up- or down-regulated genes as a result 
of ClpC loss of function. Analysis of data revealed the down regulation of an operon of 
three genes (SP0875-77) in addition to the absence of ClpC transcripts in the mutant. The 
down-regulated genes are given in table 3.4.
Table 3.4- Genes down-regulated as a result of c/pC deletion.
Gene Spot
Intensity
ratio
p-value Annotation
SP0875 0.07 6.7E-6 Lactose phosphotransferase system repressor
SP0876 0.09 6.8E-5 1 -phosphoffuctokiiiase, putative
SP0877 0.14 2.8E-5 PTS system, fructose specific IIABC components
As expected, the clpC gene was highly down regulated in the D39Ac/pC mutant strain. In 
fact, examination of the individual spot intensities revealed that the fluorescence signals of 
clpC spots in case of D39Ac/pC mutant were identical to the background signals 
suggesting the absence of ClpC transcripts in the mutant RNA. The microarray analysis 
also revealed the up regulation of twenty other genes. These genes are shown in table 3.5.
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Table 3.5- Genes up-regulated as a result of cIpC deletion.
Gene" Spot
Intensity
ratio^
/i-value^" Annotation'^
SP0285 2.2 4.1E-6 Alcohol dehydrogenase, zinc containing
SP0368 3.2 5.0E-4 Cell wall surface anchor family protein
SP0577 6.1 5.1E-5 PTS system, beta-glucosidase-specific IIABC 
components
SP0578 3.7 2.6E-5 6-phospho-beta-glucosidase
SP0648 2.3 l.lE -3 Beta-galactosidase
SP0706 2.2 1.8E-3 Hypothetical protein
SP1185 3.1 1.5E-4 PTS system, lactose-specific IIBC component
SP1190 2.8 1.9E-4 Tagatose 1,6-diphosphate aldolase
SP1191 2.2 3.7E-4 Tagatose-6-phosphate kinase
SP1471 3.2 1.2E-3 Oxidoreductase, putative
SP1472 3.4 2.3E-4 Oxidoreductase, putative
SP1802 3.4 5.9E-5 Hypothetical protein
SP1803 2.8 6.5E-4 Conseiwed hypothetical protein
SP2026 2.2 6.3E-5 Alcohol dehydrogenase, iron-containing
SP0057 2.1 1.2E-3 Beta-N-acetylhexosaminidase
SP0061 3.3 5.6E-4 PTS system, IIB component
SP0063 4.0 3.3E-7 PTS system, IID component
SP0064 4.2 1.5E-5 PTS system, IIA component
SP0066 2.4 4.7E-4 Aldose 1-epimerase
SP0092 2.3 5.6E-4 ABC transporter, substrate-binding protein
a, Gene designation of microarray ORFs which match the TIGR designations 
(http://www.tlgr.org). b, Mutant/wild type Intensity ratios as determined In 
microarray experiments, c, p-value represents the mean p-value calculated from 
Individual f-tests of Intensity changes between the wild type and mutant. A p- 
value of less than 0.0001 Is considered significant for up- or down-regulated 
genes, d, Annotations as published In TIGR4 genome (http://www.tigr.org/).
3.5,2 In vitro analysis of the revertant strain
To confirm that the phenotype observed for D39Ac/pC mutant strain is due to the mutation 
in clpC gene and not due to other mutations introduced elsewhere into the chromosome, 
the clpC mutation was repaired by transformation with the wild type gene. Following 
transformation of D39Ac/pC with the wild type clpC gene, several pneumococcal colonies 
that had lost the erythromycin resistance phenotype were recovered. Analysis using PCR 
and nucleotide sequencing revealed the existence of wild type clpC allele in the revertant 
strain. The in vitro growth of the revertant strain, D39 clpCf', compared to that of the wild 
type and the D39Ac//?C mutant strains in BHI media at 37 °C was studied to confirm that 
the decreased autolysis phenotype of D39Ac/pC mutant is due to the disruption of clpC. 
The growth of the revertant strain was identical to that o f the wild type as measured both 
by optical density at 600nm (ODeoonm) and by counting the viable bacteria. The revertant
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strain grew at the same rate as the wild type to about 10  ^ CFU/ml after 7 hours and then 
underwent autolysis after reaching the stationary phase of growth to reach a viable count of 
less than 10'^  CFU/ml after 12 hours in a way that is identical to that of the wild type 
(figure 3.25). On the other hand, the D39Ac//?C mutant strain also grew to 10  ^CFU/ml but 
did not undergo autolysis. The viable count of the mutant remained at 10  ^CFU/ml after 12 
hours. These data suggest that the observed phenotype of the D39Ac//?C mutant, decreased 
rate of autolysis, is solely due to the loss of function of ClpC and not due to any mutations 
elsewhere in the chromosome.
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Figure 3.25- Growth of the cIpC revertant strain, D39 cIpC*, compared to the wild type D39 
and the D39Ac/pC mutant.
Representative graphs of in vitro growth of D39 WT, D39 Ac/pC mutant and D39 
cIpC* at 37 °C. 10® CFU/ml of each strain was used to inoculate BHI prewarmed 
at the indicated temperature and samples were taken at 1h-intervals to measure 
the optical density at 600nm (A) and the viable bacterial count (B). The rate of 
growth and autolysis of D39 cIpC* strain was almost identical to that of the wild 
type.
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3.5.3 In vivo analysis of the revertant strain
The in vivo phenotype of the revertant strain was also studied to confirm that the transient 
bacteraemia caused by D39Ac/pC mutant in mice is entirely due to clpC disruption. The 
bacterial loads of the revertant strain in tail bleed were very similar to that of the wild type 
(table 3.6).
Table 3.6- Bacterial counts in blood samples taken by tail bleeding after intranasal infection. 
Mouse logio bacterial loads (CFU/ml) at indicated time (h) post-infection
no. D39 WT D39AclpC D39 clpC+
0 18 24 48 0 18 24 48 0 18 24 48
1 NF 2.20 4.57 7.70* NF NF NF 2.96 NF 2.39 4.56 7.28*
2 NF 2.21 2.87 4.72 NF 2.76 4.98 3.02 NF NF NF 6.43
3 NF 4.11 5.79 7.86 NF 2.40 3.87 NF NF 4.88 6.32 8.23*
4 NF 3.22 5.16 6.43 NF 2.22 4.99 2.52 NF 4.90 6.41 7.59*
5 NF 3.70 5.40 6.62 NF NF 3.77 NF NF 3.57 4.96 6.36
Values given are log^ o CFU/ml. NF, None found, *, Mouse sacrificed 44 h post­
infection due to reaching moribund state.
Finally to test for the presence of suppressor mutations that compensate for the lack of 
ClpC, organisms recovered from the blood of animals infected with D39AclpC and 
showing signs of disease were used to re-challenge a further group of animals. The 
phenotype obseiwed using serial tail bleeding was very similar to the original D39Ac/j^C 
(table 3.7). The mutant organisms grew in blood to a viable count of about lO'* CFU/ml by 
48 hours after intranasal infection and then the count declined to about 10^  CFU/ml by 72 
houi's. These data clearly indicate that the virulence profile o f the D39AclpC is not affected 
by serial passage. The results of the gene repair and the serial passage suggest that the 
phenotype observed is due to the lack of ClpC and not other mutational effects.
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Table 3.7- Bacterial count In blood taken by tall bleeding from a second infection of mice 
with D39Ac/pC mutant.
Mouse _________Logio bacterial loads at indicated time post-infection
no. Oh 18b 24b 48b 72b
1 NF NF 1.92 4.44 3.60
2 NF NF NF 4.28 ““
3 NF NF NF 3.41 4.20
4 NF NF 2.22 4.92 4.05
5 NF 1.92 NF 3.37 3.65
6 NF NF NF 2.52 NF
Mice were infected intranasally with 10® CFU/mouse (n=5) and the number of 
bacteria in sequential tail bleeds was determined. Values given are log^ o CFU/ml. 
NF, None found. - ,  None detected (dead mouse)
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Heat shock proteins and stress response
Pathogenic bacteria as well as other living organisms have evolved adaptational regulatory 
networks to maintain cell viability under stressful environmental conditions and to ensure 
persistence and re-gi'owth in host tissues. When entering the host from the environment, a 
microbial pathogen is confronted by several changes, some of which are highly sti’essful. 
These include nutrient limitation, changes in temperature, humidity, and osmolarity. 
Moreover, the pathogen is exposed to natural host resistance mechanisms such as 
phagocytosis by specialized phagocytes (Kaufinann, 1998). Once engulfed by phagocytes, 
the pathogen is confronted with reactive oxygen and nitrogen intermediates. To protect 
itself against the host, the pathogen activates various evasion mechanisms including the 
synthesis of heat shock proteins (HSPs). The importance of HSPs for pathogen survival in 
this stressful environment was illustrated by experiments with a mutant of the intracellular 
pathogen Salmonella enterica serovar Typhimurium, which over expresses HSPs 
(Buchmeier and Hefhon, 1990). This mutant was shown to be resistant to a variety of 
oxidizing agents and heat. On the contrary, mutants of S. typhimurium with specific HSP 
gene defects are highly susceptible to killing by activated macrophages and also express 
decreased virulence in vivo (Fields et a l, 1986, Jolmson et a l,  1991).
Heat shock proteins (HSPs) were identified as proteins whose synthesis was enhanced by 
stresses such as an increase in temperature. HSPs can be classified into HsplOO, Hsp70, 
Hsp60 and small Hsp families according to their molecular weight and are universally 
present in prokaryotes and eukaryotes (Craig et a l, 1993, Hendrick and Haiti, 1993). 
Reversing polypeptide unfolding and preventing protein aggregation are major functions of 
HSPs, especially under stress (Craig et a l, 1993, Becker and Craig, 1994, Hartl, 1996). In 
non-stressed cells HSPs are present in low concentrations while in stressed cells they 
accumulate at high levels. In Escherichia coli, for example, the hsp60 homolog GroEL, 
which was first described by Hendrix et al (Hendiix, 1979), represents 1 to 2 % of the total 
protein content under normal conditions. Under stress conditions, however, its 
concentration is increased foui- to fivefold (Shinnick, 1991). Although HSPs do not 
accumulate to such high levels in eukaryotes, their concentrations are also increased after 
heat shock (Welch, 1990, Shinnick, 1991).
While the importance of HSPs for survival in the host holds true for a diversity of 
intracellular pathogens, HSP induction seems to be less appropriate for some other 
microbes, including monocytogenes. The ability of T. monocytogenes to survive in
macrophages in the absence of increased HSP synthesis could be explained by the potential
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of this pathogen to evade the stressful endosomal environment at an early phase after 
phagocytosis and therefore can giow in macrophages without the support of proteins 
induced by environmental stresses (Hanawa et a l, 1995). Thus, the impact of HSPs on 
microbial survival in the host varies in different infections.
One of the mechanisms that bacteria have developed to survive in unfavourable conditions 
is the induction of targeted intracellular proteolysis performed by energy-dependent 
proteases such as Clp ATP-dependent proteases (Parsed and Lindquist, 1993, Gottesman, 
1996, Fedhila et a l, 2002). The Clp proteins constitute a family of stress proteins, which 
are highly conserved and universal. Members of this family have been shown to exist in 
many prokaryotes such as Escherichia coli (Squires et a l,  1991), Streptococcus mutans 
(Shiroza and Kuramitsu, 1988) and Streptococcus pneumoniae (Pearce et a l, 1993) and in 
several eukaryotes, including Saccharomyces cerevisiae (Parsed et a l, 1991) and 
Trypanosoma hrucei (Gottesman et a l, 1990b).
HSPs as molecular chaperones or proteases
The folding of many newly synthesized proteins in the cell depends on a set of conserved 
proteins known as molecular chaperones. These prevent the formation of misfolded protein 
structures, both under nomial conditions and when cells are exposed to stresses such as 
high temperature. Although many chaperones are classified as stress proteins, they also 
carry out essential functions under normal physiological conditions. Some HSPs 
temporarily stabilize unfolded or partially folded proteins and thus promote the generation 
of the correct tertiary structure (Becker and Craig, 1994, Hartl, 1996). For those "hopeless 
case proteins" that are impossible to be refolded, the chaperone molecules may act as 
regulators of proteolysis by presenting these proteins for degradation by the protease 
subunit. These proteases are integi'al parts o f the cell’s protein quality control system 
which is responsible for clearing the cell of non-functional proteins (Wickner et a l, 1999, 
Dougan et a l, 2002). Most of these proteases also perform important regulatory functions 
by controlling the availability of transcriptional regulators, enzymes and other proteins via 
conditional degradation (Jenal and Hengge-Aronis, 2003). Proteolysis by Clp requires a 
serine type peptidase ClpP subunit and a regulatory ATPase subunit (Schiimer et a l, 
1996). The proteolytic subunits, ClpP, perform the actual hydrolysis of substrates. 
However, their active sites are buried within the cavity of the so-called proteolytic core 
formed by 14 ClpP subunits. Therefore, hexamers of ATPase subunits (ClpA, ClpC or 
ClpX), which are members of the Clp/HsplOO superfamily (Schiimer et a l, 1996) and 
associate with the core, are required in order to recognize, unfold and ultimately
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translocate substrate proteins into it (Hlavacek and Vachova, 2002). Streptococcus 
pneumoniae contains putative orthologues of four ATPase specificity factors (ClpC, ClpE, 
ClpL and ClpX) (Hoskins et a l, 2001, Tettelin et a l, 2001) and a single protease subunit 
ClpP.
Regulation of Clp ATPases
The cellular concentration of Clp has to be adapted in response to environmental 
conditions resulting in the accumulation of non-functional, i.e. truncated, misfolded or 
aggregated, proteins. The principal regulatory phenomena are well studied in 
enterobacteria and low G+C Gram-positive bacteria. In Escherichia coli, RNA polymerase 
(RNAP) containing the alternative sigma factor is responsible for heat-triggered 
transcriptional activation of clpX, clpP and other stress genes (Arsene et a l, 2000), 
whereas the transcriptional repressor CtsR controls expression of the clpC, clpE and clpP 
genes in Bacillus subtilis (Ki’uger and Hecker, 1998, Derre et a l,  1999a). The activity of 
as well as of CtsR is at least partially controlled at the level of protein stability, is 
normally directed by the DnaKJ-GrpE chaperone machinery into a degradation pathway 
involving several ATP-dependent proteases. However, stability increases rapidly 
during heat stress because the amounts of DnaKJ-GrpE available for sequestration 
become limited as the chaperone machinery is now required for disaggregating and 
refolding non-native proteins, hi contrast, CtsR stability is apparently modulated via heat- 
triggered post-translational modification by a putative protein kinase, McsB, and 
subsequent ClpCP-dependent degradation (Kinger et a l,  2001). In Bacillus subtilis and 
Listeria monocytogenes, CtsR negatively controls expression of the class III heat shock 
genes clpP, clpE and of the clpC operon (which encompasses ctsR and is thus 
autoregulated) by binding specifically to a direct heptanucleotide repeat in their promoter 
regions (Derre et a l, 1999b, Nair et a l, 2000a)
As S. pneumoniae lacks the sigma factor of E. coli, concentration of Clp is likely to be
regulated by alternative mechanisms. Sequence analysis of the genome database of S, 
pneumoniae released by The Institute for Genomic Research (TIGR) revealed that clpC in 
S. pneumoniae belongs to a locus organized differently from that in B. subtilis and L. 
monocytogenes. Immediately upstream of clpC, an open reading frame encoding a protein 
with 43% amino acid sequence identity with CtsR of B. subtilis was found (DeiTe et a l, 
1999b). Analysis of the pneumococcal amino acid sequence of CtsR revealed that the 
protein contains a predicted helix-turn-helix DNA-binding motif as noted previously for
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CtsR in B, subtilis (Derre et a l, 1999b). The translational termination codon of ctsR is 
located four bases downstream of the translational start codon of clpC. A consensus CtsR 
recognition sequence (AGTCAAACAAGGTCAAG) was identified 502 bp upstream of 
the clpC translational start codon within the promoter region of dpC, at the beginning of 
the coding sequence of ctsR. Upstream of clpC, three genes potentially encoding members 
of an ABC transporter were identified (Chaipentier et a l,  2000). Six hundred and forty- 
two base pairs downstream of the clpC gene, a putative two-component system was found. 
Reverse transcriptase polymerase chain reaction (RT-PCR) analysis revealed that this two- 
component system is transcribed from its own promoter (Charpentier et a l, 2000).
Analysis in vitro
As the role of ClpC in the autolysis and virulence of S. pneumoniae is controversial 
(Polissi et a l, 1998, Charpentier et a l,  2000, Chastanet et a l,  2001, Robertson et a l, 
2002), the role of ClpC in different pneumococcal strains was studied here. In addition, the 
contribution of ClpP to the stress response and virulence of the pneumococcus was also 
investigated. Two versions of the pneumococcal strain D39 have been used in this analysis, 
one of which is mouse virulent (teimed mouse-adapted; MA) and the other is avimlent in 
mice and termed laboratory-adapted (LA). The basis for the difference in the virulence of 
these two isolates is unknown but appears not to be related to phase variation or capsule 
expression as judged by visual analysis of colonies. These strains differed not only in their 
vimlence for mice but also their resistance to penicillin-induced lysis. The mouse-adapted 
strain was resistant to penicillin-induced autolysis whereas the laboratory-adapted strain 
was not. As penicillin-induced autolysis is believed to involve the action of the major 
autolysin (LytA), these strains may differ in their basal activity of LytA. The nucleotide 
sequence of the LytA gene has been determined and is not mutated when compared to the 
D39 sequence present in the database. Total levels of LytA, as judged by Western blotting 
are also similar in D39(MA) compared to D39(LA). The difference may be related to 
activation of the LytA enzyme or by some other aspect of differences in the cell wall on 
the strains. Whether the difference in penicillin-induced lysis in these strains is reflected in 
their virulence is not clear at the present time. ClpC and ClpP seem to play different roles 
in different strains and serotypes (see below).
Role of ClpC in autolysis
The AclpC mutants of all strains studied were able to grow at high temperatuie in a manner 
similar to the parent strains. However, the AclpC mutants of type 2 strain D39 did not
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undergo autolysis after stationary phase of growth, grew in long chains, and were resistant 
to penicillin-induced lysis suggesting an impairment in the function of LytA. In the case of 
the mouse-adapted strain of D39, the parent strain was also resistant to penicillin-induced 
lysis. Charpentier and co-workers reported that a KclpC mutant of strain R6 (a derivative 
of D39) showed increased tolerance to high temperatures, formed long chains and failed to 
undergo lysis after penicillin treatment (Charpentier et a l, 2000). Contrary to this report, 
Chastanet and colleagues reported that a l^clpC mutant of strain R348 grew as diplococcal 
cells and did not form chains and was indistinguishable from the wild type in response to 
penicillin or DOC-induced autolysis and also in the growth at different temperatures 
(Chastanet et a l, 2001). A third paper by Robertson et al reported that ClpC was not 
involved in the gi'owth at elevated temperatui'es and also did not affect autolysis in strains 
R6 and D39 (Robertson et a l, 2002). The dramatic phenotype of the hclpC  mutant 
observed by Charpentier and co-workers (Charpentier et a l,  2000) may be due to a strain 
not being a pneumococcus. The ZmpB phenotype reported by the same group (Novak et 
a l,  2000a) has been found by another group to be due to a strain related to Streptococcus 
viridans (Berge et a l, 2001). Data presented in this chapter suggest that ClpC is not 
involved in thermal tolerance but can play a role in autolysis, cell-separation and resistance 
to penicillin-induced lysis. However, the findings with the two variants of D39 also show 
that this phenotype can vary according to the history of the strain. This presumably reflects 
accumulation of other mutations that affect the phenotype o f ClpC mutants. Differences 
also occur- between strains as shown by the effect of the ClpC mutation in the TIGR4 strain 
reported here.
In a Wester-n blot analysis, the quantity of released pneuruolysin was less in the AclpC 
mutant than in the wild type and no release of LytA in the culture supernatant of the 
mutant was detected. Autolysin is activated during the stationary phase or upon penicillin 
treatment to cause lysis of bacteria and the release o f cytoplasmic contents including 
pneumolysin and other vir-ulence factors (Ronda et a l, 1987, Mitchell et a l, 1997). Thus it 
appears that ClpC is involved in the control of this autolytic process and in the release of 
pneumococcal virulence factors. However, it should be noted that the extracellular release 
of pneumolysin from the pneumococcal strain WU2 (type 3) can also be independent of the 
action of LytA (Balachandran et a l, 2001). The lack of autolysis was not observed for 
strains R6, R800 and TIGR4 suggesting that the contribution of ClpC to the autolysis of 
the pneumococcus is strain-dependent.
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ClpC was also implicated in the ability of bacteria to respond to stresses other than heat 
shock. A clpC insertional mutant of Bacillus subtilis had an impaired tolerance for salt 
stress (Kruger et a l, 1994). In addition, Scharf et al reported that in Bacillus subtilis, ClpC 
and TrxA are induced at least partially in a o^-dependent mechanism and raise the capacity 
of the bacteria to recover proteins damaged by oxidative stress (Scharf et a l, 1998). The 
contribution of ClpC to the pH tolerance and oxidative stress resistance of the 
pneumococcus was tested here. ClpC was found to have no effect on the pneumococcal 
acid tolerance or resistance to peroxide. The lack of apparent stress sensitivity of AclpC 
mutants to heat and other stresses may be explained by compensation for ClpC deficiency 
by other chaperones.
In vitro phenotype of cIpP mutants
The ClpP proteolysis is indispensable for survival under conditions of stress. ClpP of E. 
coli removes abnoimal proteins that accrnuulate during stress conditions and controls the 
half-life of regulatory proteins including the stationary phase sigma factor (Zhou and 
Gottesman, 1998). ClpP-null mutants of Bacillus subtilis and Lactococcus lactis were 
unable to survive during heat shock and other stress conditions (Gerth et a l, 1998, Frees 
and Ingmer, 1999). It was also reported that ClpP was necessary for the ability of 
Staphylococcus aureus to resist oxidative stress and to grow at low temperature (Frees et 
a l,  2003). Furthermore, ClpP-mediated proteolysis was also essential for many other 
processes such as, natural genetic competence and sporulation in & subtilis (Msadek et a l, 
1998), biofilm development in Pseudomonas fluorescens (O'Toole and Kolter, 1998) and 
viability and cell cycle progression in Caulobacter crescentus (Jenal and Fuchs, 1998).
Similar to the role of ClpP in other bacteria, this study reports that ClpP is necessary for 
the growth of both type 2 and type 4 strains of the pneumococcus at elevated temperatures. 
This study also found that ClpP is required for the growth of D39 at lower temperature 
(30°C) but not for TIGR4. The defect in growth at 30°C for a ClpP mutant of D39 has been 
reported previously (Robertson et a l, 2002). The in vitro growth data in this chapter also 
indicate that D39 and TIGR4 wild type strains are different in their growth at lower 
temperatures. The D39 gi'ew at 30 °C to an ODeoomn of 0.6 after 10 hours of inoculation 
while the ODeoonm of TIGR4 at the same time and temperature was 1.4 (Figure 3.13). The 
requirement of ClpP for the sui'vival of TIGR4 under heat shock has not been reported 
before but again highlights strain differences in the role of these molecules. Data presented 
in this study also confirm the involvement of ClpP in the resistance o f 6'. pneumoniae strain
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D39 to oxidative stress, which was reported by Robertson and co-workers (Robertson et 
a l, 2002).
Analysis In vivo
ClpC was identified as a vimlence factor in a signature-tagged mutagenesis screen (Polissi 
et a l, 1998). It was suggested to play a role in the vimlence of S. pneumoniae by affecting 
expression of choline-binding proteins (Cbps) and other vimlence factors such as 
pneumolysin (Charpentier et a l, 2000). Data shown in this chapter suggest that ClpC 
infuences Ply release by affecting autolysis (Figure 3.12). The vimlence of D39Ac//?C was 
also reported to be marginally attenuated in an intratracheal model of infection (Robertson 
et a l, 2002). In the pneimionia and bacteraemia models used for this study, ClpC did not 
affect the overall outcome of pneumococcal disease judged by survival times. However, 
the growth in the lungs and blood after intranasal infection was dependent on ClpC. The 
number of ta^clpC mutants recovered from lungs declined from approximately 10  ^ to less 
than lO"^  whereas the wild type increased to more than 10 .^ Appearance of bacteria in the 
bloodstream following intranasal challenge was similar for wild type and t^clpC in that 
bacteria appeared in the bloodstream at a similar time and grew to about 10"^  per ml of 
blood by 24 h (significantly higher counts than time 0 h for both groups). Therefore, 
although b.clpC is less able to grow at 37 °C in vitro, it is able to grow normally for the 
first 24 h in mouse blood. However, the wild type bacteria then continued to grow to levels 
of approximately 10*^  per ml by 48 h whereas numbers of the mutant reduced to levels that 
were no longer significantly different to counts at time 0 h. The effect of disruption of the 
clpC gene on bacteriology is therefore dramatic, with very low numbers of the mutant 
present in the lung and blood at 48 h when animals begin to show signs of disease. This 
suggests that the lethal event is triggered early in the infection or that low numbers of 
bacteria are able to cause the effect, In fact, analysis o f serial tail bleed from the same 
animal (table 3.6) shows that the mouse can actually clear transient bacteraemia to levels 
below detection but still go on to die from the infection suggesting the fomier is more 
likely. It also remains a possibility that the levels of bacteraemia in AclpC infected mice 
increases again between 48 h and the time of death. The event triggered by the 
pneumococcus that results in death is still not laiown.
ClpP-controlled proteolysis is also essential for disease progression and virulence of 
bacterial pathogens, favouring smwival in the host organism or modulating the activity of 
virulence factors. The stress-induced ClpP serine protease contributes to virulence in
135
ClpCP Discussion
Salmonella enterica serovar Typliimuiium (Webb et al., 1999) and modulates adhesion 
invasion locus (ail) gene expression in Yersinia enterocolitica (Pederson et a l, 1997). In 
Listeria monocytogenes, ClpP is essential for intracellular parasitism and virulence (Gaillot 
et a l, 2000). Kwon and co-workers reported that ClpP also plays an essential role in the 
virulence o f S. pneumoniae (Kwon et a l, 2003). In the present study, the D39Ac//>P mutant 
was completely a virulent in a pneumonia model o f infection while the TIGR4Ac/pP mutant 
was less virulent than its TIGR4 wild type (mirroring the less pronounced effect of the 
KclpP mutation on in vitro growth, figure 3.13). A AclpP mutant of the strain D39 was 
reported to be strongly attenuated for virulence in murine lung and sepsis infection models 
(Robertson et a l, 2002). Despite the agreement on the contribution of ClpP to the 
vimlence of the pneumococcus, it is not completely understood whether this contribution is 
due to its proteolytic effect on misfolded or stress-damaged proteins or due to regulation of 
other vimlence factors. Recently, Kwon and co-workers reported that expression of 
vimlence genes such as pneumolysin and pneumococcal surface antigen A is modulated by 
ClpP protease (Kwon et a l, 2003). The same gioup fmther investigated the underlying 
mechanism of virulence attenuation by the AclpP mutant and reported that the mRNAs of 
pneumolysin (ply) and a serotype 2 capsule locus (cpsA) were regulated post- 
transcriptionally by ClpP and that ClpP is translocated into the cell wall after heat shock 
(Kwon et a l, 2004). In addition, ClpP was found to be required for colonization of the 
nasopharynx and suiwival in the lungs of mice after intranasal infection (Kwon et a l, 
2004).
Global transcriptional profile of AclpC mutant
To address the genetic basis for the AclpC phenotype, analysis of global transcription of 
the T)?)9AclpC mutant compared to the D39 wild type was performed. As an internal 
control o f this method, clpC transcript was not detected from the D39AclpC compared to 
the parent strain. Fuithemiore, the level of transcription ftom the c/pC-downstream genes 
was the same in Y>39AclpC and its parent strain D39, indicating the lack of polarity on the 
surrounding genes.
The global transcription analysis showed that only an operon of thi'ee genes (table 3.4) was 
repressed by clpC deletion. This operon contains the gene for LacR (13.4-fold down 
regulation), which belongs to a group of DNA-binding repressors including GalR and Lad, 
and most of the members of this group contain a helix-turn-helix structure at their N- 
terminal regions (Weickert and Adhya, 1992). It also contains genes homologous to the L.
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monocytogenes FitxA and FinB, which are involved in fructose metabolism (11.4- and 6.9- 
fold down regulation, respectively). The most notable among the up-regulated genes were 
some of those genes involved in sugar transport and metabolism including PTS systems 
and the beta-glucosidase, bglA (table 3.5) in addition to a cell wall surface anchor family 
protein and some hypothetical proteins of unlaiown function. The phospho- transferase 
systems (PTS) are multicomponent complexes involved in transport and concomitant 
phosphorylation of various sugars in bacteria. The phosphorylation cascade takes place 
from phosphoenolpyi'uvate (PEP) to the sugar via two cytoplasmic proteins (El and HPr) 
commonly used by all the PTS, and a carbohydrate specific enzyme II (Eli). The latter is 
composed of at least three domains, two cytoplasmic IIA and IIB, and one membrane 
bound domain IIC, (Postma et a l, 1993).
The significance of up-regulation of these genes involved in sugar metabolism in response 
to clpC mutation is not clear at present. In addition, as ClpC probably regulates protein 
folding or directs damaged proteins for degradation by the proteolytic subunit, it is likely 
that microarray is not the best approach to study the effect of clpC deletion.
Summary
The ATP-dependent caseinolytic proteases (Clp) are fundamental for stress tolerance and 
virulence in many pathogenic bacteria. The role of ClpC in the autolysis and virulence o f 
S. pneumoniae is controversial. In this study, the role of ClpC was tested in a number o f S. 
pneumoniae strains and the contribution of ClpC to autolysis was found to be strain- 
dependent. ClpC is required for the release of autolysin A and pneumolysin in serotype 2 
S. pneumoniae strain D39. vivo, ClpC is required for the growth of the pneumococcus in 
the lungs and blood in a mmine model of disease but it does not affect the overall outcome 
of pneumococcal disease. Repair of clpC mutation and expression of downstream genes, 
determined by micro array analysis, revealed the lack of downstream polar effect of the 
mutation and confirmed that the phenotype observed is solely due to lack of ClpC. This 
study also reports the requirement of ClpP for growth at elevated temperature and 
virulence of serotype 4 strain TIGR4 and confnms its contribution to the thermotolerance, 
oxidative stress resistance and virulence of D39.
The difference in virulence phenotype between AclpC and AclpP shows that other ATPase 
specificity factors interact with ClpP or that ClpP has roles independent of the activity of 
these factors. Investigation into the role of other ATPase specificity factors in the virulence 
process is therefore required.
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Chapter 4
ROLE OF HtrA IN THE PNEUMOCOCCAL STRESS
RESPONSE, RESULTS
HtrA Results
Bacteria use multiple regulatory pathways to respond to stresses that affect cytoplasmic 
physiological processes. The synthesis of a variety of heat shock proteins (HSPs) 
consisting of cytoplasmic chaperones and proteases is induced in response to elevated 
temperature, oxidative stress and other stressful stimuli. The function of HSPs is to 
facilitate survival by mediating refolding or degradation of misfolded or stress-damaged 
proteins.
The High Temperature Requirement A (HtrA), also loiown as DegP or DO Protease (Seol 
et al., 1991), is a heat shock-induced serine protease that was first described in Escherichia 
coli to be involved in the degi'adation of periplasmic misfolded proteins (Strauch et al., 
1989). This ATP-independent protease has both general molecular chaperone and 
proteolytic activities and switches from chaperone to protease in a temperatui'e-dependent 
manner (Spiess et a l,  1999), the protease activity being most apparent at elevated 
temperatuie.
This chapter summarizes the investigation into the role of HtrA protein in the 
pneumococcal stress response. HtrA-null mutants were constructed and their in vitro and in 
vivo phenotypes compared to the wild types.
4.1 Characterization of HtrA
Analysis of the complete genome sequence of Streptococcus pneumoniae strain TIGR4 
(The Institute for Genomic Research at http://www.tigr.org/) revealed a single copy of the 
gene for HtrA. The 1179 bp gene encodes for a 393-amino-acid protein with molecular 
weight of 42 IcDa. The protein possesses an amino-terminal hydrophobic region, a trypsin 
like catalytic domain (residues 116-277) with conserved His^^^, Asp^^  ^ and Ser^ "^^  residues 
and a PDZ domain at the carboxyl-terminal (residues 289-382). Purified HtrA shows ATP- 
independent endopeptidase activity against p-casein that can be inhibited by diisopropyl 
fluorophosphate, a specific inhibitor of serine proteases, confirming that HtrA is a serine 
protease (Lipinska et a l, 1990). The pneumococcal HtrA is homologous to HtrA of many 
Gram-positive bacteria. The amino acid sequence alignment shown in figure 4.1 highlights 
this homology.
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Figure 4.1- Multiple sequence alignment of HtrA protein from some Gram-positive bacteria.
Amino acid sequences were aligned using ClustalV Method (MegAlign, 
DNASTAR Inc.). Conserved residues are highlighted. The conserved sequence 
around the active site is boxed. Arrowheads point at the catalytic triad of His^ ^^ , 
Asp^" and Ser^ ^^  (S. pneumoniae numbering). The membrane anchor region of 
S. pneumoniae HtrA lies between valine 17 and serine 29. The PDZ domain is 
the region between the two arrows.
4.2 Construction of AhtrA mutants
The htrA gene of S. pneumoniae strains D39 and TIGR4 was disrupted by the introduction 
of a spectinomycin resistance cassette into the gene. A knockout plasmid was constructed 
as discussed below and used to mutate the pneumococcal htrA gene using homologous 
recombination. Figure 4.2 summarizes this process.
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Figure 4.2- Construction of htrA mutant
4.2.1 Plasmid construction and confirmation
A  1.2 kb fragment representing the whole htrA gene was cloned in PCR-Script™ Amp 
cloning vector (3 kb). The inverse PCR resulted in ~ 3.5 kb DNA fragment with Ascl 
restriction sites, which represent the 5’ and 3’ ends of htrA together with PCR-Script. The 
/l5cl-cut inverse PCR product was ligated to a spectinomycin resistance cassette (1.2 kb) to 
facilitate the selection of transformed cells and the resulting plasmid was used to transform 
E. coli competent cells (see Materials and Methods). This plasmid was confirmed by 
restriction digestion and PCR.
4.2.1.1 Confirmation by restriction d igestion
The construction of the plasmid was confirmed by digestion with Ascl endonuclease. The 
10-pl reaction included 5 pi of the plasmid, 3.6 pi of dHzO, 1 pi of buffer 4 and 0.4 pi of 
Ascl (New England Biolabs, UK). The reaction was incubated at 37 °C in a water bath for 
2 hours and then run in loading buffer on a 1 % agarose gel to visualize DNA bands. 
Figure 4.3 shows the result of this restriction digestion.
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Figure 4.3- Agarose gel electrophoresis of Ascl-digestion of the plasmid used for making 
AhtrA mutant.
Lane 1, 1 kb plus ladder; lane 2, uncut plasmid; lane 3, Ascl-cut plasmid 
showing 1.2 kb fragment representing the spectinomycin cassette and *>3.5 
fragment representing PCR-Script and the 5’ and 3' ends of htrA.
4.2.1.2 Confirmation by PCR
The plasmid was also confirmed using different combinations of htrA forward and reverse 
primers (HtrA for and HtrA rev, table 2.2) and spectinomycin forward and reverse primers 
(Spec up and Spec dn, table 2.2) as shown in figure 4.4. When HtrA for and HtrA rev 
primers were used, a 1.7 kb fragment was amplified instead of 1.2 kb corresponding to 
htrA gene. The spectinomycin resistance cassette (1.2 kb) was amplified when primer pair 
Spec up and Spec dn was used. PCR reactions using HtrA for and Spec dn or HtrA rev and 
Spec up combinations were negative. However, those reactions using HtrA for and Spec up 
or HtrA rev and Spec dn resulted in 1.45 kb products. These PCR products confirmed the 
construction of the plasmid shown in figure 4.4.
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Figure 4.4- Agarose gel electrophoresis of PCR reactions carried out for confirmation of the 
plasmid used for making AhtrA mutant.
Lane 1,1.7 kb product using primer pair HtrA for and HtrA rev; lane 2,1 kb plus 
ladder; lane 3, 1.2 kb product using primer pair Spec up and Spec dn; lane 4,
1.45 product using primer pair HtrA for and Spec up; lane 5, negative reaction 
using primer pair HtrA for and Spec dn; lane 6, negative reaction using primer 
pair HtrA rev and Spec up; lane 7, 1.45 product using primer pair HtrA rev and 
Spec dn.
4.2.2 Transformation of S. pneumoniae
The mutated htrA gene was amplified by PCR with primer pair HtrA for and HtrA rev (1.7 
kb) and used to transform S. pneumoniae strain D39 (serotype 2) as mentioned in the 
Materials and Methods. Genomic DNA was prepared from the transformed cells and the 
mutation was confirmed by using diagnostic primers, htrA Cl and htrA C2 (table 2.2) 
flanking htrA to amplify a PCR fragment of 1.7 kb from the chromosomal DNA of the 
transformed cells grown on spectinomycin compared to the 1.2 kb fragment of the wild 
type copy of htrA (Figure 4.5). This PCR fragment was sequenced to further confirm that 
the mutation occurred in the right position of the pneumococcal chromosome. This 
mutation was later moved to the TIGR4 strain (serotype 4) to investigate the role of HtrA 
in the virulence of the pneumococcus in different backgrounds.
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1.65 kb 
1 kb
Figure 4.5- Confirmation of htrA mutation in strain D39.
Primer pair htrA 01 and htrA 02 flanking htrA gene was used to amplify a 1.7 kb 
band from the D39 AhtrA mutant (Lane 3) compared to the 1.2 kb fragment 
representing the wild type copy of htrA (Lane 2). The 1 kb plus DNA ladder is 
shown in lane 1.
4.3 In vitro analysis of AhtrA mutant
The in vitro phenotypes of AhtrA mutants were compared to the wild type strains in a 
number of assays to investigate the role of HtrA in pneumococcal biology and stress 
response. The pneumococcal strain D39 was used in these assays unless stated otherwise.
4.3.1 Growth phenotype
The growth of D39 AhtrA mutants at normal and elevated temperatures was compared to 
D39 wild type; 1x10^ CFU/ml from glycerol stocks of known viable counts of wild type 
and mutant strains was used to inoculate BHI prewarmed at 37 °C and 40 °C and the 
cultures incubated in water baths adjusted at these temperatures. At 1-hour intervals, 
samples of the cultures were withdrawn under aseptic conditions and the ODeoonm and 
viable counts were determined.
The D39AhtrA mutant was found to grow at a similar rate as the wild type at 37 ®C. 
However, the mutant grew more slowly at 40 ®C compared to growth of D39 wild type. 
The effect of htrA deletion was to slow growth rather than prevent it and the mutant 
organisms still reached the same final optical density (figure 4.6 A). Moreover, the 
D39AhtrA mutant had a decreased rate of autolysis compared to its parent strain at 40 °C 
as indicated by the viable count at stationary and decline phases o f growth (figure 4.6 B).
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Figure 4.6- Growth phenotype of AhtrA mutant compared to D39 wild type at 40 °C.
Representative graphs of three independent experiments showing growth of 
D29AhtrA mutant and D39 wild type measured by ODeoonm in (A) and by viable 
counts in (B). BHi prewarmed at 40 °C was inoculated with either bacterial strain 
to 10° CFU/ml. Samples were taken at 1h-intervais to measure the ODeoonm and 
viable counts on BAB.
4.3.2 Hydrogen peroxide sensitivity
Sensitivity to hydrogen peroxide, which represents oxidative stress, was studied for the 
D39AhtrA mutant and its D39 wild type. 1-ml aliquots of bacterial cultures grown to 
ODôoonm ~ 0.3 were exposed to 40 mM of H2O2 for 5, 10, and 15 min at room temperature 
and the viable counts measured before and after exposure to peroxide. Results were taken 
as percentage of cells survived per total cells. The D39AhtrA was more sensitive to H2O2 
than D39 wild type. The percentage survival of the mutant was significantly less than that 
of the wild type at all indicated time points (figure 4.7).
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Figure 4.7- Hydrogen peroxide sensitivity assay for D39 wild type and D39A/ifrA mutant.
Hydrogen peroxide (final concentration 40 mM) was added to 1-ml aliquots of 
culture grown to ODeoonm ~ 0.3. Viable counts were performed on BAB plates 
before and after the addition of peroxide and the % survivals were calculated. 
Values expressed are the mean (SEM) of three independent experiments. *, p <
0.05 lower survival for A/itrA mutant than wild-type.
4.3.3 Transformation efficiency
The ability of the strains to take up exogenous DNA was also compared. Pneumococcal 
genomic DNA conferring kanamycin resistance (from a AclpP mutant containing 
kanamycin resistance cassette) (Chastanet et a i, 2001) was used as the transforming DNA. 
0.3 jLtg of this DNA was used to transform competent cells of D39 wild type and AhtrA and 
AhtrA!phtrA^ mutants as described in the Materials and Methods. The efficiency of 
transformation was expressed as the percentage of transformed cells to the total number of 
cells used. The disruption of the htrA gene caused a decrease in transformation efficiency 
of approximately 32-fold. This reduction could be reversed by complementation with a 
plasmid containing the htrA gene, pAL2-HtrA plasmid (table 4.1).
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Table 4.1- Transformability of AhtrA mutant compared to D39 wild type.
Experiment
number
% transformants
D39 wild type X)39AhtrA T>39AhirAlphtrA^
1 0.825 0.024 0.522
2 0.394 0.017 0.321
3 0.408 0.011 0.517
Mean ± SEM 0.542 ± 0.141 0.017 ±0.004 0.453 ± 0.066
D39AhtrA mutant had a lower transformation efficiency than D39 wild type (P 
<0.05), This decrease in transformation efficiency was reverted in the 
complemented mutant DZSAhtrAlhtrA* by expression of HtrA using the pAL2- 
HtrA plasmid. The percentage transformants was indicated as (kanamycin- 
resistant colonies per total viable cells used) xIOO.
4.3A  Other in vitro anaiyses
The T)39AhtrA mutant was also analyzed by a number of other assays. The sensitivity to 
Paraquat, which is taken up by bacterial cells and generates superoxide within the 
cytoplasm (Hassett et a l, 1987), and the effect of htrA deletion on the ability to grow at 
different pHs were also studied. There was no difference in the effect of paraquat and no 
significant differences between wild type and mutant strains in the growth at different pHs 
(data not shown).
The amount o f the toxin pneumolysin and the major autolytic enzyme LytA expressed at 
37 ”C and 40 “C were studied by Western blotting. Total protein samples from cultures 
gi'own to mid-logarithmic phase were separated on 12 % SDS-PAGE, electroblotted onto 
nitrocellulose membranes and reacted with specific antisera against pneumolysin and 
autolysin A by standard methods (Sambrook et a l,  1989). There was no significant 
difference between the wild type and mutant strains in the amount of pneumolysin or LytA 
(data not shown).
The distribution of tlmee known surface proteins of the pneumococcus was also examined. 
No difference in the levels of CbpA, hyaluronidase or neuraminidase associated with the 
different cell fi'actions could be found as determined by Western blotting. In addition, there 
were no differences in the distribution of enzymatic activity of hyaluronidase or 
neuraminidase between the mutant and wild-type organisms (data not shown).
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4.4 In vivo analysis of AhtrA m utants
The effect of htrA deletion on the virulence of the pneumococcus was studied in two 
different serotypes, serotype 2 (strain D39) and serotype 4 (strain TIGR4) using a number 
of in vivo assays.
4.4.1 Intranasal infection
Groups of M Fl mice (5 mice each) were infected intranasally with either type 2 or type 4 
wild types or their AhtrA mutants. The effect of HtrA was examined in two genetic 
backgrounds as it was recently shown that genetic background could have a major 
influence on the role o f virulence factors (Blue and Mitchell, 2003). After administering 
the infectious dose (10^ CFU/mouse in case of D39 and either 10  ^ or 10  ^ CFU/mouse in 
case o f TIGR4), mice were observed and the development of symptoms was recorded over 
a period of eight days. Mice infected with D39 wild type started to show symptoms of 
illness 24 h post-infection and all mice were moribund by 72 h. However, none of the 
D39AhtrA infected mice showed any signs of illness thi’oughout the experiment (Figure 4.8 
A). In the case o f the TIGR4 strain, which is more vimlent than D39, all mice infected with 
a dose of 10  ^ CFU of TIGR4AA W  survived the experiment, while 80 % of those infected 
with the wild type TIGR4 became moribimd (Figure 4.8 B). When using a dose of 10  ^
CFU/mouse, mice infected with wild type TIGR4 became moribund very rapidly (all were 
sacrificed by 29 h) while the first moribund case of TlGK4AhtrA infected mice was not 
recorded until 120 h post-infection and 60% of the animals were normal at the endpoint of 
the experiment, eight days. (Figure 4.8 C).
4.4.2 Bacterioiogicai investigation
The behavior ofD39AhtrA  mutant compared to the D39 wild type in the hmg airways, lung 
tissue and blood after intranasal infection was studied at 0, 6, 12, 18, 24, and 48 h after 
infection. In the hmg aii*ways, both D39 and D39AhtrA mutant were cleared over time. 
However, the D39AhtrA mutant was cleared more rapidly. The number of T>39AhtrA 
recovered was significantly lower than that of D39 at 6 and 12 hours post-infection 
(p<0.05) (Figure 4.9 A). In the lung tissue however, while D39 gi’ew very well, D39AhtrA 
was unable to survive (Figure 4.9 B). Furthermore, D39 appeared in blood 12 h post­
infection and grew dramatically, whereas, D39AhtrA mutant was never detected in blood 
(Fig 4.9 C).
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Figure 4.8- Survival of MF1 mice infected intranasally with D39 and TIGR4 wild types or their 
AhtrA mutants.
Mice infected intranasally with 10® CFU/mouse (n=5) of D39 or D39 AhtrA in (A),
10® or 10® CFU/mouse of TIGR4 or TIGR4AhfrA mutant in (B) and (C) 
respectively. *, p <0.05 longer survival times for the AhtrA compared to wild 
type.
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Figure 4.9- Bacterial loads In the lung and blood of MF1 mice after Intranasal Infection with 
D39 wild type or D39A/?frA mutant.
Time course of mean (SEM) bacterial growth In the lung lavage (A), lung tissue 
(B), and blood (C) after Intranasal Infection with 10° CFU/mouse (n=5) of D39 
wild type or Its AhtrA mutant. Broken line represents the limit of detection of the 
assay. p <0.05 lower bacterial loads for D39A/itr4 mutant than for D39.
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4.4.3 Bacteraemia after intranasal Infection (TIGR4)
The ability of TIGR4A/z^r/l mutant to cause bacteraemia in mice after intranasal infection 
was also tested. Mice were bled 24 h and 48 h after challenge with 10  ^ CFU/mouse of 
either TIGR4 wild type or TlG'KAls.htrA mutant and the number of pneumococci in blood 
was determined by plating on BAB. The number of TIGR4 wild type was between log 5- 
6.8 in 60 % of mice after 24 h of infection while no bacterial count was detected in the rest 
of the group. Mice with detectable bacterial count died and those with no count survived 
48 h post-infection, hi contrast the TlGRAishtrA mutant was not found in the blood of mice 
at any time point (table 4.2).
Table 4.2- Counts of bacteria In tail blood from MF1 mice after intranasal infection with 10 
CFU/mouse of TIGR4 wild type or TlGR4A/7frA mutant.
Mouse
number
Logio bacterial load (CFU/ml) at indicated time post-infection
24h 48h
TIGR4 TlGR4AhtrA TIGR4 TIGR4AA/rA
1 6.041 ND — ND
2 6.791 ND — ND
3 ND ND ND ND
4 5.097 ND — ND
5 ND ND ND ND
Mice were bled 24h and 48h post-infection and the viable count was determined 
by plating on BAB plates. TIGR4AhfrA was not detected in blood of all infected 
mice at either time points. P < 0.05 at 24 h post-infection. ND, none detected. —, 
Dead mouse.
4.4.4 intravenous infection
To determine if the role played by HtrA was specific for the lung, organisms were injected 
directly into the bloodstream to by-pass the respiratory tract. M Fl mice were given 1x10^ 
CFU/mouse and both survival of mice and bacterial loads in blood were determined. Wild 
type D39 gi'ew in the blood and resulted in all injected animals becoming moribund while 
AhtrA mutant organism caused no disease, all mice infected with AhtrA mutant were quite 
healthy at the endpoint of the experiment (figure 4.10 A). The wild type strain established 
itself well and multiplied rapidly while the mutant strain was cleared from the blood 
(figure 4.10 B). HtrA therefore plays a critical role in the survival and growth of the 
pneumoeoccus in the vascular compartment.
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Figure 4.10- Survival of MF1 mice and bacterial load in blood after intravenous infection with 
D39 wild type or D39AhtrA mutant.
Survival of MFl mice (A) and time course of mean (SEM) bacterial growth in 
blood (B) after intravenous challenge with 10^  CFU/mouse (n=5) of D39 wild type 
or its AhtrA mutant, in A *, p<0.05 shorter survival times for D39 than for AhtrA 
mutant and in B *, p<0.05 lower bacterial loads for AhtrA than for D39 wild type. 
Dashed line represents the limit of detection of the assay.
4.4.5 Measurement of immune modulators
To study the inflammatory response to D39AhtrA compared to that of D39 wild type, IL-6 
and TNF-a levels in the lung lavage and in the lung tissue o f MFl mice after intranasal 
infection were measured (figure 4.11). D39 induced high levels of IL-6 at 24 h post­
infection, which was reduced after 36 h in the lung lavage and increased by time in the 
lung tissue. No or very low IL-6 levels were detected both in the lung lavage and in the 
lung tissue in the case of D39AhtrA mutant. D39 gave peak TNF-a levels in the lung 
lavage after 24 h which declined sharply while TNF-a concentrations were increased over
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time in the lung tissue. In contrast, the mutant induced very low TNF-a in the
lung lavage fluid, and levels in the lung tissue that were less than those induced by D39. 
Although these results are complicated by the fact that the lungs contain different numbers 
of organisms, it is clear that D39A/?rr/f induces much less inflammation in the lung. The 
bacterial count of both organisms present in the lavage fluid at 24 h was very similar 
(Figure 4.9) but the mutant still did not induce IL-6 or TNF-a production.
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Figure 4.11- Levels of IL-6 and TNF-a In the lung lavage and lung tissue of MFl mice after 
Intranasal Infection with D39 wild type or Its AhtrA mutant.
Median (MAD) levels of IL-6 and TNF-a induced In the lung lavage and In the 
lung tissue of MFl mice (n=5) Infected intranasally with 10^  of D39 wild type or 
Its AhtrA mutant. (A) Levels of IL-6 In the lung lavage, (B) levels of IL-6 In the 
lung tissue, (C) levels of TNF-a In the lung lavage, and (D) levels of TNF-a In the 
lung tissue. *, p< 0.05 lower cytokine levels for AhtrA mutant than for D39 wild 
type.
4,4.6 Histological analysis
Histological examination revealed that the influx of inflammatory cells into the lungs of 
mice infected with wild type bacteria was greater than in those infected with D39AhtrA
153
HtrA Results
mutant. At 48 h post infection lungs of mice infected with D39 contained more lesions, 
especially at the pleural interface (figure 4.12 A). These areas were swollen and congested 
with recruited cells (nuclear morphology indicates the majority of cells were neutrophils). 
In contrast, lungs from mice infected with D39A/i/ry4 had few inflammatory lesions (figure 
4.12 B). Perivascular alterations were also scored. The perivascular areas of D39 wild 
type-infected mice had inflammatory cell recruitment, whereas some of lung sections of 
mutant-infected mice had no such cells (figure 4.12 C & D). This difference in perivascular 
alteration between the wild type and mutant organisms was not statistically significant 
however.
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Figure 4.12- Lung tissue sections from mice infected intranasally with either D39 wild type 
or D39AhtrA mutant.
Mice were sacrificed 48 h post-infection and their lungs removed, fixed, and 
stained with H+E. The sections show a blood vessel (BV) in close proximity to 
the pleural interface (PI). The pleural interface is swollen with inflammatory cells 
in the lungs infected with D39 shown in (A) but is narrow and healthy in the 
lungs infected with the D39AhfrA mutant shown in (B). Inflammatory cells can 
also be seen marginating out of the blood vessel towards the pleural interface 
between the two large arrowheads in panel A. The perivascular areas of wild 
type-infected mice were noticed to have inflammatory cell recruitment (C) 
whereas in some mutant-infected mice, these perivascular alterations (PA) 
contained no ceils (D). However, this difference in perivascular alterations was 
not statistically significant.
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4.4.7 Nasopharyngeal colonization
The colonization of the nasopharynx by D39AhtrA mutant compared to that of D39 wild 
type was also studied (figure 4.13). The number of bacteria recovered from the 
nasopharynx was about the same in both cases early (6 h post-challenge) and late in the 
infection (48 h post-challenge).
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Figure 4.13- Nasopharyngeal colonization with either D39 wild type or D39AhtrA mutant.
Groups of mice were infected with 10° CFU/mouse (n=5) of either D39 wild type 
or DZ9AhtrA mutant. At the indicated time points, bacteria colonizing the 
nasopharynx were collected and counted on BAB plates. Data given are the 
mean ± SEM of bacterial counts in individual mice.
4.4.8 Effect of complementation with HtrA on virulence
To confirm that the attenuation of virulence in the D39AhtrA mutant was entirely due to 
lack o f HtrA, this mutant was complemented with the pAL2-HtrA plasmid, which 
expresses HtrA constitutively from the Gram-positive ami promoter. When the HtrA level 
was restored in the D39AhtrA mutant, the strain was again fully virulent in a pneumonia 
model of infection (figure 4.14). The virulence phenotype o f D39AhtrA mutant is therefore 
confirmed to be solely due to deletion of htrA.
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Figure 4.14- Effect of complementation with HtrA on virulence of D29AhtrA mutant.
DZSAhtrA strain showed attenuation in virulence as judged by survival time of 
mice (n=5) after intranasai infection with 10° CFU/mouse. Complementation with 
HtrA (from plasmid pAL2-HtrA) reverted this strain to full virulence.
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identification of pneumococcai HtrA
An HtrA homologue has been identified in Streptococcus pneumoniae (Gasc et al.^ 1998). 
Searching of the S. pneumoniae strain TIGR4 sequence database (at http://www.tigr.org/) 
revealed a gene for HtrA about 1.2 kb that encodes for a 42-kDa protein. The BLAST? 
search (Altschul et a l , 1990) was used to compare the amino acid sequence homology of 
pneumococcal HtrA to that of other serine proteases. The pneumococcal HtrA homologue 
revealed extensive amino acid sequence identity with Streptococcus mitis (95.7%), 
Streptococcus mutans (53.6%), Lactococcus lactis (55.2%), Streptococcus pyogenes 
(53.7%), Bacillus subtilis (42.2%), Staphylococcus aureus (36%), Listeria monocytogenes 
(46.3%), and&  coli (36.8%).
HtrA has an N-terminal protease domain and a single C-terminal PDZ domain in addition 
to the transmembrane domain located near the N-terminal by which HtrA is anchored to 
the membrane. The protease domain contains the conserved sequence GNSGGPL, which is 
similar to the consensus sequence GDSGGPK surrounding the active site serine residue of 
many trypsin-like serine proteases (Lipinska et a l,  1990). It also contains the catalytic triad 
of His, Ser, Asp residues. The PDZ domain of HtrA protease plays a critical role in 
substrate recognition by binding misfolded proteins. PDZ domains are identified as 80-100 
residue repeats and named after the thi'ee eukaryotic proteins, PSD-95 (post-synaptic 
density), Dgl (Discs large), and ZO (zonula occludens) (Ponting, 1997). They generally 
mediate protein-protein interactions by specific binding to the last several residues at the 
C-terminal ends of target proteins (Doyle et a l, 1996, Harrison, 1996, Songyang et a l, 
1997, Harris and Lim, 2001, Walsh et a l,  2003, Wilken et a l, 2004), and some protease 
PDZ domains appear to function in substrate recognition and tethering (Beebe et a l, 2000,
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Members of the HtrA class of stress response proteins are serine proteases, which 
apparently function by degrading oxidatively or otherwise damaged proteins before they 
can accumulate to toxic levels in the cells. Homologues of HtrA have been described in a 
wide range of organisms including bacteria, yeast, plants, and humans (Zumbrunn and 
Trueb, 1996, Ponting, 1997, Gray et a l, 2000). Some bacteria have more than one 
paralogue of HtrA (Noone et a l, 2001). hi all cases, the evidence points to a m ^or role for 
these proteases in helping organisms to suiwive environmental stresses such as elevated 
temperatuie, oxidative and osmotic stresses. HtrA is of interest because HtrA-null mutants 
of several Gram-negative and Gram-positive bacteria have been shown to be attenuated in 
animal models of infection (Elzer et a l,  1996, Li et a l,  1996, Jones et a l, 2001, Cortes et 
a l,  2002) and it can also be used as vaccine (Fallen and Wren, 1997).
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Spiers et a l, 2002). Other protease PDZ domains, however, seem to negatively regulate 
activity by blocking access to the active sites of the protease domain. For example deletion 
of the HtrA2 PDZ domain enliances degiadation of a non-specific substrate (Clausen et a l, 
2002, Krojer et a l, 2002, Li et a l,  2002).
Construction of mutants
To study the role of HtrA in S. pneumoniae stress response, bhtrA mutants were 
constructed in two different backgiounds by insertion of a spectinomycin resistance 
cassette into the gene and inactivation of the wild type copy by double-crossover 
homologous recombination. Prior to studying the in vitro and in vivo phenotypes, mutant 
organisms were analyzed for their ability to grow in the presence o f an antibiotic selection 
and also were confirmed to be S. pneumoniae using the relevant tests mentioned in section 
2.3.
Sensitivity of htrA mutant to high temperature and peroxide
The HtrA proteases are essential for the removal of misfolded and aggregated proteins in 
the periplasm of E. coli (Strauch et a l, 1989) and many other Gram-negative bacteria and, 
therefore, promoting growth at elevated temperature, oxidative stress, or any other 
conditions that may result in protein damage. HtrA orthologs have been also identified in 
many Gram-positive bacteria (Poquet et a l, 2000, Jones et al., 2001, Noone et a l, 2001, 
Sebert et a l, 2002). These bacteria lack the outer membrane of Gram-negative bacteria, 
and as a consequence, lack the periplasmic space. Thus, the folding of the secretory 
proteins is likely to occur at the membrane-cell wall interface following translocation 
across the cytoplasmic membrane (Tjalsma et a l, 2000, van Wely et a l, 2001). HtrA in 
Gram-positive bacteria is thought to be anchored to the membrane by a single 
transmembrane domain located near the N-terminous of the protein (Poquet et a l, 2000, 
Noone et a l, 2001).
The results in this chapter indicate that HtrA plays a role in resistance to elevated 
temperature and oxidative stress. However, the effect of a lack of HtrA at higher 
temperature was to slow growth rather than prevent it and mutant organisms still reached 
the same final optical density the wild type reached. HtrA appears to have specific 
functions in different microorganisms. For instance, while HtrA was found to be essential 
for bacterial suiwival at an elevated temperature in many bacteria (Seol et a l, 1991, Jones 
et a l, 2001, Cortes et a l,  2002, Foucaud-Scheunemann and Poquet, 2003, Wonderling et
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a l, 2004), the Salmonella enterica serovai’ Typhimurimn mutants have been shown
to be temperature insensitive (Johnson et a l, 1991). Furthermore, inactivation of the 
ykdA/htrA in Bacillus subtilis unexpectedly improves survival to heat shock and H2O2 
exposure due to overexpression of the other genes (Noone et al., 2001). There is also a 
variation of phenotypes associated with htrA deletions. Elzer et al reported that Brucella 
abortus htrA mutants were sensitive to both temperature and oxidative stress (Elzer et a l, 
1996), but Tatum and colleagues observed that B. abortus htrA mutants were insensitive to 
both stimuli (Tatum et a l, 1994). The effect of HtrA on protection from oxidative stress 
was observed for hydrogen peroxide but not for parquat. Paraquat is taken up by bacterial 
cells and generates superoxide within the cytoplasm (Hassett et a l, 1987). This suggests 
that HtrA provides resistance to hydrogen peroxide but not to superoxide probably because 
superoxide is generated inside the cells while HtrA is anchored to the membrane. Skorko- 
Glonek and co-workers have reported a similar finding where the E. coli HtrA was found 
to participate in bacterial survival against ferrous ions and cumene hydroperoxide but not 
against H2O2 or paraquat (Skorko-Glonek et a l, 1999). Resistance to oxidative stress is 
known to be mediated in part tlu'ough the ABC transport system encoded by the Psa 
operon (Tseng et a l,  2002). This operon is laiown to control the level of expression of 
superoxide dismutase and NADH oxidase (Tseng et a l, 2002) and is involved in virulence. 
Wliether there is an interaction between HtrA and the Psa proteins remains to be 
determined.
Effect of htrA deletion on transformation
HtrA also plays a role in the transformation of the pneumococcus. Deletion of the gene for 
HtrA resulted in an approximate 32-fold decrease in transformation efficiency, which 
could be restored by expression of HtrA from a plasmid. Competence development is 
controlled in S. pneumoniae by the quorum-sensing signal, competence-stimulating peptide 
(CSP) (Havarstein et a l, 1995), which is derived from a ribosomally synthesized 
precursor, ComC (Morrison, 1997). CSP is sensed by the ComDE two-component system 
(Havarstein et a l, 1996, Pestova et a l, 1996). A second system, CiaR/H operates upstream 
of the ComDE pathway and has been shown to modulate competence (Guenzi et a l,  1994, 
Echenique et a l, 2000). The CiaR/H system also positively regulates HtrA, as tsciaRJH 
mutants are characterized by sti'ongly decreased expression of HtrA (Sebeit et a l, 2002, 
Mascher et a l, 2003). The possibility raised by Sebert and co-workers (Sebert et a l, 2002) 
that HtrA might play a role in the competence pathway is therefore confirmed. However, 
the presence of HtrA seems to be required for transformation, rather than for inliibition of
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competence. It may be that HtrA is required for the correct folding of one of the protein 
components of the competence pathway.
The role of HtrA in pneumococcal pathogenesis
HtrA is loiown to be involved in the vimlence of many Gram-negative bacteria such as 
Salmonella enterica serovar Typhimurium (Baumler et a l, 1994), Brucella abortus (Elzer 
et a l, 1996), Yersinia enterocolitica (Li et a l, 1996) and Klebsiella pneumoniae (Cortes et 
a l, 2002). This protease is required for full virulence o f the Gram-positive bacterium 
Streptococcus pyogenes (Jones et a l,  2001). A S. pneumoniae strain lacking the htrA gene 
showed a decreased fitness in a competitive model of colonization (Sebert et a l, 2002). 
HtrA was identified as a vimlence factor of the pneumococcus in a signature tagged 
mutagenesis screen (Hava and Camilli, 2002). The in vivo data presented in this chapter 
clearly indicate that HtrA-negative mutants of S. pneumoniae are dramatically reduced in 
vimlence. The effect of a htrA deletion was tested in two strains of the pneumococcus. In 
D39, deletion of the gene completely attenuated the organism. All animals infected with 
the IshtrA mutant suiwived the challenge whereas those infected with the wild type 
succumbed to the infection. In the case of TIGR4 strain, vimlence was dramatically 
reduced, although using higher doses of the more vimlent TIGR4 strain did result is some 
disease in the /ShtrA gioup. Analysis of the infection by measuring bacterial loads in 
different locations showed that the mutant organism could not survive in the lung and was 
cleared rapidly from the air spaces. The mutant never invaded the bloodstream from the 
lungs. The wild type organism grew dramatically to more than 10  ^ CFU/ml in the lung 
tissue by 48 h post-infection while the number of mutant organisms was less than 10  ^
CFU/ml at the same time point. Furtheraiore, wild type bacteria appeared in the 
bloodstream 18 h post challenge and multiply rapidly to more than 10  ^CFU/ml by 48 h 
while the mutant organism was not detected in blood at any of the time points studied. To 
investigate whether the role of HtrA was specific to the lungs, the organisms were injected 
directly into the bloodstream to bypass the respiratory tract. The wild type strain overcome 
the host defenses and was able to multiply in blood to a level of 10  ^ CFU/ml by 36 h post­
infection causing bacteraemia that led to the death of all animals infected. The mutant 
strain, on the other hand, was unable to survive in the blood, the bacterial load declined 
from more than 10"^  CFU/ml to levels just above the limit of detection of the assay (about 
10  ^ CFU/ml) and the mutant-infected mice were healthy at the endpoint of the challenge. 
The hhtrA mutant strains are therefore potential live vaccine candidates. The in vivo 
phenotype of the D39AAr/U mutant appears to be consistent with the proposed function of
161
HtrA Discussion
bacterial HtrA proteases as component of a line of defense against oxidative damage 
caused by the host. However, an htrA mutant of strain of Brucella abortus was reported to 
be dispensable for virulence in a mouse model (Phillips and Roop, 2001). This htrA mutant 
was not attenuated in BALB/c mice through 4 weeks post-infection despite being more 
sensitive to oxidative killing and less resistant to killing by cultured murine neutrophils and 
macrophages in vitro than the virulent parent strain.
Colonization of the nasopharynx is an important step in pneumococcal pathogenesis. Using 
the M Fl mouse model in this study, no difference was obseiwed between the wild type and 
mutant strains in the number of bacteria colonizing the nasopharynx early or late in the 
infection (6 h and 48 h post challenge respectively). Sebert and colleagues reported that an 
htrA mutant of S. pneumoniae 0100993 strain (type 3) showed decreased fitness in a 
competitive model of colonization using newborn Sprague-Dawley rats (Sebert et ah, 
2002). This again may indicate that HtrA proteases have specific functions in different 
strains or backgrounds (e.g. the virulence of htrA mutants was slightly different between 
D39 and TIGR4 strains, see figure 4.8) or it could simply be attributed to the difference in 
animal models used. This could also be explained by the difference between the 
competitive infection assay used in the study by Sebert and co-workers (Sebert et ah,
2002) and the direct infection assay used here.
Altered inflammatory response to D39AhtrA mutant
Pneumococcal infection is characterized by an intense inflammatory response that is 
coordinated mainly by cytolrines. Tumor necrosis factor (TNF) is a pro-inflammatory 
cytokine that exerts powerful effects on the immune system including the release of other 
pro-inflammatory cytokines, activation of neutrophils, and the induction of adhesion 
molecules, which lead to a rapid attraction of inflammatory cells to the inflammatory site 
(Ming et ah, 1987, Neumami et ah, 1996). TNF has been implicated as a central mediator 
of the host response to bacterial infection, in which it may play a dual role. Systemic and 
excessive release of TNF into the circulation is harmful to the host, as documented by 
numerous laboratory studies in which anti-TNF strategies prevented death during 
otheiwise rapidly fatal sepsis (Tracey et ah, 1987, Hinshaw et ah, 1990). However, local 
production of TNF, at the site of an infection, is important for adequate antibacterial 
defense. Following recruitment of phagocytic cells, TNF can promote antimicrobial 
activity by activating the respiratory burst of neutrophils (Dusi et ah, 1996) and by 
activating the capacity to degranuolate (Klebanoff et ah, 1986). Moreover, this importance 
has been demonstrated in mui ine models of pneumonia in which treatment with anti-TNF
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impaired host defense against various respiratory pathogens, including S. pneumoniae (van 
der Poll et a l, 1997a, Rijneveld et a l, 2001). Reduced capacity of CBA/Ca mice to induce 
rapid TNF-a activity within lung aii*ways following infection with S. pneumoniae was 
reported to be a factor in their elevated susceptibility to pneumococcal pneumonia (Kerr et 
a l, 2002). In light of its presmned detrimental role in the pathogenesis of overwhelming 
sepsis, anti-TNF has been evaluated in a fairly large number of controlled clinical trials of 
patients with sepsis. Although individual trials did not reveal a significant benefit for 
patients treated with anti-TNF, pooled data from trials that evaluated monoclonal 
antibodies directed against TNF demonstrated a statistically significant reduction in 
mortality (Marshall, 2000). In another study, the effect that anti-TNF therapeutically 
administered together with antibiotics has in mice with ongoing pneumococcal pneumonia 
was deteimined. Treatment with anti-TNF was associated with both an enhanced 
inflammatory response in lung tissue and unaltered or modestly reduced IL-6 level. It was 
also associated with a diminished effect of the antibiotic, ceftriaxone (Rijneveld et a l,
2003).
The cytokine interleukin 6 (IL-6) has been shown to have multiple biological activities 
against many cellular targets. It has been ascribed both pro- and anti-inflammatory effects. 
IL-6 can activate monocytes (Borish et a l, 1989) and can synergize with TNF to increase 
the respiratory burst of neutrophils in vitro (Mullen et a l, 1995). This synergy between IL- 
6 and TNF-a may represent an important mechanism by which IL-6 potentiates the effect 
of TNF-a in vivo. However, in pneumococcal pneumonia IL-6'^' mice have been shown to 
mount significantly higher levels of inflammatory responses in comparison to wild-type 
animals (van der Poll et a l, 1997b). IL-6 may play a significant role in host defense 
against bacterial infection (van der Poll et a l, 1997b) whereas previously it was considered 
merely a marker for the severity of the bacterial challenge.
In this study, the measurement of the cytokines IL-6 and TNF-a was used as an indicator 
of the overall pattern of inflammatory cytokine release after stimulation with either wild 
type or àhtrA mutant strains. Analysis o f the inflammatory response showed that a tAitrA 
mutant induced markedly less inflammation than D39. These results are complicated by 
the differences in number of organisms present in the wild type and mutant infected lungs 
and the lack of inflammatory cytokine production induced by the mutant may simply be a 
reflection that the number of organisms present is below that needed to trigger the 
response. However, the number of organisms present in the lavage fluid at 24 h was very 
similar between wild type and mutant but the mutant still does not induce IL-6 or TNF-a
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production. Histological examination of the tissues confirms an altered host response to the 
mutant. Lungs exposed to the mutant organism have much fewer lesions of inflammatory 
cells at the pleur al interface. A possible use of pneumococcal htrA mutant as a live vaccine 
should therefore be considered. As both the htrA mutant and the wild type strains similarly 
produce pneumolysin (Ply) in vitro and Ply is known to induce the inflammatory response 
to the pneumococcus, it is likely that the effect of Ply in the htrA mutant is masked 
somehow in vivo. The possibility of pneumolysin being not produced or released by the 
mutant strain in vivo is yet to be investigated.
Changes in inflammatory response and tissue histology may reflect either a direct action of 
the serine protease on some unlaiown substrate or may reflect altered expression o f other 
vimlence factors. With this in mind, the expression of several known vimlence factors o f 
the pneumococcus was examined. No effect of the htrA mutation could be found on the 
amount of pneumolysin, autolysin, CbpA (PspC), hyalur onidase or neuraminidase made by 
the organism. Recent work on L. lactis showed that in an HtrA-null mutarrt several surface 
proteins failed to be properly processed (Poquet et a l, 2000). Therefore the distribution 
and activity of several pneumococcal surface proteins in ÊshtrA mutant were examined. 
Cellular h'actionation and Western blotting showed there was no difference in the 
distribution of CbpA, hyaluronidase and neuraminidase between the wild type and àhtrA 
mutant. Moreover, there was no difference between wild type and AhtrA mutant in the 
amount of neuraminidase and hyaluronidase enzymatic activity associated with the 
different cell fiuctions. Mutagenesis of either the gene for neuraminidase (nanA) or that for 
hyaluronidase (hyl) had no significant impact on virulence (Berry and Paton, 2000). Other 
studies have showed that these enzymes are involved in pneumococcal invasion (Berry et 
a l, 1994) and in colonization (Tong et a l, 2000). It is thought that hyaluronidase might 
contribute directly to invasion as it hydrolyzes hyaluronic acid, which is an important 
component of comiective tissues. It has also been suggested that neuiaminidase activity 
promotes colonization by exposing host cell receptors otheiwise covered by sialic acid 
(Tong et a l, 2001). HtrA therefore does not appear to play a role in cell surface protein 
location and activity, at least for the proteins examined. The HtrA homologue in S. 
pyogenes was also shown not to affect cell surface protein expression (Jones et a l, 2001).
Recently, Lyon and co-workers reported that in-frame deletion of htrA of Streptococcus 
pyogenes did not result in attenuation in a murine model of subcutaneous infection (Lyon 
and Caparon, 2004) while the insertional mutagenesis of htrA of the same organism has 
been associated with a reduced capacity to cause disease in an animal model of systemic
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infection (Jones et a l, 2001) raising the issue of the possibility of polar effect of mutation 
on the downstream genes (e.g. spoJ). To address this, the A/zW mutant was complemented 
with pAL2-HtrA plasmid, which constitutively expresses HtrA and the virulence of the 
complemented strain was tested in a pneumonia model of infection. When HtrA level was 
corrected, the strain was again fully virulent suggesting that the observed virulence 
phenotype of the mutant is solely due to absence of HtrA. In addition, microarray analysis 
of AhtrA mutant also suggested that the expression of downstream genes was almost 
identical to those of the wild type confirming no polar effect of htrA mutation occurred 
(see chapter 6).
Summary
Data in this chapter demonstrate that HtrA is a major virulence factor of S. pneumoniae. 
Deletion of the gene for HtrA from strain D39 (serotype 2) completely abolished its 
virulence in mouse pneumonia and bacteraemia models, while the virulence of the TIGR4 
(serotype 4) strain was dramatically reduced. HtrA-negative mutants induced much less 
inflammation in the lungs during pneumonia than the wild type. HtrA is involved in the 
ability o f the pneumococcus to grow at higher temperatures, to resist oxidative stress and 
to undergo genetic transformation. The expression and cellular location of several known 
virulence factors of the pneumococcus were not affected by the lack of HtrA.
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RELATIONSHIP BETWEEN HtrA AND THE TWO 
COMPONENT SYSTEM CiaR/H, RESULTS
HtrA & CiaR/H Results
Signal transduction across biological membranes is essential in enabling bacterial cells to 
identify and respond to environmental stimuli. Recent studies have demonstrated the role 
of bacterial two-component signal-transducing systems (TCSTS) in mediating adaptive 
responses to enviromnental signals (Parkinson, 1993, Stock et a l, 1995). The 
pneumococcal CiaR/H two-component system (figure 5.1) consists of a sensor histidine 
kinase, CiaH, anchored in the cell membrane and a cytoplasmic response regulator, CiaR 
which is a DNA-binding protein involved in the regulation of genes in response to 
environmental signals sensed by CiaH (Guenzi and Hakenbeck, 1995). This system was 
identified as one of thirteen TCSTS in two genomic screens (Lange et a l, 1999, Throup et 
a i,  2000). Pleotropic effects caused by cia mutations in the pneumococcus include 
sensitivity to cefotaxime, the ability to form protoplasts, susceptibility to lysis by 
deoxycholate (Giammarinaro et a l,  1999) and tendency to early lysis (Lange et a l, 1999). 
CiaH mutants also have a transformation deficiency (Giammarinaro et a l, 1999, 
Hakenbeck et a l,  1999, Echenique et a l, 2000). In vivo, the CiaR/H has been shown to 
contribute to colonization of the mouse lung (Throup et a l , 2000) and the nasopharynx of 
infant rats (Sebert et a l , 2002) and to be involved in systemic infection in mice (Marra et 
a l,  2002a). Previous studies have shown that the CiaR/H regulon contains many genes, 
including the High Temperature Requirement A gene and that the htrA gene is highly 
down-regulated in CiaR-null mutants (Sebert et a l, 2002, Mascher et a l, 2003). These 
studies demonstrated that the regulation of htrA is probably direct as CiaR was shown to 
bind to DNA upstream of the htrA gene.
Data in the previous chapter demonstrated that HtrA is a crucial virulence factor of the 
pneumococcus. As HtrA is down regulated in AciaR mutants, the study presented in this 
chapter was intended to investigate to what degi'ee the phenotype resulting from deletion of 
ciaR can be attributed to HtrA. The AciaR mutant was complemented with HtrA that was 
constitutively expressed from a plasmid and the effect of this complementation on the in 
vitro phenotype and virulence was studied.
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Environm ental 
signals Sensor
CiaH Cell membrane
Response
regulator
Cytoplasm
Others ComEDC X JitrA ^  spoJ
(See Mascher et al 2003) Part o f CiaR target region
Figure 5.1-The CiaR/H two-component system.
The environmental signal is sensed by the membrane histidine kinase CiaH, 
which then transmits the signal to the cytoplasmic response regulator CiaR 
which in turn mediates the appropriate response to this signal.
5.1 Construction of plasmid pAL2-HtrA
Plasmid pAL2 (Beard et a i, 2002) was used for constitutive expression of htrA from the 
pneumococcal ami promoter (Alloing et al., 1990). The pAL2 plasmid (-12.5 kb, see 
appendix) was kindly provided by Dr. V. Salisbury (University of the West of England). 
The gene for HtrA containing 5’ and 3’ EcoRI sites and a ribosome binding site (RBS) at 
the 5’ end was amplified with PCR (Figure 5.2A) and the pAL2 plasmid was digested with 
EcoRI to release the lux operon (figure 5.2B). The htrA gene was then ligated to the 
EcoRI-digested pAL2 fragment, which carries the ami promoter to create plasmid pAL2- 
HtrA. The construction of pAL2-HtrA was confirmed by restriction digestion and the 
orientation of htrA in the plasmid was confirmed by PCR as described below. The htrA 
gene was also sequenced using the forward primer pAL2Yl upstream from htrA and the 
reverse primer HtrA2 for further confirmation.
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(A) (B)
Figure 5.2- Construction of pAL2-HtrA plasmid used for expression of HtrA In S. 
pneumoniae.
Agarose gel electrophoresis of DNA products used for construction of the 
pAL2-HtrA plasmid. In A, 1 kb plus ladder Is shown In lane 1 and an amplified 
fragment containing htrA gene Is shown In lane 2 (1.2 kb). In B, digestion of 
pAL2 with EcoRI. Lane 1, 1 kb plus ladder; lane 2, uncut plasmid (12.5 kb); lane 
3, EcoRI-cut pAL2. The upper band Indicated by the arrow (~7 kb), which 
contains the ami promoter, was used for ligation.
5.1.1 Confirmation of pAL2-HtrA
After ligation of htrA to pAL2, the resulting plasmid was propagated in E. coli Top 10 
electrocompetent cells (Invitrogen) using electroporation and the plasmid was prepared 
from transformed cells by using a miniprep kit (Qiagen). The construction of plasmid 
pAL2-HtrA was confirmed by restriction digestion with EcoRI. The restriction digestion 
reactions were analyzed by running on 1 % agarose gels. From the six clones analyzed, 
three carried the htrA gene, clones 2, 3 and 5 as shown (figure 5.3) in lanes 3,4 and 6.
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Figure 5.3- Confirmation of pAL2-HtrA plasmid by restriction digestion.
Agarose gel electrophoresis of EcoRI-digested pAL2-HtrA plasmids. Lane 1, 1 
kb plus ladder; lanes 2-7 plasmids from different bacterial clones. Plasmids 2, 3, 
and 5 were positive (shown in lanes 3, 4 and 6). RBS, Ribosome Binding Site. 
Pam/, the ami promoter.
5.1.2 Orientation of htrA in pAL2-HtrA piasmid
For expression of htrA from the ami promoter in pAL2-HtrA, the gene should be in the 
proper orientation with respect to the ami promoter. This was confirmed by PCR using 
primer pair pAL2Yl and pAL2Y2 (table 2.2). The forward primer pAL2Yl was designed 
to anneal upstream from htrA and downstream from the ami promoter. The sequence of the 
reverse primer pAL2Y2 was within the htrA gene. A PCR product of 600 bp would result 
from the htrA gene in the correct orientation whereas no product would be expected from 
the gene in the opposite orientation. The forward and reverse primers HtrA for and HtrA 
rev (table 2.2), which amplify the whole gene were also used to confirm the presence o f the 
htrA gene. Analysis of PCR products using agarose gel electrophoresis revealed that 
plasmids from clones 2 and 3 were confirmed to carry htrA gene in the correct direction 
while the plasmid from clone 5 contained the gene in the opposite orientation (figure 5.4).
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Figure 5.4- Determination of htrA gene orientation in pAL2-HtrA plasmid.
Agarose gel electrophoresis of PCR reactions carried out for determining the 
orientation of the htrA gene in pAL2-HtrA plasmids. Clones 2 and 3 gave 1.2-kb 
bands using primers HtrA for and HtrA rev and 600 kb fragments when using 
pAL2Y1 and pAL2Y2 primers. This confirms the orientation shown in A. Clone 5 
gave a 1.2-kb band using the gene specific primers confirming the presence of 
htrA, but no product was found when using pAL2Y1 and pAL2Y2 primers, 
suggesting that htrA is found in the orientation shown in B. Pam/, the ami 
promoter.
5.2 CiaR mutation and com plem entation with HtrA
The ciaR mutation in strain 0100993 (type 3) was made by allelic replacement with an 
erythromycin resistance marker and was kindly provided by Martin Burnham (Throup et 
a i,  2000). In order to perform the complementation experiments with the pAL2-HtrA 
plasmid (erythromycin selection) another antibiotic marker was needed to disrupt the ciaR 
gene. Therefore, the ciaR mutation with the spectinomycin resistance gene was moved into 
D39 (type 2) from the AciaR mutant strain cia spc 136b (Martin et a i, 2000) kindly 
provided by Jean-Pierre Claverys (Toulouse, France). A single colony from cia spc 136b 
strain streaked on blood agar plates was picked and used to inoculate BHI. After overnight 
incubation at 37 °C, genomic DNA was prepared and used as a template in PCR reactions. 
Primer pair MPI44 and MPI45 (Martin et al., 2000) (table 2.2) was used in PCR for
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amplification of a 6 kb fragment corresponding to the AciaR mutation carrying the 
spectinomycin resistance cassette. This PCR product was used to transform D39 to create 
the D39AciaR mutant strain and transformed cells were selected on spectinomycin agar 
plates. The genomic DNA was then prepared from transformed cells and PCR was used for 
confirmation. Using primer pair MPI44 and MP145 resulted in a 5 kb fragment from the 
wild type strain and a 6 kb fragment from AciaR mutants (figure 5.5).
Mut ant
( 6  kb)
Figure 5.5- Confirmation of introduction of a ciaR mutation into D39.
Agarose gei eiectrophoresis of PCR reactions used for confirming the ciaR 
mutation. Lane 1 ,1-kb pius iadder; iane 2, c/a/? from wild type D39 (5 kb); iane 3, 
mutated ciaR amplified from transformed ceils (6 kb).
The CiaR/H-null mutants are known to have a transformation deficiency and therefore 
difficulty in complementation of the AciaR mutant with HtrA from pAL2-HtrA plasmid 
was expected. To overcome this problem, the pAL2-HtrA plasmid was used to transform 
wild type D39 strain first and then the ciaR mutation was introduced into the resulting 
strain to create the complemented strain D39AciaR/phtrA^ in which the HtrA level is 
corrected by constitutive expression from the pAL2-HtrA plasmid.
5.3 HtrA W estern immunoblot analysis
As CiaR is involved in virulence and regulates htrA, which has been shown in the previous 
chapter to be a crucial virulence factor, the question of whether the CiaR phenotype was 
associated with the down-regulation of htrA was addressed. In order to test this, a plasmid 
was constructed to allow the constitutive expression of htrA in the pneumoeoccus. Plasmid
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pAL2-HtrA (section 2.8, figure 2.2) allows the expression of HtrA from the pneumococcal 
ami promoter (Alloing et al., 1990). Western blotting was used to examine the levels of 
HtrA expressed by pneumococcal strains. Expression of HtrA was shown to be higher at 
40 °C than 37 °C in the wild type D39 but not in the D39AciaR mutant (figure 5.6 A) 
confirming HtrA to be a heat shock protein of the pneumococcus and to be up-regulated by 
CiaR in response to heat shock. As expected, HtrA expression was abolished in D39AhtrA. 
Levels of expression of HtrA could be restored in the D39AhtrA mutant to levels similar to 
wild type with the plasmid pAL2-HtrA. The level of HtrA was reduced but not abolished 
in AciaR and introduction of pAL2-HtrA into the AciaR strain resulted in expression of 
levels of HtrA similar to wild type (figure 5.6 B). Visual examination of these blots 
suggested that deletion of CiaR resulted in an approximate 4-fold reduction in production 
of HtrA. Expression of HtrA in the AciaR strain from the plasmid returned the level of 
HtrA to that of the wild type. Expression of HtrA from the plasmid in the wild-type strain 
did not increase total levels of HtrA.
(A)
D39 wt
D39 AciaR
(B)
37°C 40°C
AciaR/phtrA^ AciaR AhtrA/phtrA^ AhtrA D39
*:
Figure 5.6- Western immunoblot analysis of HtrA levels in different pneumococcal strains.
in (A) expression of HtrA at 37 °C and 40 °C in wild type strain D39 and strain 
D39AhtrA. In (B) levels of HtrA in strain DZdAhtrA and strain DZSAciaR and their 
complemented strains grown at 37 *C.
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5.4 In vitro growth phenotype of AciaR mutants.
HtrA has been shown to be involved in the ability of the type 2 pneumococci to grow at an 
elevated temperature and that the effect of a htrA deletion was to slow growth rather than 
prevent it. The D39AhtrA mutant was also found to have decreased rate of autolysis 
compared to its parent strain at 40 °C as indicated by viable count at stationary and decline 
phases of gi'owth (chapter 4, section 4.3.1). The growth phenotype o f D39AciaR mutants at 
normal and elevated temperatures was also studied. Similar to D39AhtrA, the growth of 
D39AciaR mutant was less than that of the wild type at 40 as judged by OD (figure 5.7 
A). D39AciaR showed a decreased rate of autolysis after reaching the stationary phase of 
giowth at both 37 °C and 40 °C compared to the D39 wild type (figure 5.7 B). This growth 
phenotype of strain D39AciaR could be restored by increasing HtrA levels in the 
complemented strain Y939AciaR/phtrA^ (figure 5.7 A&B). hitroduction of the pAL2YI 
vector had no effect on the growth of D39 at either 37 °C or 40 °C (data not shown). Also, 
introduction of the pAL2-HtrA plasmid into D39 wild type did not result in altered growth 
at these temperatures (data not shown).
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Figure 5.7- In vitro growth analysis of AciaR mutant in type 2 background.
Growth curves of D39 WT, D39Ac/aR and D39AciaR/phtrA* at 37 °C and 40 ®C 
represented as optical densities at 600nm in (A) and as viable counts after 
reaching the stationary phase of growth in (B). 10^  CFU/ml of each strain was 
used to inoculate BHI prewarmed at the indicated temperatures and samples 
were withdrawn at 1-hour intervals to measure the ODeoonm and viable counts.
The effect of ciaR mutation in type 3 strain 0100993 was more dramatic at elevated 
temperature when compared to a type 2 strain. Growth of the 0100993Ac/a/? mutant was 
similar to the wild type and showed a similar rate of autolysis at 37 °C, whereas growth of 
the 0100993Ac/a/? mutant at 40 °C was prevented by the mutation (figure 5.8).
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Figure 5.8- In vitro growth analysis of AciaR mutant in type 3 background.
Growth curves of type 3 strain 0100993 wild type and its AciaR mutant at 37 ®C 
and 40 ®C represented by ODeoonm in (A) and viable count in (B). The growth of 
the 0100993 AciaR mutant was impaired at 40 ®C and showed a rate of autolysis 
similar to that of the wild type at 37 °C.
5.5 Peroxide sensitivity of AciaR mutant
HtrA has been shown in the previous chapter (section 4.3.2) to be involved in the ability of 
D39 to resist oxidative stress posed by hydrogen peroxide. To determine whether reduced 
expression of HtrA in D39AciaR mutant resulted in sensitivity to oxidative stress, the 
D39AciaR mutant strain was compared to the wild type and to the complemented strain
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D39AciaRJphtrA^ for sensitivity to 40 mM of hydrogen peroxide. The D39AciaR strain 
was significantly more sensitive to peroxide than the parent strain D39 after 10 and 15 min 
of exposure to hydrogen peroxide. There was no statistically significant difference 5 min 
after peroxide treatment probably because strain D39AciaR still expresses some HtrA. By 
restoring HtrA to a level similar to the wild type in the complemented strain 
D39AciaR/phtrA^, the strain was again identical to the wild type in response to oxidative 
stress (figure 5.9). The sensitivity of strain D39AciaR to oxidative stress is, therefore, 
similar to what was observed previously for strain D39AhtrA and could be explained by the 
down-regulation of HtrA in the CiaR-null mutant.
100
■ D 39W T
□ D39 AciaR
□ D39 AciaR/phtrA^
^  40
5 min 10 min 15 min
Time after peroxide addition
Figure 5.9- Hydrogen peroxide sensitivity of D39Ac/aR mutant.
H2 O2 sensitivity assay for D39 wild type, DZSAciaR and DZ9AciaR/phtrA* strains. 
40mM of H2 O2 was added to 1-ml aliquots of culture grown to ODeoonm ~ 0.3. 
Viable counts were performed on BAB plates before and after the addition of 
peroxide and the % survival were calculated. Values expressed are the mean 
(SEM) of three independent experiments. *, p< 0.05 lower survival for DZ9AciaR 
mutant than wild-type.
5.6 In vivo analysis of AciaR mutant (type 3)
5.6.1 intranasal challenge
The CiaR/H system has previously been reported to play a role in mouse lung colonization 
(Throup et a l,  2000) and colonization of the nasopharynx of infant rats (Sebert et a l,
2002) and has also been identified as playing a role in a mouse model of systemic disease 
(Marra et a l,  2002a). The role of CiaR in the virulence o f the pneumococcus was
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confirmed and further investigated in the MFl model of infection. Initially, a AciaR mutant 
on a serotype 3 background was compared with its wild type parent (strain 0100993). This 
is the same mutant as that used previously (Tliroup et a i,  2000, Sebert et al., 2002) in the 
studies described above. All animals challenged intranasally with 10  ^ CFU of the parent 
strain were moribund by 144 hours post infection. In contrast, the 0100993 AciaR mutant 
only caused a moribund state in 25 % of the animals (figure 5.10 A). Bacteriological 
analysis showed that the 0100993 AciaR strain grew to a viable count of approximately 10  ^
CFU in the lung compared to 10*^  for the wild type organism. The level of bacteraemia 
caused by the 0100993 AciaR strain was below the limit of detection of the assay 
(approximately 100 organisms per ml) (figure 5.10 B). CiaR was also confirmed to play a 
role in the virulence of strain D39 (see below).
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Figure 5.10- In vivo analysis of AciaR mutant (type 3).
Effect of CiaR on virulence of strain 0100993. (A). Survival of animals given 10^  
CFU of wild-type or AciaR mutant by the Intranasal route (n=10). (B). Mean (SEM) 
bacteriology In lung and blood during Infection, n=5. Broken line represents the 
limit of detection of the assay. In A *, p<0.05 shorter survival times for WT than 
for AciaR mutant and In B *, p<0.05 lower bacterial loads for AciaR than for WT.
5.6.2 Competitive anaiysis of viruience
Competitive analysis of virulence was examined using a slight modification of the method 
of Hava and Camilli (Hava and Camilli, 2002). Challenge doses of the wild type strain 
0100993 and its AciaR mutant were mixed in a 1:1 ratio and inoculated intranasally (2 x 
10^) or intraperitoneally (2 x 10^) using two separate groups o f mice. After 24 h and 48 h, 
bacteria were recovered from the lungs and blood. The number of wild type versus mutant 
bacteria recovered was determined by plating onto non-selective and selective 
(erythromycin) BAB plates and competitive indices calculated as the ratio of mutant to
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wild type bacteria recovered from each animal. When the competitive index value is less 
than one, this means that the mutant is attenuated in the assay. Competition experiment 
results showed that CiaR plays a role in both the lung and systemic infection models (table 
5.1).
Table 5.1- Competitive index for 0100993 WT vs 0100993 AciaR mutant in intranasal and 
intraperitoneal infections.
Mouse Competitive Index (Cl)
no. Intranasal infection Intraperitoneal infection
1 0.14 0.07
2 0.12 0.013
3 0.014 0.032
4 0.007 0.03
5 0.012 ND
Mean 0.059 0.036
SEM 0.02 0.012
The in vivo Cl was calculated for each animal as the ratio of mutant to wild type 
divided by the input ratio of mutant to wild type. Intranasal and intraperitoneal 
infections were done in two separate groups of 5 mice. ND, none detected. SEM, 
standard error of the mean.
5.7 In vivo effect of complementation with HtrA (type 2)
As the gi'owth phenotype and sensitivity to peroxide of D39AciaR mutant could be 
reverted by complementation with HtrA, the virulence phenotype of the knockout and 
complemented strains was investigated in a mouse pneumonia model. For these studies all 
mutants used were in a D39 background (serotype 2) and a dose of 10  ^ CFU was given 
intranasally. For D39 wild type all animals succumbed to the infection by 72 hours 
whereas no animals became sick when challenged with D39A/î/rrt (figure 5.11). A AciaR 
mutant of D39 showed attenuation in the model with 40 % of the animals becoming 
moribund during the experiment. When the pAL2-HtrA plasmid was introduced into the 
D39 AhtrA strain it reverted to full vimlence. Moreover, when the level of HtrA expression 
was corrected in the D39AciaR mutant, this also reverted to full virulence. HtrA therefore 
can complement the AciaR mutant and restore virulence.
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Figure 5.11- Effect of complementation with HtrA on the virulence of CiaR-null mutant.
Survival of MPI mice after intranasal infection with 10® CPU/mouse (n=5). 
Strains DZSAhtrA and D39Ac/a/? show reduced virulence as judged by survival 
time. Complementation with HtrA (from plasmid pAL2-HtrA) reverts these 
strains to full virulence.
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HtrA & CiaR/H Discussion
Bacteria live in a constantly changing environment in which nutrients, temperature, 
osmolarity, acidity, humidity, and many other conditions are subject to abrupt and 
unexpected changes. In order to sui'vive, bacteria must monitor external conditions and 
alter their stmcture, morphology, and physiology accordingly. The sophisticated two- 
component signal transducing systems (TCSTS) have evolved in bacteria to elicit adaptive 
responses to environmental stimuli. These systems typically consist of two modular 
proteins; a sensor histidine kinase (HK) that auto-phosphorylates at a histidine residue in 
response to environmental stimulus creating a high-energy phosphoryl gioup and a cognate 
response regulator (RR) to which an activated phosphate is transfeiTed and that then 
mediates a downstream response, often acting as a DNA-binding protein to cause changes 
in gene expression (Parkinson, 1993, Stock et a l, 2000).
CiaR/H system and virulence
Streptococcus pneumoniae causes disease in a wide range o f sites, including the lung, 
middle ear, sinuses, blood, and meninges. Continued existence of the pneumococcus in 
these different environments requires adaptive responses that involve the utilization of 
TCSTS. Thirteen pairs of such two-component systems and an oiphan response regulator 
have been identified in the pneumococcal genome (Lange et a l,  1999, Thioup et a l,  
2000). Two-component systems possibly play essential roles in regulating genes required 
for successful colonization and infection by human pathogens, such as S. pneumoniae (Lau 
et a l, 2001, Hava and Camilli, 2002, Hubbard et a l, 2003, Kadioglu et a l, 2003). The 
CiaR/H two-component system was the first to be identified (Guenzi et a l, 1994) and is 
known to be important in a number of aspects of pneumococcal biology. Mutations in the 
histidine protein kinase gene, ciaH, conferred resistance to p-lactam antibiotics suggesting 
that the system may control genes important in cell wall metabolism (Guenzi et a l, 1994). 
The system is also involved in the control of bacterial lysis (Giammarinaro et a l,  1999, 
Hakenbeck et a l, 1999, Lange et a l, 1999) and the regulation of genetic competence 
(Guenzi et a l,  1994, Echenique et a l,  2000, Martin et a l,  2000). Previous studies have 
shown that this system plays a role in colonization of the lungs of mice (Throup et a l,  
2000) and the nasopharynx of infant rats (Sebert et a l,  2002). The same mutant o f S. 
pneumoniae (kindly provided by Martin Bumliam of SmithKlineBeecham; now 
GlaxoSmitliKline) used in these two studies was also used here to show that CiaR/H also 
plays a major role in the causation of disease in the mouse. The AciaR mutant of strain 
0100993 was much reduced in its overall vimlence (as judged by suiwival times) when 
given intranasally. The mutant organism grew to about 10  ^CFU/ml in lungs compared to 
10  ^CFU/ml for the wild type organism (a reduction of 3 logs). A large reduction in growth
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in the lung was also observed by Tlrroup and co-workers (Throup et a l, 2000) who 
observed a reduction of approximately 5 logs in growth in the lung following disruption of 
the ciaR/H  operon. Because the nasopharynx is the primary reservoir of the pneumococcus 
from which cases of pneumococcal disease arise, Sebert and colleagues have examined the 
ability of a AciaR/H  mutant to persist during nasopharyngeal carriage by using an infant rat 
model of colonization where carriage is maintained for up to several weeks without the 
development of either localized or invasive disease. Results of this study revealed that 
inoculation of wild type organisms resulted in maximum colonization levels of about 10  ^
CFU/ml of nasal wash whereas the AciaR/H mutant did not colonize the nasopharynx 
(Sebert et a l,  2002). hi the experiments reported here, the mutant organism only invaded 
the bloodstream to very low levels (at the limit of detection of 100 organisms per ml). This 
two-component system therefore seems to be very important for colonization, growth in 
the lungs and also for invasion of the bloodstream.
Low-level bacteraemia following intranasal challenge could be caused either by poor 
invasion from the lungs or by poor growth in the blood. Competition experiments between 
wild type and mutant strains showed that the mutant was much less able to colonize the 
lungs and also less able to gi'ow systemically. CiaR/H was also found to play a role in the 
virulence of the type 2 strain D39. It is important to investigate the role of these systems in 
more than one strain as it has recently been shown that the contribution of two-component 
systems to virulence can be strain-dependent (Blue and Mitchell, 2003). A role of CiaR/H 
in the systemic virulence of D39 was also shown by Marra and co-workers (Marra et a l, 
2002a). The authors of this study used differential fluorescence induction (DPI) method to 
identify S. pneumoniae genes involved in pathogenesis and then studied the effect of 
deletion of these genes on virulence in both respiratory tract infection (RTI) model and a 
systemic model of infection. A CiaR/H-null mutant of strain D39 was attenuated in the 
systemic model but not in the RTI model, an observation that contradicts what was 
reported by Throup and co-workers for strain 0100993 (Tlrroup et a l, 2000) concerning 
the role of CiaR/H in the RTI model. This perhaps reflects differences in pneumococcal 
strains, methods of generating mutants, or even mouse strains used. Here, CiaR/H was 
found to play a role in strain D39 using the pneumonia model of infection with 60 % of the 
animals surviving the challenge.
Level of HtrA expression in CiaR mutant
Western immunoblotting was implemented to study the level of HtrA produced by 
different strains. The blots indicated that T)'i9AciaR expressed approximately 4-fold less
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HtrA protein than wild type D39. When HtrA was expressed from a plasmid (pAL2-HtrA) 
in the D39Ac/ai? strain, Western blotting showed the level o f HtrA was restored to a wild- 
type level. When HtrA was expressed from the plasmid in the wild type strain, there was 
no increase in the level of HtrA protein. This finding is surprising and suggests that there is 
a regulatory mechanism for controlling maximal levels of HtrA and that this mechanism 
may not be dependent on CiaR/H. On the transcriptional level, Sebert and co-workers 
reported that the htrA gene was 27-fold down-regulated in CiaR-null mutant when they 
used micro array teclmology to identify transcriptional changes due to inactivation of nine 
TCSTS (Sebert et a l, 2002). They also found 37.2-fold down-regulation of htrA in the 
same mutant using real time quantitative RT-PCR. Mascher et al also reported that htrA 
was differentially down-regulated in Ac/nR mutant (Mascher et a l, 2003). More recently, 
Dagkessamanskaia and co-workers reported that the ratios of htrA gene expression of 
competent to non-competent cells were 8.4/2.3 for wild type strain R800 and 1.4/1.0 for 
CiaR-null mutant and concluded that the extent of down-regulation for htrA is much higher 
when calculated for competent CiaR-null mutant cells than for non-competent cells 
(Dagkessamanskaia et a l, 2004). The results of HtrA Western blot shown in this chapter 
are therefore consistent with and hirther confirm these reports.
Effect of complementation with HtrA on In vitro growth
In this study, HtrA has been shown to behave as a typical heat shock protein with levels of 
the protein increasing after exposure of bacteria to a temperature of 40 °C. Interestingly, 
the increased expression of HtrA at high temperature was demonstrated to be dependent on 
the presence of CiaR/H. Based on these findings, the strain D39Aczai? was predicted to be 
defective in gi'owth at 40 °C (due to decreased expression of HtrA). Analysis in vitro 
indicates that the growth of D39Ac/nR mutant was less than the wild type at elevated 
temperature. The CiaR/H system is also involved in the control of bacterial lysis 
(Giammarinaro et a l, 1999, Hakenbeck et a l, 1999, Lange et a l,  1999, Mascher et a l, 
2003) and in particular Lange and co-workers (Lange et a l,  1999) reported that a ciaR 
mutant of the strain R6 had an increased rate of autolysis when grown in Todd-Hewitt 
medium at 37 °C. Conti'ary to this report, the D39Ac/ai? mutant in this study showed 
decreased rate of autolysis as judged by viable count at stationary and decline phases of 
growth both at noimal and elevated temperatures. This may reflect differences in the 
genetic content of R6 and D39, which are now known to differ at several loci (Tettelin et 
a l, 2001). Sebert and co-workers found that the in vitro doubling time (growth rates) of the 
AciaR/H mutant strain was not significantly different from that of the wild type strain
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0100993 and concluded that attenuation of the mutant in nasal carnage could not
be explained by a constitutive defect in gi'owth (Sebert et al., 2002). Autolysis is a 
characteristic mechanism that enables the pneumococcus to release and exchange its 
genetic material and also to release virulence factors during infection. The decreased rate 
of auto lysis of the D39Ac/ui? mutant may therefore explain the attenuation in virulence of 
this mutant due to less virulence factors available at the site of infection. The in vitro 
growth phenotype of the ciaR mutant of serotype 3 strain was also studied. The effect of 
the ciaR deletion in this strain was more dramatic as the growth of this mutant was 
completely prevented at an elevated temperature but it showed a similar rate of autolysis to 
that of the parent strain at 37 °C. These findings highlight the differences of the effects of 
mutations in different strains. The growth phenotype of D39Ac/ai? was restored to wild 
type by introducing the pAL2-HtrA plasmid in the complemented strain suggesting that the 
D39Ac/ai? growth phenotype is due to the low level of HtrA expressed by this strain.
The strongly decreased expression of the htrA in the AciaR mutant suggested that HtrA 
might participate in the Cup phenotype (for Competence u^) of the AciaR mutant (Sebert et 
a l, 2002) probably by degrading the secreted CSP at the surface of the cell or through 
some other functional connection. The observation that the D2>9AhtrA mutant taken up 
external DNA less easily as shown in the previous chapter confirmed this possibility. 
Dagkessamanskaia et al found that htrA was depressed in non-competent ciaR cells 
(Dagkessamanskaia et a i,  2004); an observation that lends some weight to the proposal 
that HtrA is involved in competence for genetic transformation. However, authors of the 
same study reported that inactivation of htrA of the strain R800 by mariner mutagenesis 
did not up-regulate competence. They, therefore, concluded it is unlikely that the down- 
regulation o f htrA in ciaR cells is responsible for the Cup phenotype of the ciaR mutant. 
With this controversy in mind, it can be postulated that HtrA seems to be required for 
transformation, rather than for inliibition of competence. Analysis of the growth curves of 
wild-type strain and its ciaR derivative in competence-pemiissive medium in the above- 
mentioned study (Dagkessamanskaia et al., 2004) suggested a direct connection between 
competence and stationary phase auto lysis. In the absence of CSP, the two strains 
exhibited very similar growth curves, whereas the addition of CSP had a dramatic effect on 
the ciaR mutant strain, competence induced stationary phase autolysis of this mutant. 
These data suggested that the CiaR/H system is required for S. pneumoniae to cope with 
physiological changes induced during differentiation to competence and for a normal exit 
from competence.
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Sensitivity to oxidative stress
Hydrogen peroxide is an example of reactive oxygen species that can cause damage to 
DNA and other cell components. As it has been previously shown that deletion of HtrA is 
associated with increased sensitivity of the pneumococcus to oxidative stress, it was 
predicted that reduced levels of HtrA in strain D39àciaR would also result in reduced 
resistance to oxidative stress. The sensitivity to hydrogen peroxide of D39Ad«i? was 
increased although not to the same extent as found previously for D39A/zW mutant. After 
5 min exposure to 40 mM hydrogen peroxide the suiwival of strain D2>9is.ciaR was similar 
to that of the wild type (figure 5.9) whereas the survival o f strain D39A/zW was 
significantly reduced at this time (figure 4.7 in the previous chapter). This probably reflects 
the expression of low levels of HtrA in strain D39Aczhi?. Resistance of strain D39AcmR to 
hydrogen peroxide could be reverted to wild type levels by complementation with HtrA, 
which again confimis that the T)39l\ciaR phenotype could be explained by down- 
regulation of HtrA in this mutant.
Complementation with HtrA restores virulence of CiaR mutant
As CiaR/H plays a role in virulence the next question is how does this system mediate 
pathogenesis of infection? The cia regulon has already been defined and includes genes 
important for the synthesis and modification of cell wall polymers, peptide pheromone and 
bacteriocin production and the htrA-spoJ region (Mascher et aL, 2003). Because it is 
already known that CiaR/H regulates the gene for HtrA (Sebert et al., 2002, Mascher et a l,
2003) and that deletion of the htrA gene reduces the ability o f the pneumococcus to 
colonize the nasopharynx (Sebert et a l, 2002) and attenuates a type 2 pneumococcal strain 
in both pneumonia and bacteraemia models of infection, attempts were made to define the 
contribution of HtrA to the overall CiaR/H phenotype.
Both CiaR and HtrA-null mutants have reduced vimlence and the CiaR/H system is known 
to regulate HtrA expression. Therefore, whether the reduced vimlence of a AciaR mutant 
could be explained by a down-regulation of HtrA expression was investigated, hi order to 
do this, a AciaR version of D39 was made and confirmed to be less virulent than its parent 
strain. The reduction in lung colonization was of the order of several orders of magnitude, 
a finding similar to that of previous studies (Throup et a l, 2000). Restoring the level of 
HtrA to wild type levels in strain T>?>9AciaR produced a strain that was again fully virulent 
in mice. This shows that the vimlence phenotype of T>?>9AciaR can be completely
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explained by the reduced expression of HtrA. Interestingly D39 AciaR still expresses low 
levels of HtrA and this may explain why it is more virulent than D39 AhtrA.
Sum m ary
Data presented in this chapter confirm that the CiaR/H system is involved in controlling 
the levels of HtrA within the cell and have shown that up-regulation of HtrA in response to 
heat is dependent on the CiaR/H system. As the response regulator CiaR has been shown to 
bind physically to DNA in the region of HtrA, this regulation is proposed to be directly at 
the level of transcription (Mascher et a l, 2003). A number of the phenotypes associated 
with deficiency in CiaR/H has been shown to be due to alterations in levels of HtrA. Thus, 
the resistance of cells to autolysis, the increased sensitivity to oxidative stress and the 
decreased vimlence of strain D39AciaR can all be explained by alterations in levels of 
HtrA. It has also been shown that transformation efficiency is altered by HtrA. While the 
CiaR/H regulon is obviously very complex, many of the phenotypes obseiwed in mutants 
of this regulon can be explained by changes in HtrA. The exact mechanism by which HtrA 
controls these processes is still unclear. Further analysis of htrA mutants is likely to 
provide clues as to how HtrA plays its role in the pneumococcal biology and stress 
response.
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Chapter 6
PROTEOMIC AND MICROARRAY ANALYSES OF 
htrA MUTANTS, RESULTS
Proteomics & Microarray Results
Determining protein expression and any changes in defined circumstances is a key to 
understanding cellular mechanisms. Integrated data sets from protein expression studies 
encompassing relative abundances, subcellular localization, profiling of isoforms and post- 
transcriptional modifications are very important to understanding physiological protein 
function (Steiner and Witzmaim, 2000). Much of this information can be derived from 
two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) in combination with mass 
spectrometric identification. 2D-PAGE as a proteomic methodology is able to resolve and 
investigate the abundance of several thousands of proteins in a single sample. In addition, 
it can be used to compare quantities of proteins in related samples, such as those from 
altered enviromnents or from mutant and wild type (Lilley et a l, 2002). Proteomics 
technology was used to examine the proteins synthesized by erythromycin-susceptible and 
erythromycin-resistant S. pneumoniae strains (Cash et a l,  1999). It was also used to 
compare the protein expression pattern of the transparent variant to that of the opaque 
variant of the pneumococcus (Overweg et a l, 2000a). Furthermore, among the attempts for 
new antimicrobial drug discovery, proteomics technologies should aid in the identification 
of novel drug targets and compounds with unique mechanisms of action other than those 
currently provided by the traditional antibiotics (Rachakonda and Cartee, 2004).
In fact, proteomics is now also yielding important findings across a wide range of 
applications concerning human health. Proteomic profiling is used as a diagnostic tool. For 
instance, proteomic approaches to the identification of novel biomarkers for cancer 
diagnosis and staging have relied on the identification of differentially expressed proteins 
between tumor cells and their normal counterparts based on the patterns of protein 
expression observed by two-dimensional gel electrophoresis (2D-PAGE) (Rodland, 2004). 
Proteomics has also been used for characterizing the modifications in protein expression 
during the development of lung diseases (Waldburg et a l, 2004), in mapping of human 
signalling pathways (Colland et a l, 2004) and in many other applications.
Another technology that is now widely used for the study of genome-wide expression 
profiles is the microaiTay. DNA micro arrays provide a system for the simultaneous 
measiuement of the expression level of thousands of genes in a single hybridization assay. 
Each array consists of a reproducible aiTangement of thousands of DNAs (PCR products or 
oligonucleotides) attached to a solid support, usually glass. Fluorescently labelled cDNA 
prepared from messenger RNA is hybridized to complementary DNA on the anay and then 
detected by laser scanning. Hybridization intensities for each DNA sequence on the array 
are determined using an automated process and converted to a quantitative read-out of 
relative gene expression levels. The data can then be further analyzed to identify
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expression patterns and variation that correlate with cellular development, physiology and 
function (Hanington et a l, 2000). Several studies have already taken advantage of DNA 
microarrays to aid in the understanding of complex regulatory pathways in S. pneumoniae 
(de Saizieu et a l,  2000, Sebert et a l, 2002, Mascher et a l, 2003, McCluskey et a l, 2004). 
Microarrays were used to evaluate transcriptional changes associated with entrance of S. 
pneumoniae into a specialized state in which the bacterium becomes competent for DNA 
uptake, a process implicated in virulence (Lau et a l, 2001, Dagkessamanskaia et a l,
2004). It was also used to analyze responses to pneumococcal virulence factors (McDaniel 
et a l, 2004).
Transcriptome and proteome studies are now becoming more refined in their approach and 
are shedding light on the role of pathogen-specific mechanisms/structuies in pathogenesis. 
In addition, studies of gene expression in vivo have shed new light on how the host 
influences the niche occupied by bacteria. Such approaches combined with modem 
functional genomics technologies represent a powerful tool in understanding host-bacteria 
interactions (Walduck et a l, 2004).
As HtrA was found to be a major virulence factor of the pneumococcus, it was selected for 
further analysis. The aim of the study presented in this chapter was to apply proteomics 
and micro array teclniologies to the analysis of the effect of htrA deletion in an attempt to 
explore the function of HtrA protein in the pneumococcal biology and stress response.
6.1 Proteom ic analysis
The proteomic analysis was carried out at the Institute of Food Research (IFR), Noiwich, 
UK. The proteome of the D39A/zW mutant was compared to that of the wild type D39 by 
separating equal amounts of protein samples by 2D-PAGE, picking up some of the protein 
spots showing differences and identifying them using MALDI-TOF-MS analysis.
6.1.1 Protein sample preparation
Protein samples from D39 wild type and the D39AhtrA mutant were prepared fi'om 100-ml 
cultures grown at 37 °C to ODgoonm ~ 0.4. Cell pellets were collected by centrifligation, 
washed with cold PBS buffer pH 8.0 and resuspended in solution 1 and solution 2 as 
described in the Materials and Methods (section 2.12.1). Total protein extracts were
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prepared by passing cell suspensions through a French pressure cell and cell debris was 
removed by centrifugation. The supernatants were then aliquoted and stored at -80 °C.
The amount of protein in samples was determined using the PlusOne™ 2-D Quant Kit 
(Amersham Biosciences). This procedure has a precipitation step that removes interfering 
substances such as SDS and DTT present in samples. These substances are incompatible 
with common protein assays such as Bradford, Lowry and Biuret. This method was 
adopted to allow accurate quantification of the protein samples to be analyzed, as identical 
amounts of proteins to be loaded is necessary for proper interpretation of the 2D results. 
Protein samples were also visualized by running an SDS-PAGE. Figure 6.1 shows protein 
bands of both the D39 wild type and the D2>9ùs.htrA mutant separated by SDS-PAGE. No 
differences (i.e. bands that are absent/present) between the wild type and mutant strains 
can be observed from this gel. Samples were then transported to the IFR in dry ice for 
analysis.
Figure 6.1- Representative SDS-PAGE analysis of protein samples of D39 wild type and 
D39AhtrA used for proteomics study.
Lane 1, Kaleidoscope Prestained Standards ladder; lane 2, 15 pg of D39 wild 
type protein; lane 3,15 pg of D39A/itrA mutant protein; lane 4, 7.5 pg of D39 wild 
type protein; lane 5, 7.5 pg of D39AhfrA mutant protein.
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6.1.2 20-ge/ electrophoresis
In the 2D-PAGE, proteins are separated first according to their isoelectric points (pi) and 
then on the basis of their molecular weights in the second dimension. Two different protein 
preparations o f both D39 wild type and D39 à^htrA mutant strain were analyzed in this 
assay. The first dimension electrophoresis was done by using 18-cm immobilized pH 
gradient gel (IPG) strips (pH 4-7; Amersham) and the pHaser system (Genomic Solutions). 
50 pg of each protein sample was separated on individual IPG strips for 24 hours. After, 
the gel strips were equilibrated, the proteins were separated in the second dimension on 10 
% duracryl gels. After separation, gels were stained with Sybro Ruby (Molecular Probes) 
according to the manufacturer’s recommendations. Sybro Ruby is slightly less sensitive 
than silver but has a much better dynamic range and is mass spectrometry compatible. 
Images of the gels were taken after at least 1 hour of destaining using the proXPRESS 
Proteomic Imaging System (Perkin Elmer, UK). Representative 2D images of D39 wild 
type and D39 d^htrA mutant are shown in figures 6,2 and 6.3, respectively.
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pH
D39 wt
Figure 6.2- Representative 2D gel image of D39 wild type.
2D-PAGE analysis of total proteins of S. pneumoniae wild type strain grown at 
37 °C. Extracted proteins were separated by isoelectric focusing in the pi range 
of 4 to 7 in the first dimension and 10% duracryl gel in the second dimension. 
Resolved proteins were visualized following staining with Sybro Ruby stain.
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htrA mutant
Figure 6.3- Representative 2D gel image of D39 A/7fr4 mutant.
2D-PAGE analysis of total proteins of S. pneumoniae D39 AhtrA mutant strain 
grown at 37 °C. Extracted proteins were separated by isoelectric focusing in the 
pi range of 4 to 7 in the first dimension and 10% duracryl gel in the second 
dimension. Resolved proteins were visualized following staining with Sybro 
Ruby stain.
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6.1.3 Analysis of 2D images
The gel images o f D39 wild type and D39AhtrA mutant (four gels each) were analyzed 
using the ProteomeWeaver software (Définiens AG, Munich, Germany). Every gel image 
was compared to the rest of images to identify similar and different 2D samples. This 
softwar e enables the determination of protein spot intensities and performs overlays of gel 
images. The 3D images of protein spots could also be compared using this analysis to 
identify real protein spots from any dye crystals or backgi'ound. The results of this analysis 
showed many protein spots, which were unique to the proteome o f X)39AhtrA mutant but 
not found in case of the D39 wild type. Figure 6.4 shows some examples of 3D images of 
proteins expressed in the D39AhtrA mutant but not in the D39 wild type. The overlay 
analysis results also showed some protein spots whose intensities were different between 
the two gi'oups. An example of these overlays is shown in figure 6.5. The protein spots 
showing differences between the two groups were picked up for identification analysis 
using mass spectrometry.
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Figure 6.4- Example of 3D Images of protein spots generated by the ProteomeWeaver.
The 3D Image of protein spots In D39 wild type gel section was compared to that 
of the corresponding section of D39A/itrA mutant. Spots pointed at by the green 
cones are unique In the D39AhtrA mutant.
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Figure 6.5- An example of 2D image overlays generated by the ProteomeWeaver.
The ProteomeWeaver was used to generate overlays of the 2D Images of both 
039 wild type and D39A/)frA mutant to Identify differences between their 
proteomes. Green boxes highlight spots showing consistent changes In protein 
spots between the D39 wild type and the D39A/ifrA mutant In both sample 
preparations 1 and 2. The red boxes show Inconsistent changes between 
sample preparations 1 and 2.
6.1.4 Identification of protein spots
Current practices for the identification of proteins from 2D gels frequently involve 
interrogation of the genomic sequence data available for many species. Protein spots that
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showed differences between the wild type and htrA mutant were excised for subsequent 
protein identification using ProPick Spot Picker (Genomic Solutions). These spots were 
digested with trypsin using in-gel protocol and analyzed using MALDI-TOF mass 
spectrometry to generate distinctive peptide mass fingerprints, which were compared to the 
annotated genomic database available at (http://www.matrixscience.com/) to allow the 
identification of unknown proteins. Because this analysis was carried out towards the end 
of the project, not all spots that showed differences were identified. These investigations 
provided identifications for some cellular proteins from S. pneumoniae that were 
differentially expressed due to htrA deletion. Among the identified proteins are those 
involved in cellular processes and stress response such as DnaK and superoxide dismutase 
(SodA), those involved in central and intermediary metabolism such as glyceraldehyde-3- 
phosphate dehydrogenase, lactate dehydrogenase, fomiate acetyltransferase and also 
transcription and translation proteins such as elongation factor Tu. Table 6.1 shows the 
identity of S. pneumoniae proteins up- or down-regulated, or showing no difference in 
expression due to loss of htrA and figures 6.6 and 6.7 show examples of gel sections of the 
identified proteins.
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Table 6.1- Identity of S. pneumoniae proteins picked up from 20 gels.
Spot
no."
Gene
symbol
Protein identity No. of
peptides
matched*
Mean 
spot vol. 
ratio‘s
30 Pfl Formate acetyltransferase 7 0.81
65 Pfl Formate acetyltransferase 14 0.79
311 pfl Formate acetyltransferase 16 0.89
2608 pfl Formate acetyltransferase 12 1.00
275 gap Glyceraldehyde-3 -phosphate dehydrogenase 8 0.95
295 eno Enolase 21 0.71
1374 eno Enolase 12 1.27
1958 eno Enolase 16 1.55
479 flsZ Cell division protein FtsZ 20 1.13
586 phtA Hypothetical protein phtA 6 2.01
702 Spectinomycin adenyltransferase 9 9.46
1060 Spectinomycin adenyltransferase 10 N.A.
850 rpsA 3OS Ribosomal protein SI 14 1.35
1033 rpsA 3OS Ribosomal protein SI 12 1.08
1727 rpsA 30S Ribosomal protein SI 16 0.68
944 Type 2 capsule locus. Glucose-1-phosphate 
thimidylyl transferase (cpsl9aL)
26 1.18
966 cysRS Cysteinyl-tRNA synthetase; cystein-tRNA 
ligase (CysRS)
23 0.56
986 Idh Lactate dehydrogenase 14 0.76
1189 Nitroreductase 21 1.40
1249 rpoA DNA-directed RNA polymerase 22 0.95
1721 Outer membrane protein A 19 1.01
1773 pgm Phosphoglucomutase 20 0.97
1809 accA Carboxyltransferase 14 1.23
1817 Hypothetical protein Spr0309 21 1.17
1853 frr Ribosome recycling factor 17 1.03
1873 sodA Superoxide dismutase (Fe) 9 3.06
2076 tu f Elongation factor Tu 23 2.20
2335 tu f Elongation factor Tu 18 0.48
2349 tu f Elongation factor Tu 19 0.51
2456 ppaC Pyrophosphate phosphohydrolase 20 0.95
2485 dnaK DnaK 8 0.94
4608 dnaK DnaK 13 1.67
2709 Aspartate-tRNA ligase 14 0.72
Analysis of the htrA mutant proteome compared to that of the wild type strain 
D39. Proteins were identified by MALDI-TOF MS a, Refers to the number of 
protein spot labelled in this analysis, b, Number of tryptic peptides observed in 
mass spectra, c, ratio of mean spot volume of mutant to wild type, values below 
one represent down-regulated proteins and those above one represent up- 
regulated proteins. N.A. none available.
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Figure 6.6- Representative S. pneumoniae proteins down regulated in htrA mutant.
2D sections from individual gels showing spots of proteins down regulated as a 
result of htrA deletion. Proteins from D39 wild type or htrA mutant grown at 
37°C were separated by two dimensional gel electrophoresis and identified by 
MALDI-TOF MS. A, Elongation factor Tu. B, 308 Ribosomal protein 81. C, 
Cysteinyl-tRNA synthetase (CysRS).
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Figure 6.7- Representative S. pneumoniae proteins up reguiated in htrA mutant.
2D sections from individuai geis showing spots of proteins up reguiated as a 
resuit of htrA deietion. Proteins from D39 wiid type or htrA mutant grown at 
37°C were separated by two-dimensionai gei eiectrophoresis and identified by 
MALDI-TOF MS. A, Spectinomycin adenyltransferase. B, Superoxide dismutase 
(Fe). C, Hypothetical protein phtA. D, DnaK.
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6.2 Microarray analysis
This analysis was intended to compare the transcriptome of ùJitrA mutants to that of the 
wild type strain in an attempt to understand the effect of htrA deletion on the global gene 
expression. The microarray was designed to represent 2131 ORFs from S. pneumoniae 
TIGR4 strain in addition to 118 unique ORFs from R6 (37) and G54 (81). Gene expression 
profiles of both strains were compared in microarray experiments using fluorescent probes, 
labelled with Cy3 and Cy5, consisting of the first strand cDNA made from randomly 
primed total cellular RNA (Eisen and Brown, 1999). The relative representation of a 
transcript between the two RNA pools was assayed by measuring the fluorescence 
intensities of the two dyes at a given target on the array. Each comparison with a given 
RNA pair was repeated twice with the dyes swapped and the experiment was repeated 
once.
6.2.1 Preparation and analysis of RNA
RNA samples were prepared from TIGR4 wild type or TIGR4AAW mutant strains grown 
in BHI at 37 °C to mid-log phase using Qiagen RNeasy® Midi Kit (see section 2.13.1 in 
the Materials and Methods). Preparing RNA under these conditions yielded 1.9 pg/p.1 of 
wild type RNA and 2.1 pg/pl of the mutant RNA. The concentrations of RNA were 
determined using NanoDrop® ND-1000 UV/Vis spectrophotometer (NanoDrop® 
Technologies, USA). Because it is essential for the microanay analysis to have a high 
quality RNA, the RNA samples were also tested for integrity and concentration using the 
agilent tecluiology. Figure 6.8 shows the results of this analysis, which clearly indicate the 
purity, and integrity of RNA samples.
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F ig u re  6.8- A n a ly s is  o f RNA s a m p le s  p re p a re d  from  TIGR4 WT a n d  TIGR4 AhtrA m u ta n t.
T he RNA w a s  p re p a re d  fro m  c u l tu re s  g ro w n  In BHI a t 37 °C to  ODeoonm -  0.6 
u s in g  Q iag en  R N easy®  Midi Kit. RNA s a m p le s  w ere  c h e c k e d  fo r  In teg rity  a n d  
c o n c e n tra tio n  u s in g  RNA 6000 N ano  a s s a y  w ith th e  A g ilen t 2100 B io an a ly ze r.
6.2.2 RT-PCR for htrA
RT-PCR was used to confirm the absence of htrA transcript in the RNA sample prepared 
from AhtrA mutant strain. RNA samples (2 pg each) prepared from TIGR4 wild type or 
TlGR4AArr/f mutant strains grown at 37 °C were used to synthesize cDNA using random 
hexamers. The synthesis of cDNA was carried out using ThermoScript™ RT-PCR system 
as described in section 2.13.8. 5 pi of each cDNA reaction was used as a DNA template in 
PCR reactions, which were carried out using Vent® polymerase and the htrA specific 
primer pair HtrA for and HtrA rev (table 2.2 in the Materials and Methods). The PCR 
reactions were heated to 94 °C for 5 min and run through 30 cycles of (94 °C for 1 min, 
52°C for 30s, 68 °C for 1 min). Samples of PCR reactions were withdrawn after 15 and 30 
cycles and the products were visualized by agarose gel electrophoresis. Figure 6.9 shows 
the results of these PCR reactions. The gene for HtrA was amplified after 15 and 30 PCR 
cycles in case of TIGR4 wild type but not in TlGRAAhtrA mutant.
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1 Kb
F ig u re  6 .9 - A g a r o s e  g e l e l e c t r o p h o r e s i s  fo r  th e  a n a ly s i s  o f  R T -P C R  p r o d u c t s  fo r  htrA.
5pl o f  cD N A  s a m p le s  p r e p a r e d  fro m  RNA o f  b o th  s t a in s  w a s  u s e d  in P C R  
r e a c t io n s  to  a m p lify  htrA g e n e  to  e x a m in e  th e  e x i s t e n c e  o f  a  t r a n s c r ip t  fo r  htrA. 
L a n e  1, 1 k b  p lu s  la d d e r ;  la n e  2, htrA (1 .2  kb) f ro m  th e  w ild  ty p e  a m p lif ie d  a f te r  
15  c y c le s ;  la n e  3, m u ta n t  a f te r  15 c y c le s  (n e g a tiv e ) ;  la n e  4 , htrA f ro m  th e  w ild  
ty p e  a f te r  30  P C R  c y c le s ;  la n e  5, m u ta n t  a f te r  30  c y c le s  (n e g a tiv e ) .
6.2.3 Microarray design and data analysis
Microarray analysis of large-scale gene expression patterns in the TIGR4 wild type and 
TIGR4AArr/t was used in an attempt to identify the molecular basis for the virulence 
attenuation of AhtrA mutants and to obtain a comprehensive view of the extent to which 
HtrA activity impacts pneumococcal gene expression. 10 pg of RNA prepared from either 
TIGR4 wild type strain or TlGKAAhtrA mutant strain was used in the reverse transcription 
reactions to synthesize cDNA, which was labelled by the fluorescent dyes, Cy3 and Cy5 
before hybridization to the array. The incorporation of Cy3 and Cy5 is known to be of 
different efficiencies. In order to overcome this problem, a dye swap was performed with 
the cDNA from the wild type labelled with Cy3 and that from the mutant labelled with Cy5 
in one slide and the labelling was done in a reverse order in the second slide i.e. wild type 
with Cy5 and mutant with Cy3.
The labelled cDNA samples were hybridized to the probes spotted on the array slides and 
the hybridized slides were scanned using a ScanArray™ Express microarray scanner 
(Packard Bioscience, Biochip Technologies). The signal intensities for each spot of both
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samples on the array were measured using QuantaiTay™ (Packard Bio science). The 
calculated ratio of signal intensities for each spot delivers a measure for fold changes in 
gene expression. However, the corresponding fold changes might reflect experimental 
biases (e.g. dye bias) rather than changes in gene expression. For this reason, a 
normalization step was perfonned prior to data analysis. This step aimed to adjust the 
fluorescence intensities of the two colour chamiels, blue (Cy3) and red (Cy5) and to correct 
experimental factors such as differing labelling efficiencies, fluorescence quantum yields, 
background intensities, scamiing sensitivity and signal amplification (Schuchhardt et ah, 
2000, Holloway et a l,  2002, Yang et a l, 2002)
The array data from two independent experiments was imported to the Genespring™ 
software, which enables the determination of signal ratios, the identification of regulated 
genes and the perfonnance of statistical analysis of results. In the Genespring™ analysis, a 
signal ratio of 1.0 indicates that the expression of paiticular genes is equal in both wild 
type and mutant, a ratio of more than 1.0 indicates increased expression in the mutant 
compared to the wild type and a ratio of less than 1.0 corresponds to lower expression in 
the mutant compared to the wild type. This software also allows spot intensities to be 
colour coordinated to help identify differential gene expression. Genes showing equal 
expression levels result in yellow spots, those showing up-regulation in the wild type 
appear blue and red spots represent those down-regulated genes.
6.2.4 Array results
The scatter plot in figure 6.10 shows the relationship between the average hybridization 
intensities of the wild-type control cells and htrA mutant cells. This simple procedure 
provided an overview of the data and indicated that most of the spots fell along the 
diagonal lines and were equally labelled. The spots that were not on the diagonal were 
candidates for genes with expression changes.
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Figure 6.10- Representative scatter plot comparing gene expression in the TIGR4AhtrA 
mutant to that of the wild type TIGR4.
Labelled cDNA samples were hybridized to the probes on the array and 
scanned. Data was analyzed using the Genespring^ software. The plot 
illustrates the spot intensities of all genes detected for the wild type on the X- 
axis and the mutant on the Y-axis. Yellow spots (within the diagonal lines) 
indicate similar expression level, red spots (above the diagonal lines) indicate 
up-regulated genes and blue spots (below the diagonal lines) indicate down- 
regulated genes in the mutant strain compared to wild type strain.
Whereas most of the pneumococcal genes remained unaltered, showing comparable 
expression levels between the TIGR4 wild type and T\GKAà.htrA mutant, some genes were 
shown to have significant differences in expression levels between wild type and mutant 
organisms. Genes were selected if they demonstrated at least two-fold difference in signal 
intensity between the wild type and mutant and if this intensity was found to be statistically 
significant {P < 0.05) using /-test in the Genespring™ analysis. The microarray analysis 
revealed five down-regulated genes and twenty up-regulated genes. Lists of down- and up- 
regulated genes are shown in tables 6.2 and 6.3 respectively.
Table 6.2- TIGR4 down-regulated genes due to htrA deletion.
TIGR4
annotation
Gene
symbol
Mean
intensity
ratio
/?-value Putative identification
SP0366 aliA 2.0 0.0012 Oligopeptide ABC transporter
SP0783 2.5 0.0011 Conserved hypothetical protein
SP1241 2.3 0.0000 Amino acid ABC transporter
SP2239 htrA 6.6 0.0002 Serine protease
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As expected, the htrA gene was highly down regulated in the TIGR4A/z?r/i mutant strain. 
In fact, examination of the individual spot intensities revealed that the fluorescence signals 
of htrA spots in case of TigrAhhtrA mutant were identical to the background signals. Of 
interest was the down-regulation of the oligopeptide ABC transporter aliA, which is an 
ATP-binding cassette transporter involved in nutrient uptake and in other processes such as 
colonization (Kerr et a l, 2004).
Table 6.3- TIGR4 up-regulated genes due to htrA deletion.
TIGR4
annotation
Gene
symbol
Mean
intensity
ratio
/;-valiie Putative identification
SP0459 pfl 2.2 0.0006 Formate acetyltransferase
SP0517 dnaK 2.4 0.0009 DnaK protein
SP0519 dnaJ 3.1 0.0012 DnaJ protein
SP0875 lacR 2.1 0.0001 Lactose phosphotransferase system 
repressor
SP0876 2.6 0.0001 1 -PhosphoRuctokinase, putative
SP0877 2.7 0.0004 PTS system, fructose specific 11 ABC 
components
SP1715 2.3 0.0001 ABC transporter, ATP-binding protein
SP1883 dexS 2.0 0.0005 Dextran glucosidase DexS, putative
SP1884 2.7 0.0001 PTS system, 11 ABC components
SP1906 groEL 2.7 0.0001 Chaperonin, 60 kDa
SP2030 recP 2.0 0.0003 Transketolase
SP2055 2.5 0.0001 Alcohol dehydrogenase, zinc-containing
SP2206 yfiA 2.0 0.0008 Ribosomal subunit interface protein
SP2216 usp45 2.2 0.0281 Secreted 45 kDa protein
SP0044 purC 2.9 0.0001 Phosphoribosylaminoimidazole- 
succinocarboxamide synthase
SP0045 3.1 0.0000 Phosphoribosylformylglycinamidine 
synthase, putative
SP0046 pur F 2.1 0.0003 Amidophosphoribosyltransferase
SP0047 purM 2.1 0.0002 Phosphoribosylformylglycinamide
cyclo-ligase
SP0050 purH 2.0 0.0000 Phosphoribosylaminoimidazolecarboxa 
mide formyltransferase/lMP 
cyclohydrolase
SP0095 2.1 0.0019 Conserved hypothetical protein
This microarray analysis also confirmed no polar effect of htrA mutation occurred on the 
downstream gene spoJ. Analysis of data revealed sp o j average expression level of 2.6345 
(normalized intensity) in the TIGR4 wild type and 3.1635 in the TIGR4A/i^rrt mutant. This 
slight difference in the expression level of spoJ in both strains was not statistically 
significant. This obseiwation mles out the possibility of the polar effect of the mutation 
highlighted by Lyon and co-workers (Lyon and Caparon, 2004) who observed that deletion
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of htrA of Streptococcus pyogenes did not result in attenuation in a murine model of 
subcutaneous infection contradicting what Jones and colleagues have reported about the 
insertional mutagenesis of htrA of the same organism (Jones et al., 2001).
209
Chapter 6 Discussion
Proteomics & Microarray Discussion
HtrA protein contributes in a number of aspects to the biology and stress response of 
Streptococcus pneumoniae. This serine protease is implicated in the ability o f the 
pneumococcus to grow at higher temperatures, to resist oxidative stress and to take up 
exogenous DNA in the process of transformation. Moreover, deletion of htrA resulted in 
organisms much attenuated in virulence using animal models of infection (see chapter 4). 
However, the exact mechanism by which HtrA controls these processes is still unclear. The 
study presented in this chapter was designed to explore this mechanism by employing the 
powerful tools of proteomics and microarray to investigate the effect of HtrA on the 
expression of other proteins.
Proteomics analysis
The resolving power of two-dimensional polyacylamide gel electrophoresis facilitates the 
monitoring of expression of thousands of proteins simultaneously. In this study, the 
methodologies of proteomics were employed to investigate the effect of htrA inactivation 
on the differential expression of proteins by comparing the proteome of the wild type D39 
strain to that of D39AAW mutant strain. Identification of proteins by MALDI-TOF 
enabled the confirmation that the proteomic experiment was earned out properly. The 
spectinomycin adenyltransferase, which was used as an antibiotic resistance marker in the 
mutant, was only identified in the four gels corresponding to D39àhtrA mutant proteins but 
not in the wild type. However, the overall expression level of most of the identified 
proteins was found to be similar in the wild type and mutant organisms (table 6.1) due to 
differences between individual gels in the same group. Some of the identified proteins 
existed as isoforms, presumably due to deamination or phosphorylation or by modification 
with a group resulting in a shift of the pi toward the acidic range of the 2D map (Kilstrup 
et a l,  1997). Furihermore, due to time limitation, not all the protein spots showing 
differences were identified. This is why HtrA protein, for example, was not found among 
the identified proteins and also as expected from doing one experiment, no statistical 
analysis was properly carried out. Therefore, it should be noted that the results of this 
proteomic analysis are only preliminary and more experiments are needed to validate these 
data.
(I) Down-regulated proteins
The proteomic analysis presented here revealed that the most noticeably down-regulated 
proteins are those involved in the process of protein synthesis, namely 30S ribosomal 
protein SI, aminoacyl-tRNA synthetase (CysRS), and Elongation factor Tu. In bacteria,
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two RNA-protein subunits consisting of a small 3OS subunit and a large 50S subunit 
assemble around a mRNA template into a roughly spherical 70S particle that translates the 
nucleotide sequence into a polypeptide chain through repetitive, codon-dependent binding 
of aminoacylated tRNA. Translation of genetic information encoded by mRNA is the last 
step of the gene expression pathway. The essential components and principal steps of 
translation have been delineated tlirough genetic, biochemical, and kinetic methods (Wilson 
et a l,  2002). The synthesis of peptide bonds is done by the ribosome, which is constructed 
using three rRNAs and more than fifty ribosomal proteins in bacteria. Translation involves 
additional factors that play important role in each step, as represented by initiation, peptide 
elongation, tennination, and recycling of the ribosome. The process of polypeptide 
elongation has been most extensively characterized (Rodnina et a l, 2000). Gene 
expression is regulated at thi'ee steps, transcription, translation and post-translation. The 
critical regulation point in the translation process is initiation, during which the 30S 
ribosomal subunit binds to the Shine-Dalgarno (SD) sequence (Shine and Dalgamo, 1974) 
in the mRNA. Ribosomal protein SI is the largest protein of eubacterial ribosomes. It is an 
RNA-binding protein involved in retention of mRNA dining initiation of translation and, 
maybe, during elongation (Subramanian, 1983, Sorensen et a l,  1998).
Aminoacyl-tRNA synthetases play a critical role in protein biosynthesis, since they 
catalyze the accurate charging of a given set of tRNAs with the cognate amino acid. The 
insertion of cysteine into nascent peptides during protein synthesis is dependent on the 
interaction of cysteine codons with cysteinyl-tRNA (Cys-tRNA) in the ribosomal A site. 
The pneumococcal cysteinyl-tRNA synthetase (CysRS) was found in this analysis to be 
down regulated in the D39A/zW mutant. Disruption of the homologous gene cysS 
encoding CysRS of B. subtilis was found to be lethal for the cells, indicating that these 
genes code for essential and unique functions in these organisms (Gagnon et a l,  1994).
Elongation factor Tu (EF-Tu) (Krab and Parmeggiani, 1998) is a guanine nucleotide- 
binding protein responsible for the delivery of aminoacyl-tRNA (aa-tRNA) to the ribosome 
during the elongation phase of protein synthesis. EF-Tu belongs to a superfamily of 
regulatory GTP hydrolases (G proteins) that is implicated in the sorting and amplification 
of transmembrane signals and the direction of the synthesis and translocation of proteins 
(Sprang, 1997). A role of EF-Tu in attaclmient of lactobacilli to human cells was also 
reported. Granato and co-workers demonstrated an adhesin-like role of Lactobacillus 
johnsonii EF-Tu and showed that it is able to induce a pro-inflammatory response (Granato 
et a l, 2004). Work with E. colt elongation factors suggested that some of them possess 
chaperone properties in addition to their role in translation (Caldas et a l,  1998, Caldas et
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a l,  2000). Caldas et al have reported that the E. coli elongation factor EF-Tu increases the 
refolding of unfolded proteins in a manner similar to that of molecular chaperones, protects 
proteins against thennai dénaturation, and forms complexes with unfolded proteins. This 
report proposed that, in addition to its role in translational elongation, EF-Tu protein might 
help in protein folding and renaturation in the cytoplasm (Caldas et a l, 1998). In the 
present study, proteomic analysis revealed the down-regulation of EF-Tu in the ~D39EhtrA 
mutant. Giving the role of EF-Tu as a chaperone, it is sensible to postulate that the down- 
regulation of EF-Tu partly accounts for the accumulation of damaged proteins that results 
in the slower gi'owth of AhtrA mutant at elevated temperatures compared to the wild type.
(ii) Up-regulated proteins
SodA, PhtA, and DnaK were among the up-regulated proteins revealed by this proteomic 
analysis. Reactive oxygen intennediates, including superoxide anion ( O2 ), hydrogen 
peroxide (H2 O2), and hydroxyl radical ( OH"), have many deleterious effects on living 
organisms, ranging from DNA damage to peroxidation of membrane lipids (Uchida et a l,  
1965, Janssen et a l, 1993). Sources of reactive oxygen intermediates are abundant and 
include incomplete reduction of oxygen during respiration, exposure to radiation or to 
redox-active compounds, and the respiratory burst of phagocytes (Halliwell and Cutteridge, 
1990). In the presented proteomic study, the oxidative stress protein superoxide dismutase 
(SOD) was identified among proteins up regulated as a result of HtrA deletion. Superoxide 
dismutases (SODs) are metalloenzymes that catalyze the conversion of superoxide 
molecules to hydrogen peroxide and molecular oxygen and therefore form one of the cell’s 
major defence mechanisms against oxidative stress (McCord and Fridovich, 1969). 
Escherichia coli contains two highly homologous SODs, a manganese- and an iron- 
containing enzyme (Mn-SOD and Fe-SOD, respectively). In contrast, a single Mn-SOD is 
present in Bacillus subtilis. hi E. coli, the absence of SODs was found to be associated 
with an increased sensitivity to cadmium, nickel and cobalt ions. Mutants lacking either 
sodA or sodB exhibited metal resistance to levels comparable to that of the wild-type 
strain. On the other hand, in B. subtilis, the sodA mutation had no effect on cadmium and 
copper resistance (Geslin et a l, 2001). The htrA mutant studied here showed increased 
sensitivity to hydrogen peroxide but not to paraquat (see chapter 4) suggesting that SODs 
have no effect on the pneumococcal resistance to superoxide generated by paraquat.
Phagocytes undergo a sharp burst of oxygen consumption when engulfing bacteria. This 
oxygen is enzymatically reduced to toxic metabolites, which are essential to the 
bactericidal action of the cell. As well as being important in the detoxification of
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superoxide radicals during aerobic metabolism, SOD has also been shown to be a virulence 
factor for several pathogenic bacteria. Pesci and co-workers (Pesci et al. y 1994) reported 
that a sodB insertion mutation in Campylobacter jejuni caused a significant reduction in the 
ability o f the bacterium to invade an embryonic intestinal cell line. Inactivation of sodA in 
Yersinia enterocolitica resulted in a marked reduction in virulence of the organism in a 
mouse infection model after intravenous infection when compared to its parental strain 
(Roggenkamp et a l, 1997). More recently, it was reported that a superoxide dismutase 
mutant strain o f Neisseria meningitidis was less virulent in a mouse intraperitoneal 
infection model than the wild-type strain (Wilks et a l . y  1998). On the other hand, it should 
be noted that the role of superoxide dismutase is not the same in all microorganisms. A 
sodA deletion mutation o f Bordetella bronchiseptica and Bordetella pertussis did not affect 
the vimlence of these species in mice following intranasal infection (Graeff-Wohlleben et 
a l, 1997). SODs were reported to be a virulence factor in many other organisms, including 
Candida albicans (Hwang et a l, 2002), Vibrio shiloi (Banin et a l,  2003) and Leishmania 
(Ghosh et a l, 2003).
The pneumococcus is a facultative anaerobic bacterium that lacks catalase (Hardie, 1986). 
Thus, the absence of this enzyme suggests that superoxide dismutase may play a critical 
role in response to oxidative stress, affecting both the survival and, consequently, the 
virulence of the organism. Yesilkaya and co-workers (Yesilkaya et a l, 2000) reported that 
a SodA mutant of the virulent type 2 strain D39 had a lower growth rate than the wild type 
and exhibited susceptibility to the redox-active compound, Paraquat. In vivo, mice infected 
with the SodA mutant had a longer median survival rate than those infected with the wild 
type. The growth of the mutant in the lungs and its appearance in the bloodstream were 
also delayed (Yesilkaya et a l, 2000). The up-regulation of superoxide dismutase revealed 
by the proteomic analysis in this study therefore suggests the mutant pneumococcal cells 
may respond to the loss of HtrA function by increasing the amount o f those proteins 
known to be involved in the resistance against oxidative stress to compensate for the 
absence of HtrA.
Among the up-regulated proteins is the pneumococcal histidine triad protein A (PhtA), also 
known as BVH-11 (Hamel et a l, 2004). This protein belongs to a family of analogous but 
separate proteins capable of eliciting protection against pneumococcal infections. The 
amino-acid sequences of these proteins contain three histidine triad motifs (HxxHxH). 
Within S. pneumoniae, there are four related pneumococcal histidine triad proteins (PhtA, 
PhtB, PhtD and PhtE). These proteins are approximately 800 amino acids in length and are 
highly conseiwed within this organism. They were selected as potential vaccine candidates
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based upon their possession of hydrophobic leader sequences, which presumably target 
these proteins to the bacterial cell surface (Inouye et a l, 1982, Munoa et a l, 1991). This 
family of protein antigens has been reported to elicit protection against certain 
pneumococcal capsular types in a mouse model of systemic disease (Adamou et a l, 2001). 
Another report (Wizemaim et a l, 2001) has shown that immunization using a fragment of 
PhtA (residues 18-230) protects mice from subsequent infection by several strains of S. 
pneumoniae (in contrast to other potential protein vaccines, which elicit a response but are 
strain-specific). The possible use of these proteins as vaccine components to control 
pneumococcal diseases has also been reported by Hamel and co-workers (Hamel et a l, 
2004). Recently, residues 18-230 of the PhtA was expressed, purified and X-ray- 
characterized (Riboldi-Tumiicliffe et a l, 2004a) but its actual frinction is currently 
unknown. It is proposed that these proteins play a role in metal or nucleoside binding on 
the cell surface but no reports confirm that at present. The question of a possible role for 
this family of proteins in the vimlence of the pneumococcus is also left unanswered. 
Adamou and co-workers have shown that sera from pneumococcal bacteremia patients 
recognize PhtA and PhtD, indicating that these proteins are exposed and recognized by the 
immune system during natural S. pneumoniae infection in humans (Adamou et a l, 2001). 
The up-regulation of proteins that are potential vaccine candidates such as PhtA in the htrA 
mutant reported here strengthens the idea of using these mutants as live vaccines as these 
proteins are exposed to the host immune system. This also signifies the role of proteomics 
and microanay approaches in providing information on the global changes in strains of 
particular interest.
As part of the major heat shock proteins (HSPs), DnaK. promotes proper folding and 
translocation of proteins (Craig et a l, 1993, Hendrick and Hartl, 1993). Heat shock of the 
pneumococcus has been found to induce the synthesis o f heat shock proteins. The major 
proteins induced by heat shock were 62, 72, and 84 kDa in size, identified subsequently as 
GroEL, DnaK, and ClpL, respectively (Choi et a l,  1999). The pneumococcal DnaK was 
cloned and characterized by Kim et al (Kim et a l, 1998). In E. coli, DnaK is part of a 
chaperone machine consisting of DnaK, DnaJ and nucleotide exchange factor, GrpE 
(Georgopoulos and Welch, 1993). The DnaK chaperone system functions mainly in the 
folding of nascent polypeptides and provides protection against aggregation during heat 
shock.
The major HSP, DnaK, is highly immunogenic in S. pneumoniae (Hamel et a l, 1997) and 
might be a good candidate as a vaccine (Kim et a l, 1998). The highly conseiwed and 
immunodominant antigenic nature of DnaK suggests that this protein may play some role
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in defense against pneiunococcal infection and pathogenesis. Since HSPs function as 
chaperones and promote renaturation of unfolded proteins (Hendrick and Hartl, 1993) and 
are induced during infection in a wide variety of bacterial pathogens (Buchmeier and 
Heffron, 1990, Dorman et a i, 1990, Fernandez et a l, 1996), survival in vivo could be 
enhanced by the stabilizing effect of HSPs on bacterial macromolecular complexes in 
hostile environments (Buclimeier and Heffran, 1990). Therefore, persistence of the HSPs 
upon return to normal conditions and induction of virulence proteins by heat shock might 
contribute to or enliance the virulence of the pneumococcus. The growth phenotype of htrA 
mutant at high temperatures, that the mutant cells eventually reached the same maximum 
OD as the wild type (see chapter 4), could therefore be explained by the up-regulation of 
DnaK, which helps refold damaged proteins resulting from heat stress.
Microarray analysis
Microarray is a powerful tool for the analysis of transcriptional changes in gene expression 
following different changes in the enviromnent. Recently, pneumococcal microaiTays have 
been used to measure transcriptional changes in vitro (Sebert et al., 2002, McCluskey et 
a l, 2004) and also in vivo, during invasive disease (Orihuela et a l, 2004). A simple 
analysis has been chosen here, due to time limitation, to get an idea about alterations in 
gene expression as a result of htrA deletion. The transcriptome of both the TIGR4 wild 
type and its htrA mutant grown to mid-log phase at 37 °C were compared. The mutation 
was confmned by the absence of HtrA transcripts. Lack of HtrA transcripts in the mutant 
was also confirmed by RT-PCR. Only three genes were down regulated, aliA, the gene for 
the amino acid ABC transporter (SP2141) and a hypothetical gene (SP0783) with unknown 
function. In addition, twenty more genes were up regulated (see below).
(i) Down-regulated genes
Streptococcus pneumoniae is an obligate parasite, which requires several amino acids for 
growth. Oligopeptide uptake mediated by the Ami ABC permease is therefore important 
for nutrition. AliA is an oligopeptide-binding lipoprotein, which is highly homologous to 
the characterized Ami A (Alloing et a l, 1994) and belongs to the ABC permease Ami- 
AliA/AliB (Alloing et a l,  1990). The Ami-AliA/AliB oligopeptide permease is involved in 
the uptake of nutrients from the environment and may also act as an environmental signal 
allowing the organism to adapt accordingly (Claverys et a l, 2000). Regarding the decrease 
in transfonnation efficiency of htrA mutants compared to wild types, microaiTay analysis 
did not reveal any down regulation in genes reported to be involved in competence, as
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expected for the stage of growth from which RNA was extracted. One possible way to 
address this would be investigating differential gene expression in the mutant and wild 
type in the presence of CSP to induce genes involved in competence. It has been proposed 
that Ami-AliA/AliB may be involved in triggering competence for genetic transformation 
(Claverys et a l, 2000). Mutations in genes encoding components of the Ami oligopeptide 
transporter have been found to affect competence development (Alloing et a l, 1994, 
Pearce et a l, 1994). As the htrA mutant was less easy to take up external DNA than the 
wild type, it is likely that the down-regulation of aliA could account for this decrease in 
genetic competence. Peptide permeases also modulate pneumococcal adherence to 
epithelial and endothelial cells either by acting as adhesins or by modulating the expression 
of adhesins on the pneumococcal surface (Cundell et a l, 1995b). Recently, KeiT and co­
workers have shown that although the Ami-AliA/AliB complex is not required for 
virulence during pneumococcal pneumonia, it does play a role in colonization of the 
nasopharynx (Kerr et a l, 2004). The number of aliA mutant organisms colonizing the 
nasopharynx of mice was significantly lower than that of the wild type organism 48 hours 
post challenge (Kerr et a l,  2004). Furthermore, in a microarray analysis o f pneumococcal 
gene expression during invasive disease, designed to identify site-specific patterns of 
expression for virulence factors and others, the gene for AliA was identified among the 
genes whose expression was enlianced during epithelial cell contacts (ECC). The level of 
aliA was 3.9-fold up regulated (Orihuela et a l, 2004). Presimiably, the genes whose 
expression is altered during invasive disease are those that are required by the bacteria for 
survival in the host (Hava et a l, 2003). Taken together, AliA is considered as a good 
candidate that could explain some of the phenotypes observed for the htrA mutant 
including competence and virulence and could be considered for future work investigating 
the role of HtrA.
(ii) Up-regulated genes
Analysis of microarray data also revealed the up-regulation of several genes. These include 
stress related genes encoding for DnaK and DnaJ that are involved in protein folding and 
stabilization in addition to the 60 IcDa chaperonin GroEL. As discussed for the DnaK (see 
proteomic analysis above), the products of these genes play a significant role in the folding 
of nascent protein chains during normal growth conditions and in the refolding of proteins 
after thermal damage. Furthermore, the DnaK-DnaJ-Gi-pE chaperone complex participates 
in ATP-dependent proteolysis in the cell. It is proposed that these genes have been 
expressed in response to accumulation of misfolded or aggregated proteins, which resulted 
from lack of HtrA in the pneumococcal mutant. DnaK was up regulated in both
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microaiTay and proteomic analyses. In addition, the gene for RecP was found to be up 
regulated. RecP belongs to a diverse transketolase family and is implicated in genetic 
recombination in the pneumococcus (Reizer et a l, 1993). RecP is involved only in the last 
step of DNA processing during transfonnation, i.e., recombination, because recP insertion 
and deletion mutants were not defective in binding, degradation, or uptake of donor DNA 
or in competence induction (Rhee and Morrison, 1988). Whether RecP is linked to the 
deficiency in DNA uptake observed for the tsktrA mutant is yet to be investigated.
Genes involved in purine nucleotide biosynthesis pathway, SP0045, SP0046 (purF), 
SP0047 (purM), and SP0050 (pur H) were up regulated. These genes may be organized as 
a single transcription unit in the clnomosome. They have been identified in the in vivo 
analysis of gene expression during invasive disease (Orihuela et a l, 2004). Their levels of 
expression were up regulated in the blood by, 6.1, 11.6, 8.4, and 10.3-fold, respectively 
(Orihuela et a l,  2004). Up regulation of these genes during bacteraemia indicates a role for 
the products of these genes in the pathogenicity of pneumococcal disease. Mutation in 
pur F  of Mycobacterium smegmatis resulted in impaired survival during oxygen-starved 
stationary phase (Keer et a l,  2001). Analysis of the genome of S. pneumoniae strain 
TIGR4, published at The histitute for Genomic Research at (http://www.tigr.org/), revealed 
an operon composed of a transcriptional regulator, lacR (SP0875), a phosphofructokinase 
(SP0876), and a fructose-specific ATP-binding cassette, ABC (SP0877). This operon was 
up-regulated in the AhtrA mutant. Expression of genes required for nutrient acquisition is 
likely to be tightly regulated. Infection at different sites of the host may necessitate that 
bacteria can make use of a range of carbohydrates depending on the availability and 
streptococci are laiown to display metabolic flexibility (Neijssel et a l, 1997). Insertional 
inactivation of the genes encoding the ABC transporter substrate-binding protein and the 
fmctosidase in the homologous operon of Lactobacillus acidophilus reduced the ability of 
the mutants to grow on fructo-oligosaccharides (Barrangou et a l,  2003).
Another upregulated gene is yfiA. The product of this gene is a ribosome-associated 
protein, YfiA, which is a cold shock protein in E. coli. Synthesis of Yfia and its subsequent 
binding to ribosomes were induced by a temperature decrease (Agafonov et a l, 2001). It 
blocks the binding of aminoacyl-tRNA to the ribosomal A site and therefore protein 
synthesis declines as the production of this protein is induced. This protein is also involved 
in sugar metabolism and mutational inactivation of the yfiA gene almost abolishes growth 
of subtilis in the minimal medium containing maltose (Yamamoto et a l, 2001a).
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The microarray data discussed above was derived from two array chips that used the same 
RNA preparation taken from a single time point during in vitro growth. Thus, before 
drawing any conclusions, the anay work needs to be repeated using different RNA 
preparations from bacteria gi'own to the same stage in identical growth conditions. 
MicroaiTay analysis of gene expression in vivo during infection is now feasible (Orihuela 
et al., 2004). It would be helpful, therefore, to study genes differentially expressed by htrA 
mutants at different infection sites. Studying the effect of an htrA deletion on gene 
expression in different strains is also required. This will, for example, confirm the 
proteomic data shown for D39 and also give an idea of the possible differences of the 
function of HtrA in different pneumococcal strains and serotypes. It should also be noted 
that altered expression of the genes discussed does not prove that HtrA directly regulates 
such genes. It is likely that some genes could be affected indirectly through other 
regulatory networks.
Summary
Studies presented here were designed to explore the mechanism by which HtrA exerts its 
functions in the biology and stress response of S. pneumoniae. These studies were done at 
the end of the project and are preliminary. The effect of htrA deletion on the expression of 
proteins was investigated using the powerful tools of proteomics and microarray. Analysis 
of htrA mutants by proteomics and microarray confimied the vivacity of the mutation. The 
spectinomycin marker was only identified in the mutant proteins (proteomics) and no 
effect of the mutation was observed on the expression of AW-downstream genes 
(microarray). Expression of proteins from a number of functional categories is modulated 
as a result of htrA loss of function. Some of these are stress response proteins while others 
are key components in central and intennediary metabolism. These approaches also 
revealed a number of targets for future gene inactivation or functional enzymology studies. 
These studies would further facilitate the assessment of their role in the stress response and 
any additional pleiotropic effects. However, the presented data are only in their infancy, 
they require validation by repeating some of the experiments and designing some more 
under different physiological conditions. Measuring differential gene expression after heat 
shock or oxidative stress would be examples of such experiments.
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Concluding remarks
Streptococcus pneumoniae is responsible for a large proportion of the bacterial disease 
involving the respiratory tract (acute otitis media, sinusitis, and pneumonia) as well as 
invasive infection (septicemia and meningitis) in humans. Colonization is the first step in 
the interaction between S. pneumoniae and its human host. Carriage of S. pneumoniae in 
the nasopharynx is conmion and typically asymptomatic, yet, in infants, the elderly, and 
persons with underlying medical conditions, the pneumococcus is a major cause of 
commmiity-acquired pneumonia, bacteraemia, and meningitis. The limited efficacy of the 
current vaccine and the increasing emergence of antibiotic-resistant strains have urged the 
exploration as to how the pneumococcus cause such life-tlireatening diseases in an attempt 
to identify novel vaccine candidates and antimicrobial agents. Although the pneumococcus 
has been studied for over a century, an understanding of the mechanisms that underlie the 
course of disease remains fragmented. This work, therefore, was aimed to hopefully 
contribute to our understanding of such mechanisms.
Bacterial entry into the host organism involves significant enviroimiental changes, which 
are expected to induce the regulation of heat shock genes. Indeed, some of the heat shock 
proteins (HSPs) are themselves virulence factors while others affect pathogenesis 
indirectly, by increasing bacterial resistance to host defences or regulating virulence genes. 
This thesis was concerned with the evaluation of the role of some proteins involved in the 
pneumococcual defence against different stress conditions. To study the contribution of 
these proteins to the stress response, this thesis has made use of the available complete 
pneumococcal genome sequence and the current molecular biology techniques used for 
introducing mutations in individual genes to construct isogenic mutants in which one of 
these HSPs is deleted. The phenotypes of mutants were compared to the wild types in vitro 
as well as in murine models of pneumococcal disease.
Cip ATP-dependent proteases are involved in regulation by proteolysis in several bacteria 
and consist of a proteolytic subunit, ClpP, on which substrate specificity is conferred 
through association with ATPase subunits (ClpA, ClpC, and ClpX), which include 
members of the ubiquitous HsplOO family. In this thesis, the role of ClpC and ClpP in the 
stress response o f S. pneumoniae was investigated. ClpC has been identified previously as 
a virulence factor of the pneumococcus in a signature-tagged mutagenesis screen. In a 
previous report, ClpC was shown to play a role in thermal tolerance, control of autolysis 
and chain formation in the pneumococcus. Moreover, this report has also shown that ClpC 
plays a key role in processes related to virulence including adherence to human cells and 
production of Icnown virulence factors such as pneumolysin, LytA, CbpA and other choline 
binding proteins. However, other reports did not confirm a role of ClpC in these processes.
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Although this thesis did not resolve the controversy over the role of ClpC, it does report 
some interesting findings on the contribution of ClpC to different processes particularly 
auto lysis and in vivo bacterial growth. Among all the AclpC mutants studied, AclpC 
mutants of the serotype 2 strain D39 showed a decreased autolysis rate after stationary 
phase of growth or under exposure to antibiotics. The mutants of both virulent and 
avimlent strains of D39 maintained viability after stationary phase both at optimal and 
elevated temperatures. Moreover, cell separation in these mutants was altered and the 
organisms grew in long chains of bacterial cells. This decrease in autolysis rate suggested 
impairment in the role of the major pneumococcal amidase responsible for cell separation 
and autolysis, LytA. Investigation by Western blotting of the amount o f LytA produced 
and released by the mutant strains revealed that LytA was not released to the culture 
supernatant while it was detected, as expected, in the culture supernatant of the wild type. 
In addition, the quantity of released pneumolysin was less in the AclpC mutant than in the 
wild type. Thus it is likely that ClpC is involved in the control of auto lytic process and in 
the release of pneumococcal virulence factors. The autolysis phenotype of D39Ac^C 
mutants was not observed for AclpC mutants of the other strains tested suggesting a 
difference in ClpC function between different pneumococcal strains and serotypes. The 
contribution of ClpC to other stresses such as acid stress and oxidative stress was also 
studied. It appears that ClpC plays no role in the pneumococcal response to these stresses.
Analysis of AclpC mutants in vivo using pneumonia and bacteraemia models of disease 
revealed that ClpC has no effect on the overall outcome of pneumococcal disease. Mice 
infected with either the wild type or the mutant strains succumbed to the infection at 
similar rates. However, the growth of the pneumococcus in the lungs and blood following 
intranasal infection was dependent on ClpC. Numbers of AclpC mutant organisms 
recovered from lungs were significantly lower than that of the wild type at different time 
points after infection. Appearance of bacteria in the bloodstream following intranasal 
challenge was similar for wild type and AclpC mutant in that bacteria appeared in the 
bloodstream at a similar time and grew to a similar level by 24 hours. However, the wild 
type bacteria then continued to grow dramatically whereas numbers of the mutant were 
reduced to levels similar to that of time zero. Although the event triggered by the 
pneumococcus that results in death of mice in the Ac/pC-infected group is not known, the 
effect of clpC deletion on in vivo bacteriology seems to be dramatic.
This thesis confnms the contribution of ClpP to the stress response of S. pneumoniae 
reported previously for some strains and also reports a role of ClpP in other strains that has
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not been reported before. ClpP is necessary for the growth of both serotype 2 (D39) and 
serotype 4 (TIGR4) strains of the pneumococcus at elevated temperatures (40 °C). ClpP is 
also required for the growth of D39 at a lower temperature (30 °C) but not for TIGR4. The 
requirement of ClpP for the smwival of pneumococcal strains under heat shock highlights 
strain differences in the role of these molecules. Data presented in this thesis also confirm 
the involvement of ClpP in the resistance of S. pneumoniae strain D39 to oxidative stress.
ClpP is also involved in the pneumococcal virulence. The virulence of the D?>9àclpP 
mutant was completely abolished in a pneumonia model of infection while it was reduced 
in TIGR4 t^clpP mutant compared to its TIGR4 wild type when judged by smwival of 
mice. Moreover, the bacterial counts of D39Ac/pP in the lungs and blood of infected mice
' :s
were significantly lower than that of D39 wild type suggesting a role of ClpP in favouring y 
survival of the pneumococcus in the host organism.
As an example of the ATP-independent proteases, the role of the high temperature 
requirement A pro tease, HtrA, was also investigated in different genetic backgrounds. The 
HtrA family of stress response proteins play fundamental roles in protecting bacteria 
against stresses posed by temperature, peroxide and others. This thesis reports that HtrA is 
a major virulence factor of the pneumococcus. Deletion of the gene for HtrA resulted in 
organisms that were more sensitive to heat and oxidative stresses. The effect of HtrA loss 
of function on the growth at elevated temperatures was different from that reported for 
other organisms in that it does not prevent growth completely but rather slows it. In 
addition, HtrA was found to provide resistance to hydrogen peroxide but not to superoxide. 
Production of reactive oxygen species (ROS) is considered an important feature of 
intracellular bactericidal mechanisms in phagocytes. To prevent oxidative damage, bacteria 
have evolved adaptive responses that result in the expression of numerous genes in 
response to the stresses exerted by the ROS. These adaptations include production of stress 
proteins such as HtrA. This thesis also reports that HtrA is involved in the ability o f S. 
pneumoniae to take up exogenous DNA in the process of genetic transformation.
Mirroring the in vitro phenotypes, I\htrA mutants were unable to cause disease in animal 
models of infection. The virulence of the type 2 mutant strain was completely abolished 
while that of the type 4 mutant was dramatically reduced. The àJitrA mutants were cleared 
rapidly from the lung aiiivays and lung tissues and failed to gain access to the bloodstream 
following intranasal infection. In addition, mutants were unable to cause disease when 
injected directly into blood. Thus the IS.htrA mutants neither caused pneumonia nor 
bacteraemia. Furthemiore, the immune response to mutant organisms was altered
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compared to that of the wild type as measured by levels of IL-6 and TNF-a as well as by 
tissue histology. The pneumococcal htrA mutant is therefore potentially suitable as a live 
vaccine and could also be used as a delivery system for several antigens.
Another interesting finding on the role of HtrA is its relation with the two-component 
system CiaR/H, which is involved in controlling the levels of HtrA within the cell. This 
thesis shows that up-regulation of HtrA in response to heat is dependent on the CiaR/H 
system. Moreover, most of the phenotypes observed for the CiaR-null mutant could be 
reverted by complementation with HtrA. Thus, the decreased autolysis, the increased 
sensitivity to peroxide and the attenuation in virulence of the D39Ac/ai? strain can all be 
explained by alterations in the levels of HtrA.
The interesting findings on HtrA encouraged further investigations using proteomics and 
microarray technologies to get an idea as to how HtrA is involved in these processes. New 
developments in the RNA analysis teclnhques now enable a comprehensive view on the 
bacterial physiology. Transcriptome analyses in combination with high resolution two- 
dimensional polyacrylamide gel electrophoresis (2D-PAGE) and mass spectrometry have 
been extensively applied for the description of general and specific stress and starvation 
responses of Escherichia coli and Bacillus subtilis. This thesis reports a number of 
genes/proteins that differentially expressed as a result of htrA deletion. However, more 
work is needed to validate these data.
To conclude, this thesis has shed some light on the role of some stress proteins in the 
pneumococcal biology and pathogenesis. It also showed that it is important to study the 
role of proteins and other molecules of interest in different strains and serotypes, as it could 
be misleading to draw a conclusion based on a study of a single serotype. As HtrA looks 
promising based on the findings in this thesis, future work could involve the production of 
recombinant HtrA. Access to the purified protein will enable the study of the properties of 
this enzyme as well as the assessment of its immunogenicity and a possible use of it in a 
vaccine formulation.
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Future work
1. Site-directed mutagenesis could be used to mutate the active site of HtrA and the 
protease and chaperone activities of all mutant proteins and wild type HtrA 
compared in vitro.
2. Effect of these mutations on the virulence of the pneumococcus in vivo could be 
investigated to find out what activity (proteolytic or chaperoning) of HtrA is 
essential for virulence.
3. The protective effects of the pmified proteins can be studied in vivo by vaccination. 
htrA mutants can also be tested as live vaccines.
4. Purified wild type HtrA can be crystallized and its structure determined.
5. Effect of HtrA on gene expression following exposure to hydrogen peroxide and 
other stress-inducing conditions could also be studied using microaiTays.
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A1. PCR-Scrlpt Plasmid
fl (+) origin 135-441
|}>galoc1osidase n-frogmonl 4 6 0 -8 16
multiple cloning site 6 5 3 -7 6 0
Joe promoter 8 1 7 -9 3 8
pUC origin 1158-1825
ompicillin resistance (bJo) ORF 1978-2833
__________________________________________________Appendix
TM
ori
JacZ’o m p ic i l l in
-Kpn I
iCS
'-'Sac I
pPCR-Script Am p SK( +
3 .0  kb
P l o c
pPCR-Script A m p SK(+) M ultiple C lon ing  Site Region
(sequence sltown 598-826) A p o i
EcoOl 0 9 1
BssH II __________ T 7 P r o m o te r ___________^  1 ^ 1  Dro II
TTQTAAAACGACQQCCAGTQAQCGCQCGTAATACGACTCACTATAGQQCGAATTGGGTACCGGGCCCCCC.. .
M l 3 2 0  pnm ar binding site T7 prim ar  binding site ^ ,
6 w l 0 6 1  ,
Xho I Acc l/> lincll/Sol I C lo l  Mind III EcoRV E œ R I Psi I Smo I BomH I Smo I 
I I  I I I I I I I I I I
. . . CTCGAOOTCQACGGTATCGATAAGCTTGATATCOAATTCCTGCAGCCCGGOGGATCCGCCCteGCTAGA.. 
KS prinw r b in d n g  lit*
N o t lE o g l  folX l |  S o c I  ^  T3 P r o m o te r  B iiH  II
. ■ . GCGOCCGCCACCGCGGTGGAOCTCCAGCTTTTGTTCCCTTTAGTQAOGGTTAATTQCGCGC■ ..
T3 prinwr b inding lit*
^ h -g g l  o - t r o o i m n t  ^
. . . TTGGCGTAATÇATGGTCATAGCTQTTTCC
^  M 13 R svarie pnm er b inding lit*
PCR-Script^  ^ Amp cloning vector, adapted from Stratagene website at 
(http://www.stratagene.com).
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A2. The pAL2 plasmid used for expression of HtrA
Appendix
BamHIHindlll EcoRI
luxA
Em-R
Panii hixB
luxC
12,472 bp
luxD
Htudlll '
pi 5A ori liixE
Cra-R
EcoRl
S c h e m a t ic  d ia g ra m  s h o w in g  th e  o r ig in a l pA L2 p la s m id  u s e d  fo r  c o n s t r u c t io n  o f  
pA L 2-H trA  p la s m id ,  w h ic h  w a s  u s e d  fo r  e x p r e s s io n  o f  htrA g e n e  in  th e  
p n e u m o c o c c u s .  A rro w s  in d ic a te  th e  lo c a t io n s  a n d  o r ie n ta t io n  o f  o p e n  re a d in g  
f ra m e s .  E m -R , e ry th ro m y c in  r e s i s t a n c e  g e n e ;  C m -R , c h lo ra m p h e n ic o l  r e s i s t a n c e  
g e n e .  A d a p te d  f ro m  (B e a rd  e t al., 2002).
A3. Common solutions and buffers
Genomic DNA extraction buffer
10 mM Tris, pH 8.0
100 mM EDTA (Fischer Scientific, UK), pH 8.0 
0.5 % SDS (w/vol) (Fischer Scientific, UK)
DNA loading buffer (6X)
0.25 % Bromophenol blue (Sigma-Aldrich, UK) 
0.25 % Xylene cyanol FF 
40 % (w/vol) Sucrose in dHaO
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Agarose (1 %)
1 g agarose (GibcoBRL)
100 ml of TAB buffer
Dissolve and add 0.5 jug/ml ethidium bromide (Sigma-Aldrich, UK)
Protein gel running buffer (IX)
25 mM Tris base (Sigma-Aldrich, UK)
192 mM glycine 
0.1 % SDS 
ILdHzO
Protein separating gel (for two gels)
4.05 ml dHzO
2.5 ml of 1.5 M Tris HCl, pH 8.8 
100 ^1 of 10%  SDS
3.30 ml of 30 % acrylamide bis
50 [al of ammonium persulphate (APS)
5 pi of TEMED
Protein stacking gel (for two gels)
3.05 ml dHzO
1.25 ml of 1.5 M Tris HCl, pH 6.8
50 pi o flO % S D S
665 pi of 30 % acrylamide bis
25 pi of ammonium persulphate (APS)
5 pi of TEMED
Protein gel loading (sample) buffer
60 mM Tris HCl, pH 6.8 
25 % glycerol
2 % SDS
14.4 mM 2-mercaptoethanol 
0.1 % bromophenol blue
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Coomassie stain
Dissolve 250 mg of Coomassie blue R250 (Sigma-Aldrich, UK) in 100 ml ethanol: dH20 
(1:1 vol/vol). Add 50 ml of acetic acid: dH20 (1:1 vol/vol). Filter through a whatman No. 
1 filter paper
Destain solution for SDS-PAGE
40 % methanol 
10 % acetic acid 
50 % dHsO
Transfer buffer (Western blot)
25 mM Tris base 
192 mM glycine 
20 % vol/vol methanol
Tris NaCl, pH 7.4 (Western blot)
1.2 g Tris base 
8.7 g NaCl 
800 pi conc. HCl 
Make to IL with dH20
Developer (Western blot)
Dissolve 30 mg of 4-chloro-1 -naphthol (Sigma-Aldrich, UK) in 10 ml methanol. Add to 
50 ml Tris NaCl, pH 7.4. Add 30 pi of 30 % (vol/vol) H2O2 just prior to use
PBS, pH 7.4
Dissolve one tablet of phosphate buffered saline (Dulbecco A, Oxoid Ltd, Basingstoke) in 
100 ml of dH2 0  and autoclave
BHI medium contents, g/L (Oxoid)
Calf brain infusion solids (12.5), beef heart infusion solids (5.0), protease peptone (10), 
glucose (2.0), NaCl (5.0), disodium phosphate (2.5)
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CAT medium
10 g o f bactocasitone or bacto-casmino acid 
1 g of yeast extract 
5 g of tryptone 
5 g of NaCl 
ILofdH zO
Formal saline
3.06 g NaH2P0 4  anliydrous
6.70 g Na2HP0 4  anliydrous
100 ml Formaldehyde
9 g NaCl, Made up to 1 litre with dH20
IL-6 ELISA coating buffer
0.1 M Na2HP0 4 , adjust pH to 9.0 with 0.1 M NaH2P0 4
IL-6 ELISA blocking buffer
PBS with 10% PCS (vol/vol)
IL-6 ELISA standard diluent
PBS with 10% PCS (vol/vol) and 0.25% Tween-20 (Polyoxyethylene sorbitol 
monolaurate)
IL-6 ELISA substrate
Sufficient substrate for one plate is obtained by mixing 10 ml of solution A with 100 fxl of 
solution B and adding 4 ]x\ of H2O2
(A) 1.36 g Sodium acetate in 100 ml dli20, pH adjusted to 5.5 with citric acid
(B) 6 mg Tetramethylbenzidine (TMB) in 1 ml DMSO
TNF-a coating buffer
11.8 g Na2HP0 4  
16.1 g NaH2P04
Dissolve in 1 L dH20, adjust pH to 6.5 (use in 7 days)
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TNF-a wash buffer
25 |il of Tween-20 
500 ml of PBS
TNF-a assay diluent
31.5 mi of PBS
3.5 ml ofFBS
Use in 3 days, require 35 ml per plate.
TNF-a substrate solution
Equal volumes of tetramethylbenzidine (TMB) and hydrogen peroxide (solutions A and B 
of the Pharmingen OptEIA mouse TNF set, cat. 555268). Mix just prior to use. 10 ml per 
plate.
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